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by Siwen Wang 
 




The end of the human chromosome is protected by telomeres which contain a 
special tandem guanine-rich DNA sequence, 5’-TTAGGG. The length of telomeres is 
shortened during cell replications, and its length limits the replication capacity of cells. 
Telomerase is over-expressed in 85–90% of cancer cells, responsible for extending the 
telomere length in cancer cells. Guanine-rich DNA sequence can self-assemble into 
unique G-quadruplex structures that interfere with the extension of telomeres by 
telomerase. Therefore, DNA G-quadruplex has recently received much attention because 
of its important regulatory functions in telomerase-mediated cancerization. The formation 
of G-quadruplex requires monovalent cations (Na+ and K+) or small molecules known as 
G-quadruplex ligands. In the present work, we developed a serial of G-quadruplex 
ligands by tethering side-chains to two core structures: 1,10-phenanthroline (Phen) and 
thiazole orange (TO). Biophysical studies including DNA thermal denaturation monitored 
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by fluorescence orcircular dichroism, fluorometric titration, and ESI-MS spectrometry 
reveal that the binding of the synthesized ligands to G-quadruplex is side-chain 
dependent. The arylsulfanyl side chains significantly improve the binding affinity and 
selectivity of 1,10-phenanthroline towards G-quadruplex over duplex DNA. The 
polyamine side chains are a suitable structural motif for remarkable G-quadruplex 
binding affinity based on the results from both Phen and TO derivatives. These ligands 
greatly inhibit the telomerase activity in vitro, determined by a modified telomeric repeat 
amplification protocol (TRAP) assay. Amongst these promising telomerase inhibitors, a 
thiazole orange derivative containing a side chain of spermine shows an outstanding 
telomerase inhibition effect at nanomolar concentrations, which is comparable to the 
most effective synthetic telomerase inhibitors, BRACO-19.    
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PCR Polymerase chain reaction 
Py Pyrrole 
Phen Phenanthroline  




TFO Triplex forming oligonucleotide 
TRAP Telomeric repeat amplification protocol 
TO Thiazole orange 





Chapter 1. Introduction to DNA 
 
1.1. DNA Basics  
1.1.1. Central dogma. DNA occupies an essential position in the biological 
system, which is described by Francis Crick using the central dogma of molecular 
biology (Figure 1-1. solid and dotted arrows).1 This scheme implies the general flows of 
genetic information, which is transcribed from DNA into RNA and ultimately translated 
into protein.  
 
 
Figure 1-1. The Central dogma of molecular biology.2
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Genetic characteristics are stored in DNA as linear codes composed of nucleotide 
monomers in the chromosome. During self-replication process, DNA polymerase is 
employed to synthesize daughter sequences by adding nucleotides that are 
complementary to the DNA template. This process yields identical copies of the DNA 
which are passed down into descendent cells after cell division. High fidelity of DNA 
self-replication is the basis of biological inheritance. Transcription and translation are 
spatially and temporally separated in eukaryotic cells. Transcription occurs in the 
nucleus, and one of the DNA strands (non-coding strand with anticodon) is used as a 
template to produce mRNA by RNA polymerase. The pre-mRNA is processed to produce 
the mature mRNA, which is transported into the cytoplasm. Because of the absence of the 
nucleus, prokaryotic cells immediately translate their transcripts while the mRNA is still 
being synthesized. In the translation process, mRNA is decoded in ribosome by inducing 
the binding of complementary tRNA anticodon sequences to mRNA codons. The tRNA 
carries specific amino acids that are coupled together into a polypeptide. The polypeptide 
later folds into an active protein and performs its functions. 
Other than above general genetic information flows (solid arrows in Figure 1-1), 
Crick also included several special routes (dotted arrows in Figure 1-1) in the original 
central dogma. The discovery of reverse transcriptase in some retroviruses proved that 
RNA could make modifications to DNA.3 Telomerase is another case that RNA is used as 
a template to synthesize DNA which plays an important role in cell aging and cancer 
development.4 Most viruses have RNA genomes that are replicated and transcribed by 
RNA polymerases which provides another special case in which RNA could be 
synthesized from an RNA template.5 The direct synthesis of protein from DNA templates 
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has not been discovered so far in vivo, but has been observed under certain suitable 
conditions in vitro.6  
After decades of studies, an additional genetic flow is characterized which was 
unknown when the original central dogma was conjured. The recent studies of the 
behaviors of prions illustrated an information feedback flow from protein to the genome 
(dashed arrow in Figure 1-1). As a part of the epigenetic process, environmental stress 
resistant phenotype was coded into DNA to become genotype through protein 
conformational changes. This observation has been found to be intrinsically stochastic, 
nevertheless, important in evolution because of the look-ahead effect.7-8 
Above all, the seven general and specific genetic information flows constitute the 
comprehensive central dogma which captures the upstream role of DNA in molecular 
biology.  
1.1.2. The history of DNA discovery. DNA was first discovered by Friedrich 
Miescher in 1868, who was dedicated to identifying the fundamental components of cells. 
In his experiments, Miescher isolated an unknown substance from leukocytes and sperm 
which was distinct from protein and lipid: It was resistant to protease, containing 
phosphorous but not sulphur, and it could be stained by alkali dyes. This molecule was 
named as nuclein because of its abundance in nuclei. It was also presumed by Miescher 
that nuclein might have a role in the passing of hereditary traits because it was rich in 
sperm cells. However, what could not be rationalized, at that time, is that how the same 
substance could result in the diversity of different animal species.9 
In the 1880s, Albrecht Kossel (awarded the Nobel Prize in 1910) and Richard 
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Altmann developed new protocols that permitted them to isolate pure nucleic acids and 
enabled them to analyze its detailed chemical compositions. Kossel identified the 
fundamental building blocks of nuclein—the purine and pyrimidine bases, sugar, and 
phosphoric acid in 1901 and altered the designation "nuclein" to "nucleic acid".10 DNA 
and RNA were named as "thymus nucleic acid" and "yeast nucleic acid" after their 
isolation sources.  
Protein but not nucleic acid was considered as the chemical basis for heritable 
transformations until 1943 proved by Oswald T. Avery. In his exquisite experiments, it 
was found that inert Streptococcus pneumoniae can only be transformed into lethal 
strains in the presence of DNA but not protein or carbohydrate. Avery stated that 
“Deoxyribonucleic acid plays a central role in determining specific characteristics in the 
course of reproduction".11 This discovery excited further research into the nature of DNA, 
including X-ray diffraction studies of its structure.  
Almost a decade passed before, in 1952, Rosalind Franklin photographed 
crystallized DNA fibers. She calculated the dimensions of the strands and also deduced 
that the phosphates were on the outside of what was probably a seemly helical structure.12 
In 1953, using the available X-ray data and model building, Francis Crick and James 
Watson (awarded the Nobel Prize in 1962) deciphered the double helical structure of 
DNA. They illustrated that DNA was comprised of paired sequences of complementary 
bases and, by the order of its bases, encodes the genes.13 
In the following years, the machinery of DNA self-replication, tRNA and mRNA 
were discovered.14-15 In 1964, Marshall Nirenberg (awarded the Nobel Prize in 1968) first 
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deciphered the bases in each codon which are used in protein synthesis.16 In 1977, 
Frederick Sanger (awarded the Nobel Prize in 1958 and 1980) developed rapid DNA 
sequencing techniques which dramatically advanced the gene mapping.17 In the next 
decades, gene started to be isolated and specific genes were found to be associated with 
diseases including Huntington's disease, breast and ovarian cancer.18-19 
In 1988, the National Research Council announced a program to map the human 
genome. The Human Genome Project was officially started in 1990 and completed in 
2003.20-21 Availability of genetic information in an enlarged scale makes understanding of 
genetic basis of complex human traits become practical.   
Throughout today, the understanding of DNA has been continuously developed. 
There have also been breakthroughs in the molecular biology and medical fields in which 
not only DNA, but also DNA-associated processes have become the targets for 
therapeutic applications.   
1.2. DNA Structures and Functions 
1.2.1. DNA structure basics. The functions of a molecule in the biological 
process are driven by its structures including covalent bonding and three-dimensional 
conformations. DNA is a polymer composed of four types of nucleotides linked by 
phosphodiester bonds in a specific order. DNA primary structure commonly refers to the 
linear nucleotides sequence, which is the most basic covalent construction of the 
molecule.  
The monomer of a nucleic acid sequence, which is a nucleotide, consists of three 
components: nucleobase, sugar, and phosphate. Based on their chemical structures, 
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nucleobases are classified into purines (Adenine and Guanine) and pyrimidines 
(Cytosine, Thymine, and Uracil). A, G, C, and T are the four nucleobases that form a 
conventional DNA sequence and U is only present in RNA (Figure 1-2). It is logically 
hypothesized that DNA is originated from RNA in the course of evolution, in which, U is 
methylated to T. One of the main reasons for this modification is to identify and repair the 
deamination of cytosine into uracil in DNA, which is a common spontaneous reaction. 
By utilizing T instead of U, in DNA, these deaminated C (U) can be differentiated from 
native T and repaired by corresponding enzymes to avoid any further lethal mutations.22   
In addition to these conventional nucleobases, there are some minor modified 
nucleobases, such as 7-methylguanine, Inosine, and 5-methylcytosine playing important 
roles in epigenetic genomes (Figure 1-2). 
 
 
Figure 1-2. The structures of nucleobases present in human genome. 
 
The nucleobase is connected to a pentose sugar which brings another significantly 
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different feature between DNA and RNA: β-D-ribofuranose for RNA and β-D-2'-
deoxyribofuranose for DNA. The 2'-OH in an RNA ribose can readily attack the 
phosphodiester bond and lead to strand breaks. Hence, ribose is replaced by deoxyribose 
in the process of evolution, which makes DNA more stable than RNA. The nucleobase is 
anchored to the C1' position of the sugar by a β-N-glycosidic bond at the N9 of purine 
and N1 of pyrimidine. The torsional angle of the C'1-N-glycosidic bond can adopt two 




Figure 1-3. The two conformations of N-glycosidic bonds. 
 
The sugar ring is not planar, and the sugar pucker is described as the relative 
positions of C2' and C3' atoms with respect to the C1'-O4'-C4' plane. The sugar can adopt 
either C2'-endo or C'3-endo conformation (Figure 1-4). The conformational features of 
base torsional angle and sugar pucker significantly contribute to the stability of different 






Figure 1-4. Conformations of deoxyribose sugar pucker. 
 
A phosphate group forms two ester bonds to connect the 5'-OH and 3'-OH of the 
adjacent sugars. The DNA backbone is constituted by these repetitive linking units of 
sugar-phosphate-sugar (Figure 1-5). The terminals of 5'-OH and 3'-OH endow a 




Figure 1-5. An example of the primary structure of DNA. 
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The linear sequence of DNA is the foundation of genetic information coding. This 
unique design of DNA primary structure makes compact information storage practical in 
the biological system. In order to carry out its other functions, including reading and 
replicating genetic information, DNA employs base pairings to form a duplex.   
1.2.2. DNA duplex. DNA adopts double strands (duplex) under most 
circumstances in living cells, with two strands progressing in opposite directions. When 
replication or transcription occurs, two strands are separated in certain regions, and the 
resulted single strands have to be stabilized by particular proteins.   
In 1953, James D. Watson and Francis H.C. Crick proposed a three-dimensional, 
right-handed double helical B-DNA model based on their analysis of a DNA fiber 
diffraction data. In this famous model, the bases from two single strands form specific 
base pairs through hydrogen bonds and form rungs of a DNA ladder.13 With this base-
pairing rule, one DNA strand is able to define the complementary one which enables it to 
replicate and transcribe. Figure 1-6 shows a detailed view of the Watson-Crick base pair. 
Hydrogen bonds form between the aligned donors (oxygen or nitrogen bonded to 
hydrogen) and the acceptors (oxygen or nitrogen). The G-C and A-T base paring system 
is used because it maximizes the number of hydrogen bonds and minimizes the torsional 
strains in the backbone.23 
Since the phosphate groups are densely negatively-charged, the DNA backbone is 
very polar. To stabilize the structure, DNA adopts a conformation in which the polar 
phosphate backbones helically coil and shield the hydrophobic nucleobases inside. Thus, 
the charge distribution can be optimized to reduce the repulsion. Meanwhile, the bases 
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can be well stacked on each other, so the aromatic stacking force will greatly contribute 
to the double helix stabilization. The negative charges on the phosphate backbones are 
very important for DNA stabilities, protecting the ester linkage from being attacked by 




Figure 1-6. Watson-Crick base pairing. 
 
When the two strands are coiled into a double helix, the phosphates form two 
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ridges, and the two edges of the base pairs form two grooves back to back (Figure 1-7). 
The edge composed of the C1' from two sugars, the N3 of purine, and the C2 of 
pyrimidine is located in the minor groove, while the other edge is located in the major 
groove (Figure 1-6). The features of the grooves vary in depth and width depending on 




Figure 1-7 DNA double helix and two grooves. 
 
More than one type of helix can be formed by DNA double strands (Figure 1-8), 
and their features are summarized in Table 1-1. B-form DNA helix is the predominant 
conformation under physiological conditions and was firstly characterized by Watson and 
Crick. B-form DNA adopts a right-handed (twisting direction follows the right-hand rule) 
helix with the C'2-endo sugar pucker and anti-N-glycosidic bonds. The minor groove is 
narrow in B-form DNA while the major groove wide, with nearly the same depth (Figure 
1-8).24 These two grooves create distinguishable microenvironments for protein and small 
molecule recognition.  
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Under different environmental conditions, such as ionic strength, temperature, 
humidity, and nucleotide composition, DNA can adopt several distinct helical 
conformations.25 Two of the most well studied: A- and Z-form DNA helix, will be 
discussed here.  
With relatively low hydration and low ionic strength, B-form DNA will transform 
into A-form. RNA-DNA hybrid and RNA double strands can also adopt A-form helical 
conformation.26-27 A-form DNA has the C3'-endo sugar pucker and tilted base-pairing 
which make it distinct from B-form. From the top view of an A-form helix, a large cavity 
can be observed located at the center because the coils are displaced away from the 
axis.28 As a result of the above features, the major groove in A-form DNA is narrow, and 
the minor groove is shallow and wide (Figure 1-8).  
 
 




Z-form DNA is usually observed in continuous pyrimidine-purine sequences in 
highly concentrated NaCl solutions in vitro ((CG)n in 3-4 M NaCl). It is utilized as a 
rotor in DNA origami because it adopts a left-handed helix.29 Z-form DNA has more base 
pairs in every helical turn and is longer than the other conformations. The major groove 
in Z-form DNA is wide and shallow, and the minor groove is deep. Because of the 
torsional conformation, the sugar pucker and N-glycosidic bond conformation in a Z-




Table 1-1. Summary and comparison of double-helical DNA structure parameters. 
 
Properties A-DNA B-DNA Z-DNA  
Helix sense Right-handed Right-handed Left-handed 
 
Helix diameter 26Å 20Å 18 Å 
 
Repeating unit 1bp 1bp 2bp 
 
Base pair/turn 10.7 10 12 
 
Degrees of 
inclination of base 
pair from normal 
to the helical axis 19 -1 -9 
 
Rise per base pair 2.3 Å 3.3-3.4 Å 3.8 Å 
 
Pitch per helical 











conformation Anti Anti 
Anti at cytosine, 
Syn at guanine 
 
Major groove Narrow and deep Wide and deep Flattened 
 
Minor groove Wide and shallow 
Narrow and 




1.2.3. DNA triplex. The conventional DNA helix is based upon Watson-Crick 
base pairs (G-C and A-T), which are the most thermodynamically stable base-pairing.30 
However, several alternative base pairs have been discovered with important roles in 
DNA higher order structures and functions. One of them was Hoogsteen base-pairing, 
named after the scientist who first characterized it.31 In Hoogsteen base pairs, the N7 of 
purines can accept hydrogens and form additional hydrogen bonds. The N3 of cytosine 
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can also be protonated under acidic conditions to become a hydrogen bond donor (Figure 
1-9). The formation of Hoogsteen base pairs constructs several alternative DNA 




Figure 1-9. Hoogsteen base pairs in DNA triplexes. 
 
The three-stranded polynucleotide was first observed by using X-ray diffraction in 
1957 by Felsenfeld, in which, a synthetic third strand poly(U) binds into the major groove 
of a poly(U)/poly(A) duplex.32 Two common triplets are A-T(U)-T(U) or G-C-C+ and C 
needs to be protonated in the latter under acidic conditions. In general, a triplex is formed 
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when a pyrimidine base binds onto the Hoogsteen position of an existing Watson-Crick 
base pair (Figure 1-10).  
 
               
Figure 1-10. DNA triplex.  
 
The Triplex Forming Oligonucleotide (TFO) sequence specifically occupies the 
major groove of a DNA duplex, which is also the binding site of most proteins and small 
molecules; therefore, the binding event could significantly affect the DNA replication and 
transcription process. Because of this, the formation of DNA triple has attracted many 
interests for potential applications in site-specific gene therapy. Since the formation of a 
triplet G-C-C+ requires an unusual acidic condition, the A-T(U)-T(U) motif becomes the 
more suitable choice for genome therapy applications.  
TFOs have been successfully used for site-directed mutagenesis.33-34 However, 
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there are many difficulties in the triplex-forming strategy in clinical applications. For 
instance, sufficiently long polypurine sequences, which are critical for the binding of 
TFO, is rarely present in human genome. In addition, delivery of exogenous 
polynucleotides into cells is always problematic because of the cellular uptake and 
biological stability.35  
1.2.4. DNA G-quadruplex. The basics of G-quadruplex structures. In addition 
to triplex DNA, DNA G-quadruplex (G4) is another alternative structure that can be 
formed through Hoogsteen hydrogen bonds. The self-assembly of guanines was first 
proposed by Gellert et al. in 1962 using X-ray diffraction from a concentrated GMP 
(guanosine monophosphate) solution, and guanine-rich sequences later was found in 
telomeric DNA and many gene promotor regions.36 Figure 1-11 shows the top view of a 
G-quartet, in which, four guanines self-assemble via Hoogsteen hydrogen bonds (N1-O6 
and N2-N7). The planar G-quartets stack on top of each other with a torsional angle, 
forming a four-stranded helical structure. Naturally, G-quadruplex was proved to be 
stabilized by monovalent cations such as K+ and Na+ sitting at the center of the G-
quartets. The important factors that contribute to the G-quadruplex formation are 




       
 
Figure 1-11. The top view of a DNA G-quartet (left) and a sketch of a G-quadruplex 
(right).  
 
Hydrogen bonding of G-quadruplex. There are six electronegative atoms present 
in a guanine, and four of them are open to hydrogen bond formation except for the N9 
(used in the N-glycosidic bond) and N3 (too close to the backbone). In canonical Watson-
Crick base pairs, the O6 (carbonyl oxygen) accepts hydrogen from the N4 of cytosine, 
while the N1 and N2 donate hydrogens to the N3 and O6 of cytosine. Noticeably, guanine 
is also able to accept hydrogen bonding with its N7 on the other side. When the 
hydrogens from the N1 and N2 (Watson-Crick side) are accepted by the O6 and N7 
(Hoogsteen side) of an adjacent guanine, Hoogsteen hydrogen bonds can form.37 The two 
sides of a guanine are shown in Figure 1-12. With four guanines, a cyclic planar structure 
can be constructed (Figure 1-11). It should be emphasized that the hydrogen bonds 
between guanines are not the most crucial factors in G-quadruplex stability, because the 
strand distortion greatly reduces the hydrogen bonding strength.38 G-quadruplex can be 
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formed even with less hydrogen bonds when guanine is substituted by other derivatives, 




Figure 1-12. Hoogsteen side and Watson-Crick side for guanine hydrogen bonding. 
 
Metal cation and guanine charge-charge interactions. In the absence of cations, 
G-quadruplex does not form unless specific stabilizing ligands are present. The central 
cavity of the G-quartet produces a space that a cation with a suitable size can fit in. The 
lone pair electrons of four O6 are coordinated by the cation to reduce the charge 
repulsion. Na+ with an ionic radius of 0.95 Å is reported as the maximum size of a cation 
that can fit into the G-quartets. Larger cation such as K+, with a radius 1.33 Å, therefore, 
is observed sitting between the two quartets and coordinated by eight oxygens (Figure 
1-13).38 Other cations such as NH4
+, Rb+, Ti+ and even some divalent cations such as 
Sr2+, Ba2+, and Pb2+ were also reported stabilizing G-quadruplex to some extent.40-44  
Cations also affect the G-quadruplex polymorphism. It was reported that G-rich 
sequences adopted different conformations in the presence of Na+, K+ and other cations. 
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For instance, a telomeric repeat sequence (GGGTTA)3GGG forms a parallel G-
quadruplex in K+ solution and mixed parallel-antiparallel conformation in the presence of 
Na+.45-47 Because of this feature, G-quadruplex is also developed as a highly sensitive 




Figure 1-13. G-quadruplexes with coordinated cations. (A) A parallel G-quadruplex with 
Na+ ions, (B) A parallel G-quadruplex with K+ ions.38  
 
Base stacking force of G-quadruplex. Like other canonical nucleic acid 
structures, the nucleobase π– π stacking is crucial to the formation of G-quadruplex. 
Individual G-quadruplex can stack on the others even without covalent bond linkage.36, 49-
50 Three common stacking geometries found in the G-quadruplex unit are shown in 
Figure 1-14.51 The orientation of G-quadruplex forming strands, and the glycosidic bond 
angle are the major factors affecting the stacking mode.  
Besides the above factors, G-quadruplex is also stabilized by super helical stress, 
molecular crowding, as well as particular G-quadruplex binding proteins and small 






Figure 1-14. Illustrative examples of base stacking mode in G-quadruplexes.51 
 
Topology of G-quadruplex. G-quadruplex can be formed through one, two or four 
G-rich strands. Each G-rich strand has specific direction defined by sugar-phosphate 
backbone from 5'-3'. The segment between G-tracts will form loops hanging outside the 
unit. Therefore, G-quadruplex can adopt various topologies, as the consequence of a wide 
variety of possible combinations of strand directions and loop sequences. The general 
structure can be described as a central unit of at least two stacked G-quartets, in which 
the G-rich sections are connected by loops of intervening nucleotides that are not 
involved in the quartets.  
According to their strand directions, the polymorphic G-quadruplexes are 
classified into parallel and antiparallel structures.53 When four G-rich strands are all in 
the same direction in a G-quadruplex unit, it is termed as a parallel G-quadruplex (Figure 
1-15A). Obviously, there is no need for a loop if it is formed by four disconnected 
sequences. If at least two of these adjacent G-strands are from the same sequence in 
parallel G-quadruplex, there will be loops left outside the unit connecting the top and 
bottom quartets. This type of connecting sequence (Figure 1-15B) is referred as a 
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propeller loop which is found in both telomeric and non-telomeric G-quadruplex.50, 54 
Guanine glycosidic bonds in parallel quadruplexes all adopt the anti-conformation 
(Figure 1-16A).  
 
 
Figure 1-15. Various topologies for G-quadruplexes. 
 
When at least one of the four strands adopt the different direction from the others, 
an antiparallel or mix-antiparallel G-quadruplex is formed (Figure 1-15C). Two distinct 
types of loops, in addition to the propeller loop, are discovered in antiparallel G-
quadruplexes. When two antiparallel strands from the same sequence are adjacent to each 
other, a lateral loop connects them (Figure 1-15D). When the antiparallel sequences are 
located in diagonally, a diagonal loop connects them crossing of the G-tetrads (Figure 
1-15E).50, 55-56 Antiparallel G-quadruplexes were found in both telomeric and non-
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telomeric G-quadruplexes.57-59 Antiparallel G-quadruplexes require both anti- and syn- 
guanine glycosidic bonds to maintain the particular conformation (Figure 1-16B).  
 
 
Figure 1-16. Glycosidic bonds conformations in various G-quadruplex topologies. Syn- 
guanines are shown in yellow and anti-guanines are in grey. 
 
Four grooves are formed in a G-quadruplex structure defined by the 
phosphodiester backbones and the features are depending on the particular topology. A G-
quadruplex with only lateral and diagonal loops has relatively simple groove features, 
while propeller loops in a parallel G-quadruplex may insert into the groove generating 
more complex features.  
As mentioned in the previous section, alkali cations stabilize G-quadruplex in the 
center channel of the G-quartets and consequently neutralize the negative charges from 
the O6 of guanine. K+ and Na+ induce different topologies in some of G-quadruplexes, 
but not necessary for all of them.47, 60  
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Biological relevance of G-quadruplex. By using sequencing methods, G-
quadruplex was found extensively present in the genome frequently coupled with 
important regulating functions such as telomere length maintenance and oncogene 
expression. 
More than 300,000 potential G-quadruplex forming sequences were discovered 
across the genome, by searching using a universal G-quadruplex forming motif 
represented by d(G3+N1–7G3+N1–7G3+N1–7G3+).
61 Many of them are highly conserved in 
both prokaryotic and eukaryotic organisms. These conserved regions are mostly present 
in mammalian species, followed by non-mammalian, and lower organisms. This 
observation indicates that the natural selection pressure tends to maintain G-quadruplex 
functions in the evolution process.62  
Most of the potential G-quadruplex formation sequences were found in telomeric 
regions where up to 15,000 bps of repeated TTAGGG units were discovered.63 The G-
quadruplex formation and stabilization in telomeric regions are crucial in regulation of 
telomere length maintenance and chromosome end protection.  
G-quadruplexes are also located in many oncogene promoter regions, such as 
MYC, JUNB, FGF4, and TERT, and regulate their transcriptions. Figure 1-17 shows a 
scheme of this regulation process. In a normal transcription process, an RNA polymerase 
binds onto the non-coding strand (with anticodons) of the DNA, and the generated RNA 
will have the same sequence as the coding strand (with codons). When G-quadruplex is 
present in the non-coding strand (S region), polymerase binding and the downstream 
RNA transcription are stopped at this position. Meanwhile, an unusual G-loop will be 
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induced on the complementary coding strand. RNA can be generated from this loop and 
form a stable co-transcription RNA/DNA hybrid. Consequentially, a strand exchange 
(recombination) can be introduced, which significantly changes the genetic 
information.63-65  
Because of its crucial functions in the biological process, a range of G4-targeting 
ligands have been synthesized in order to regulate the telomere stability and oncogene 
expression. It was reported that the expression of c-MYC in cancer cell lines was down-
regulated to 20% with a 48h G4 ligand TMPyP4 treatment in vivo.66 (Design of G4 




Figure 1-17. Structures formed upon replication and transcription of regions containing 
G-quadruplex motifs. 
 
It has been noticed that G-quadruplex can be both stabilized and destabilized in 
order to regulate the related biological process. During the replication and transcription, 
DNA single strands are exposed and may spontaneously form unnecessary G-
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quadruplexes. In most cases, G-quadruplex helicases (including BLM, WRN, FANCJ, 
and others) are employed to recognize and unwind these structures to maintain genetic 
stability.67-69 Deficiency of these enzymes leads to certain genetic diseases.70  
Telomere and the DNA end replication problem. Telomeres have the highest G-
quadruplex formation sequence abundance not only in the human genome but also other 
organisms.63 They are located at the end of chromosomes and protect them against 
genome instability.71 The functions and features of telomeres will be discussed in the 
following topics:  
Structure of telomeres. Human telomeres are composed of 9-15 kb double-
stranded TTAGGG repeats (different from TTGGGG in lower organisms) ending in a 50-
300 nt long 3' single-stranded repeats, termed as G-overhang, whose complementary C-
rich sequence is digested by a 5'-3' exonuclease.72 By folding back to the double strand 





Figure 1-18. The structures of telomeres and telomeric sheltering complexes.  
 
Functions of telomeres maintaining chromosome stability. Exposed DNA strand 
ends (both blunt and sticky ends) are very lethal to cells and are considered as damaged 
sites because they tend to fuse randomly. Therefore, a range of enzymes that detect, 
remove and repair the damage sites are utilized to protect the DNA. The ends of 
chromosomes, which are natural strand terminals, have to be protected from both the end 
fusion and being recognized by damage seeking enzymes. Therefore, telomeres are 
employed to form stable higher order structures and cap the end of chromosomes.  
As discussed before, the repetitive G-rich sequence in telomeres can form G-
quadruplex which will bring challenges for DNA recognition by enzymes and self-
replication. To stabilize these higher order structures, protect the telomeres from enzyme 
attacks, and also enable its replications, a complex containing six individual proteins is 
evolved (Figure 1-18). In this telomeric sheltering complex, TRF 1 and 2 are bound to 
double strands and POT 1 to G-overhangs which are bridged by TPP1 and TIN2. These 
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binding motifs play important roles in the telomere replication regulation, chromosome 
end protection, and telomere length maintaining.73-75 
Telomeres are crucial to the chromosome protection; however, they are truncated 
after each single replication because of the end replication problem: 
End replication problem. In 1960s, Leonard Hayflick discovered that normal 
human cells have limited capacity of cell division which is termed as 'Hayflick limit'. A 
decade later, Alexey M. Olovnikov firstly proposed the DNA end replication problem and 
gave the hypothesis of the resolutions which was later confirmed by the discoveries of 
telomeres and telomerase.76-77  
End replication problem comes from the natural features of DNA self-replication 
machinery. With a template, DNA polymerase replicates DNA only in 5' to 3' direction, 
starting from a free 3'-OH of existing DNA or RNA fragments (Figure 1-19). As 
discussed earlier, a DNA double helix has two single strands that proceed in two 
directions. DNA replication is semi-conservative in which the two strands have to be 
separated and replicated as the templates, respectively (in a zipper-like replication fork). 
DNA polymerase can only synthesize daughter DNA in 5' to 3' starting from a small piece 
of RNA primer that attached to the parent DNA. This process starts in 3'-5' parent strand 
(leading strand) and can proceed smoothly. However, on the other strand (lagging strand), 
which is in 5'-3', replication has to be performed by small discontinuous pieces starting 
from RNA primers. All the RNA primers will be removed after synthesis and the gaps 
will be filled by a DNA ligase. The leading strand can be replicated to the extreme end, 
but not the lagging strand. The RNA primer removed from the 5' end of the lagging 
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strand will leave a gap without available 3'-OH group. In consequence, there is always an 
un-replicated piece left on the 5' end of the daughter sequence and the DNA gets shorter 
and shorter during replications.  
Telomeres protect chromosomes by being buffer regions at the end. G-overhangs 
of telomeres are shortened during the replications, and the length is considered as a mark 
of DNA age. In somatic cells that without any telomere length maintenance pathway, a 
loss of 100-200 bp happens in one cell division. Therefore, these cells can only undergo 
certain times of telomere replications before they start to lose the protection functions.  
 
     
 




In yeast, short telomeres, derived from the end replication problem, directly lead 
to cell senescence.78 Mice with short telomeres were found with shorter life-span and 
fertility defections.79 In human, Dyskeratosis Congenita (DC) and Idiopathic Pulmonary 
Fibrosis (IPF) have been proved related to irregularly short telomeres.80-81 Even though 
short telomeres can lead to critical cell damages, human aging is still a complicated 
process that cannot be simply explained by telomere shortening as a single factor. Age 
limitation is a consequence of accumulated effects from many contributors including 
telomere length, oxidative stress, and DNA mutation damages.  
Telomerase. Since telomeres are progressively truncated and losing the protection 
functions during cell replications, certain strategies have to be utilized to maintain the 
telomere length by those 'immortal' cells, such as stem cells, germline cells, and cancer 
cells. Telomerase, a reverse transcriptase, is found overexpressed in these cells. It 
maintains telomere length by adding TTAGGG repeats onto the telomeric G-overhangs 
using its RNA element as the template.82 Telomerase was first isolated in 1984 by 
Elizabeth Blackburn from Tetrahymena pyriformis and later was reported to be found in 
most human cancer cell lines and nearly absent in normal somatic cells.77  
Telomerase structures and functions. Telomerase is a complex with RNA-
dependent DNA polymerase activities (reverse transcriptase). The minimal requirement 
for telomerase activity in vitro is having two subunits: the RNA template (hTERC) and 
the catalytic enzyme (hTERT) (Figure 1-20).83-84  
TERC, the RNA component of a telomerase, is used as the template for telomere 
extension. Human TERC (hTERC) is produced by RNA polymerase II and consists of 
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451 nucleotides, in which, nucleotides 46-53 are used as the true template of DNA 
synthesis. The minimum segment of an RNA template for telomerase activity contains 
nucleotides 10-159. The other domains form higher order structures to bind onto TERT 
but have no contribution to DNA synthesis.85 A particular secondary structure of TERC is 
highly conserved across a variety of mammalians (Figure 1-20).4, 82  
TERT, the catalytic component of the telomerase, contains a reverse transcriptase 
motif located at the C-terminus that is highly conserved across species including human, 
mice, yeast, worm and even plant. A telomerase-specific T motif is located next to the 
reverse transcript region and a large N-terminal region containing other functional 
domains is present at the other end.86-89 
The detailed step by step process of telomerase activity is still unclear so far. 
Generally, telomerase functions in a complex process including binding, synthesizing and 
relocating. Many telomerase-associated proteins such as Hsp90, p23, and TEP1 are 





Figure 1-20. Telomerase components.91 
 
Telomerase functions and cancer. The activity of telomerase is strictly regulated 
in normal somatic cells and appears at an extremely low level during most of the time and 
only kept active in some particular tissues including germline cells, stem cells, and some 
lymphocytes.92-93 The presence of high-level telomerase activity is consistent with the 
requirement of high proliferation capacities of the listed cells. Dysfunctions of telomerase 
or its related proteins in these cells lead to certain human genome diseases. 
Studies showed that introduction of active hTERT into normal somatic cells can 
help them bypass telomere shortening problem. These cells are enabled to unlimited 
capacity of replications to some extent, but cannot differentiate and functionalize in 
tissues, which is a remarkable feature of cancer cells.94-96 It is proposed that, when 
telomeres become too short, very rare telomerase-positive cells (1 in 10,000,000) can 
help themselves overcome the apoptosis machinery and become immortalized. This 
provides a possible explanation of cell cancerization, which is supported by the 
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observations that tumor cells have short telomere length compared to normal cells and 
show no net loss of telomere in cell divisions.97  
Today, nearly 90% of different types of tumors have been proved to have irregular 
telomerase activity compared to normal tissues. J.W. Shay and S. Bacchetti did a 
comprehensive survey on nearly all major types of cancer cells (Table 1-2).93 The striking 
connection between cancer and telomerase makes anti-telomerase a promising clinical 




Table 1-2. Telomerase activity detected in different type of cancer 
 
Type of cancer Telomerase positive tested 
Head and neck squamous cell carcinoma 
86% 
Non-small cell lung cancer 
78% 








































Squamous cell carcinoma 
83% 








Immune Response Vaccines. One of the telomerase-related strategies is using 
telomerase derived peptides or oligonucleotides as vaccines that will stimulate the 
patients’ immune response to telomerase-positive cancer cells. Many approaches and 
clinical trials have been performed and showed positive anticancer responses. There is no 
toxic effect has been reported against non-cancer cells so far, but it was observed that 
some cancer cells can bypass telomerase signaling and build up resistance. Further 
modifications on the telomerase-based vaccine and more clinical trials are being 
conducted.98  
Direct telomerase inhibitors. To today, millions of molecules have been designed 
and screened for directly telomerase targeting. However, there is no any sufficiently 
effective inhibitor getting into clinical trials. The most advanced inhibitor, BIBR 1532, 
only showed activity in certain model studies.  
Nucleotides based telomerase inhibitors. The other strategy is DNA-telomerase 
interactions based, in which, oligonucleotide-based analogs are designed to block the 
access of telomerase to telomeres. One of the most advanced binders is Imetelstat which 
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is a lapidated N3'-P5' thio-phosphoramidate oligonucleotide that binds in complementary 
fashion to template RNA. The phase II research of Imetelstat showed very positive results 
on myeloproliferative disorder, and it is under phase III safety evaluations so far.99 
However, Imetelstat only exhibits inhibition effects on limited types of cancer, which 
may be the consequence of known off-target effects of the lipid moiety.100  
 G-quadruplex telomere ligands. As discussed before, telomeres tend to form G-
quadruplexes under physical conditions and these higher order structures prevent the 
access of telomerase. Thus, a number of G-quadruplex ligands (G4 ligands) have been 
designed and synthesized. The most effective G4 ligand is the natural product 
telomestatin, which was proved to inhibit leukemia cells proliferation in vitro. The main 
challenge in this strategy is to improve the selectivity of the ligands against G-quadruplex 
over duplex DNA, which will be extensively discussed in chapter 2.  
Lastly, it is noteworthy that some cancer cell lines (~ 10%) utilize alternative 
lengthening telomere mechanism (ALT) in the absence of telomerase.101 ALT happens 
when a DNA template is annealed onto the telomere and new telomeric sequences can be 
simply primed and replicated from this point. This template DNA can be another 
telomere region sequence or some linear fragments from the outside of the 
chromosomes.102 Even though the natural coexistence of telomerase and ALT in human 
cancer cells has not been found yet, it is possible in genome engineered cells in vitro. 
Therefore, ALT has to be taken into considerations for telomerase-based therapies 




Chapter 2. Small Molecule-DNA Non-covalent Interactions 
 
The structural diversity of DNA provides numerous distinguished environments 
for protein and small molecule recognition. A wide variety of proteins are employed to 
regulate DNA related cellular processes including DNA packaging, replication and 
transcription through protein-DNA interactions. Histone, for instance, is an alkaline 
protein that forms complexes with duplex DNA so that DNA can be packaged into 
chromatins (Figure 2-1).  
 
 




In another case, telomere sheltering complexes bind onto DNA telomeric regions 
and regulates their extensions and replications (Figure 1-18). Other than proteins, small 
molecules exist naturally in cells interacting with DNA. Spermine, a polyamine 
compound, binds and stabilizes DNA by neutralizing the negatively charged phosphate 
backbones. All these discoveries enlightened an active research area of DNA related 
therapeutics, in which, molecules are designed to bind with certain DNA structures and 
consequently regulate some major disease progressions like cancer.  
DNA ligands interact with DNA through both covalent and non-covalent bonds. 
The first chemotherapy drug nitrogen mustard is a DNA covalent ligand that alkylates to 
the N-7 of guanine. The resulting interstrand cross-links inhibit DNA replications and 
transcriptions (Figure 2-2a). Cisplatin also uses the same mechanism of action by 
forming interstrand links between two guanines and thus inducing apoptosis (Figure 
2-2b). These alkylating agents have been widely used against cancer till today and 









However, because of their non-selective binding, DNA alkylating ligands have 
severe side-effects including anemia, nausea, ear damage, hair loss and dysgenesis.104-106 
Furthermore, more and more cancer patients have developed drug resistance after 
repeated treatments of these drugs.107 Therefore, the need for novel chemotherapeutic 
drugs with less side-effects never ends. In the recent years, small molecules that interact 
with DNA via non-covalent binding have attracted much attention. The characteristics of 
these molecules will be explicitly discussed in the following sections based on their 
binding target including duplex and G-quadruplex DNA. 1,10-phenanthroline, thiazole 
orange and their analogous as DNA ligands will also be discussed in the last two sections.   
2.1. Duplex Binding    
Duplex is the most prevalent DNA structure in living cells and is the presumed 
target of many small molecules in DNA recognition. Generally, small molecules bind to 
DNA via three interaction modes: Non-specific binding, base interaction, and groove 
binding. The binding mode is determined by many factors including the structures of 
small molecules, DNA sequences and the experimental conditions. The same ligand may 
have different binding modes in different DNA local environments, and sometimes 
multiple binding modes can co-exist.  
Apparently, small molecules that bind to duplex DNA sequence specifically can 
effectively regulate the desired replication and transcription processes. Meanwhile, it is 
always very important to study the binding selectively between duplex DNA and higher 
order DNA structures such as G-quadruplex when designing DNA ligands. Improving the 
selectivity is always the biggest challenge in this field.  
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2.1.1. Outside edge binding (nonspecific binding). The edges of a DNA duplex 
are composed of phosphate diester groups. Under physiological conditions, one negative 
charge is retained on each phosphate group and two are retained on the terminals. 
Through electrostatic interactions, monovalent and divalent cations including K+, Na+, or 
Mg2+, are condensed in both major and minor grooves under physical conditions. These 
ionic interactions were proved to be nonspecific and the cations are free to move along 
the sequences. Since these cations partially neutralize the negative charges of the 
phosphate groups and relieve the repulsion of the two sequences in a duplex, the melting 
temperature (Tm, the temperature at which 50% duplex DNA dissociates into random 
coils) increases with the increasing cation concentrations. Cation binding competes with 
DNA ligand binding; therefore, a condition with a high salt concentration inhibits the 
ligand binding because of the electrostatic repulsion.108 Meanwhile, in the development 
of DNA groove binders, the expelled cations from the minor grooves are often observed 
when ligands bind to duplex DNA, which is considered as an important contribution of 
the DNA ligand stabilization because of favorable entropic effects.109 
Other than cations, water molecules also condense on duplex DNA and form a 
spine of hydration in the minor groove.110 The extent of hydration plays a crucial role in 
different DNA conformations (discussed in chapter 1). 
Some ubiquitous positively charged small molecules in eukaryotic cells also non-
specifically bind onto duplex DNA. Spermine and spermidine were originally isolated 
from sperm cells and were found to be abundant in ribosomes (Figure 2-3). They have 
various important functions and one of them is binding on duplex DNA through 
electrostatic interactions to reduce the charge repulsion when DNA is packaged into 
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chromatin.111 In biological studies, high concentration of spermine is often used to 
precipitate DNA in vitro.112  
 
 
Figure 2-3. Structures of spermine and spermidine. 
 
 2.1.2. DNA intercalation. Many DNA ligands with fused planar aromatic 
structures intercalate into duplex DNA by aligning themselves between base pairs. The 
intercalation of ligands is predominately driven by the π-π stacking force between the 
ligands and nucleobases. By adding various substituents into the ligand structures, 
hydrophobic interactions, hydrogen bonds, and electrostatic forces can be introduced to 
enhance the binding affinity and specify the binding orientation. Most of these duplex 
DNA intercalations are located on G-C base pairs because of the bigger stacking surface 
of purines.113 X-ray crystallography studies revealed that in the presence of a DNA 
intercalator, the base pair step is separated by several Å to accommodate the insertion. 
Meanwhile, the local DNA sequence is unwound and lengthened to release the steric 
hindrance.114 Duplex DNA intercalation follows the neighbor exclusion principle in 
which each ligand inserts into duplex DNA with 2 or 3 base pairs at a saturation level. 
This exclusion takes place due to the DNA local conformation changes after the first 
ligand binding and a decreased linear charge density.115-116    
Several DNA intercalators have been used as DNA dyes because the stacking of 
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their cyclic electron deficient surfaces on the base pairs emits fluorescence. Ethidium and 
thiazole orange are two of the most well studied and commonly used DNA dyes. An 
ethidium molecule preferably inserts into G-C base pairs, and the positively charged 
nitrogen interacts with the phosphate backbone.117 Thiazole orange shares a similar 
binding mechanism as ethidium with much less mutagenic effect and hence is a safer 
reagent in DNA research.118 Thiazole orange, as the archetypal structure of our novel G4 
ligands in chapter 4, will be extensively discussed in section 2.5.  
Many duplex DNA intercalators have been developed into anticancer drugs and 
their binding inhibit the DNA replication and interfere the biological functions of many 
DNA enzymes in cancer cells. Anthracycline antibiotics are an important class of DNA 
intercalators, which are used for the chemotherapies of leukemias, lymphomas, breast, 
stomach, uterine, ovarian, bladder cancers, and lung cancers. Daunorubicin is the first 
anthracycline antibiotic that was isolated from Streptomyces peucetius in 1963 (Figure 
2-4).119 Daunorubicin has been used for chemotherapy of acute myeloid leukemia, acute 
lymphocytic leukemia, chronic myelogenous leukemia, and Kaposi's sarcoma for more 
than 40 years.120 Daunorubicin has an anthracene moiety which perpendicularly inserts 
into successive G-C base pairs. The methoxy group of the anthracene ring is located in 
the major groove and coordinates with sodium ions there. The amino sugar group lies in 
the minor groove which will expel metal cations from the DNA. The hydroxy group of 
the sugar forms hydrogen bond with the proximate nucleobases.121 The mechanisms of 
action of anthracycline antibiotics are multifactorial, one of which is inhibition of 
topoisomerase activity by stabilizing duplex DNA. Topoisomerases are essential enzymes 
that release duplex DNA supercoils in replication. Cell’s cycle was found arrested in 
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G1/G2 when they were treated by Daunorubicin.122 In addition, anthracycline antibiotics 
function to elevate ROS level in cells by participating some enzymatic pathways and 
induce DNA damages.123 Although being prominent anti-cancer drugs, acute and long-
term cardiotoxicity has been discovered with anthracycline antibiotics in the 1970s. This 
side effect significantly depends on the dose, patient age, and physical conditions.124-126 
The exact mechanism of the cardiotoxicity is remains unclear so far.   
Transition metals including Ru2+, Rh2+, Fe2+, Zn2+, Cu2+, and Co2+ can coordinate 
with ligands such as 1,10-phenanthroline and form a rigid complex that can partially 
insert into DNA base pairs. The antiviral and antibacterial activities of these complexes 
were firstly discovered in 1952.127 Later, high-resolution NMR and X-ray crystallography 
studies showed that they bind to duplex DNA with both intercalation and groove binding 
modes. There are several advantages of metallo-intercalators: 1) By simply switching the 
coordinating ligands, a library of transition metal complexes with various structures as 
DNA ligands can be conveniently prepared. 2) Because of the chirality of their structures, 
many complexes have exhibited prominent stereoselectivities against different DNA 
conformations. The enantiomers of tris(4,7-diphenyl-1,10-phenanthroline) ruthenium(II), 
[Ru(DIP)3]
2+, preferentially bound to left-handed Z-form DNA and right-handed B-form 
DNA, respectively. In general, the complexes with the bulkier ligands have better 
stereoselectivities because of a greater steric hindrance when intercalating with DNA.128 
3) Transition metal complexes have been used as DNA probes due to their unique 
photophysical properties. For instance, [Ru(phen)2 (dppz)]
2+ glows in organic solutions 
but not in aqueous solutions because the existing hydrogen bonds deactivate the excited 
state of the metal ion. When it binds to DNA, changing from hydrophilic to hydrophobic 
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environment makes the metal ion luminesce.129 4) These complexes can also be used as 
artificial nucleases for cleavage of DNA because of their photochemical properties. The 
binding sites of the complexes can be determined based on the location of DNA strand 
breaks activated by photolysis.130 To sum up, transition metal complexes can act as DNA 
intercalators and have been developed into stereoselective DNA binders, cleavage agents, 




Figure 2-4. Structures of DNA intercalative ligands. 
 
2.1.3. Duplex DNA groove binding. Phosphate diester backbones and the edges 
of base pairs defined two distinguished grooves in duplex DNA. The major groove of B-
DNA is wide and deep and provides a suitable environment for most of the protein 
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binding. By contrast, most of the small molecules fit into the minor groove because of its 
deep and shallow geometry, with a few exceptions of bulky transition metal complexes.  
Duplex DNA minor groove binders such as netropsin and distamycin (Figure 2-5) 
share common structural features of multiple small aromatic rings (pyrrole, furan, 
benzene, imidazole etc.) linked by torsional bonds. Because of the flexible linkage, these 
ligands can twist and form a crescent shape that snugly fits into the minor groove. These 
ligands contain positive charges at the end, which further enhance the binding through 
electrostatic interactions. Different from the G-C preferred intercalation, most of the 
minor groove ligands locate themselves into A-T tracts. The O2 of thymine and N3 of 
adenine in A-T tracts can form H-bonding with the ligand. The G-C tracts are sterically 
hindered for ligand binding. The amino group at C2 of guanine, points to the minor 
groove, which causes steric hindrance for ligand interactions. Generally, groove binding 
ligands have been found with a higher sequence specificity compared to the intercalators.  
First DNA groove binder netropsin was isolated from Streptomyces netropsis in 
1951 by Finlay and the coworkers (Figure 2-5). This pyrrole-amidine structure showed 
antibacterial and antiviral activities.131 High-resolution X-ray crystallography revealed 
that the pyrrole rings of netropsin are located parallelly to the walls of the minor groove 
and displace several H2O molecules from the groove. The binding site of this antibiotic 
was identified as AATT or ATAT.132 Another polyamide-antibiotic, distamycin, was also 
harvested from Streptomyces netropsis. Interestingly, distamycin binds strongly to A-T 
base pair minor groove as a dimer. DNA minor groove binders that have elevated binding 
to G-C tracts have been developed. When one of the pyrrole rings of distamycin is 
replaced by an imidazole ring, the resulting ligand known as lexitropsin showed similar 
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affinity against G-C and A-T. In this case, the imidazole ring can form H-bonding with 




Figure 2-5. Structures of dsDNA groove binders. 
 
Studies on netropsin and its analogues revealed the polyamide motif could be 
useful for sequence-specific recognition of DNA via groove binding. In light of this 
finding, Dervan and co-workers designed and synthesized an array of hairpin-like 
polyamides with tandem imidazole and pyrrole rings: imidazole (Im), pyrrole (Py), and 3-
hydroxypyrrole (Hp). The binding of these ligands follows a base-specific recognition 
rule that four ring-pairings (Im/Py, Py/Im, Hp/Py, and Py/Hp) distinguish all four 
Wastson-Crick base pairs in the minor groove of DNA.134 By constructing a polyamide 
with a β-Alanine linker, Dervan and co-workers were able to specifically target a 16 nt 
sequence in a HIV regulatory region.135 More Recently, Sugiyama and co-workers 
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reported the recognition of telomeric duplex DNA using a polyamide trimer.136 
2.1.4. DNA intercalation vs. groove binding. Both DNA intercalators and groove 
binders have aromatic rings in their structures that interact with nucleobases. Most of the 
intercalators employ fused ring structures to form a rigid surface that stacks on 
nucleobases. Groove binders tend to utilize free flexible linkers that fit the molecules into 
the DNA groove. It is important to note that these two binding modes are not utterly 
exclusive, and some structures can adopt both of them simultaneously or depending on 
the target sequence. For instance, DAPI (4',6-diamidino-2-phenylindole) is extensively 
used in fluorescence microscopy and cell flow cytometry as a DNA dye (Figure 2-6). 
DAPI had been considered as a classical DNA groove binder for a long period of time 
preferably binding to AT-tract minor grooves. Later, an NMR titration experiment 
revealed that DAPI also intercalates to G-C base pairs, and the two binding modes co-
exist under the same conditions.137 Other DNA intercalators such thiazole orange that 








2.2. G-quadruplex Binding  
DNA G-quadruplex is formed by guanine-rich DNA single strands with stacking 
G-quartets. Because of the abundant presence of G-rich sequences in telomeres and 
oncogene promoter regions, G4 ligands have become a fast-developing area of research. 
By targeting G-quadruplexes, telomerase mediated telomeres length maintenance in most 
cancer cells can be inhibited and leads to cell cycle arresting. Oncogene such as c-myc 
can also be down-regulated after the treatment of G4 ligands. Therefore, many G4 ligands 
have been developed so far with various core structures and side chains. For the clinical 
applications of G4 ligand in vivo, precisely targeting G-quadruplex without interferences 
with duplex DNA is always the major challenge. Thus, both affinity and selectivity are 
critical for a successful G4 ligand. Because of their planar aromatic and negative charged 
structures, most of duplex DNA intercalators can also bind to G-quadruplexes with 
different affinities and selectivities. Due to the shape of the G-quartets in G-
quadruplexes, ligands with larger aromatic surfaces, especially those with similar 
geometry as a G-quartet, are more suitable for G-quadruplex binding. Therefore, 
structures including porphyrin, acridine, quindoline, and phenanthroline become the core 
archetypes of many well-developed G4 ligands. Side chains with positive charges, 
flexible linkers or sugar rings that can fit into the grooves or associate with the loops are 
often used to enhance both affinity and selectivity. In this section, the most potent G4 
ligands are discussed according to their binding mode: end stacking, intercalating and 
groove/loop binding.  
2.3.1. G-quadruplex end stacking ligands. Most of the aromatic ligands adopt 
an end stacking mode at the one or two terminal G-quartets through π-π stacking force. 
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The most potent G4 ligand with the best selectivity so far is a natural product 
telomestatin (Figure 2-7). Telomestatin was discovered when researchers were screening 
for telomerase inhibitors from natural products. It is a macrocyclic compound with five 
oxazole rings and isolated from Streptomyces anulatus 3533-SV4. The IC50 of telomerase 
inhibition of telomestatin is as low as 5 nM which is 1000-fold lower than one of the 
strongest synthetic G4 ligands TMPyP4.139 An ESI-MS study showed that telomestatin 
stacks on the two terminal G-quartets of G-quadruplexes.140 A molecular simulation study 
revealed that the heterocyclic structure of telomestatin provides rich positions for 
hydrogen bonds with guanines of the G-quartets. The nitrogen atoms in the center of 
telomestatin interact with the carbonyl channel formed by guanines through electrostatic 
force.141 More importantly, telomestatin is the best selective ligand against G-quadruplex 
and has almost no binding affinity to duplex DNA. The length of telomeric G-overhang 
was shortened when the cells were treated by telomestatin.142 The IC50 value of 
telomestatin against two telomerase positive cell lines SW39 and SW26 are 4.1 and 1.8 
µM, respectively, without obvious cytotoxicity towards normal cells.143 The high binding 
affinity and excellent selectivity of telomestatin is the consequence of its macrocyclic 
structure that facilitates its stacking on G-quartets and prevents the intercalation with 
duplex DNA. However, due to its structural complexity, the large-scale synthesis of 
telomestatin is always problematic. The total synthesis of telomestatin gave a very low 
yield, and isolation from Streptomyces anulatus only yielded 3.2 mg from 84 L culture 
fluid.144 Several attempts have been made to develop the telomestatin derivatives by 
Kazuo Nagasawa and co-workers. Two promising candidates of them, 6OTD and 7OTD, 




Figure 2-7. Structures of G4 ligands. 
 
It is noteworthy that some experiments revealed that telomestatin exhibited cell 
toxicities on ALT (Alternative Lengthening of Telomeres) cell lines, suggesting that 
telomerase-positive is not the requirement for a G4 ligand to perform its anti-cancer 
activities.146 In ALT cells, topoisomerase III binds onto telemetric region and regulates 
the recombination and elongation of telomeres. This process can be inhibited by 
stabilizing the G-quadruplexes using telomestatin. 
Cationic porphyrin compound TMPyP4 was first synthesized as a photosensitizer 
and later was used as an intercalator for duplex DNA via a threading mode (Figure 
2-7).147 In addition, it was found to stabilize G-quadruplexes with an end stacking mode 
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due to its large aromatic surface and four N-methylated side chains.148 TMPyP4 is one of 
the strongest G4 ligands, but with a poor selectivity. TMPyP4 shows positive effects on 
down-regulating the expression of oncogene c-myc by inducing G-quadruplexes in its 
promoter region. The expression of the subunit of telomerase hTERT, which is regulated 
by c-MYC was also reduced after the treatment of TMPyP4.149 The IC50 values of 
TMPyP4 against tumor cell lines are in the range of 9.0-28.2 µM, and between 1.7-15.5 
µM against normal cell lines, further suggesting its low selectivity.150 Although with a 
poor selectivity, TMPyP4 is still commonly used as a positive control since it can be 
conveniently purchased.  
Many modifications have been attempted to improve the selectivity of TMPyP4. 
By coordination with the metal ion Mn3+, its selectivity against G-quadruplex over 
duplex DNA was improved by 10-fold. In addition, side chains containing amides were 
discovered to improve the binding affinity and selectivity of TMPyP4 derivatives. Thus, a 
cationic porphyrin Mn3+ complex with extended amide side chains was found with 1000-
fold higher selectivity compared to TMPyP4. This molecule has been used to locate G-
quadruplex in living cells (Figure 2-7).151-153  
BRACO-19 is one of the best synthetic G4 ligands with a remarkable selectivity, 
in which an acridine core is surrounded by three protonated side chains (Figure 2-7). 
Molecular modeling experiments suggested that the acridine moiety in the structure 
stacks on the G-quartets and each of the side chains occupies a groove. The selectivity of 
BRACO-19 is dependent on the types and positions of the side chains.154 BRACO-19 was 
cytotoxic against human uterus carcinoma cell line UXF1138L with an IC50 value at 2.5 
µM and significant telomere shortening was observed after a long-term treatment. The G-
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quadruplex-regulated expression of telomerase subunit hTERT was found significantly 
decreased after the treatment of BRACO-19.155 In another study, BRACO-19 also 
exhibited anti-HIV activity by stabilizing the viral G-quadruplexes.156 Similar to many 
other DNA ligands, BRACO-19 has poor pharmacological properties mainly because of 
its high polarity. Therefore, the pre-clinical studies of BRACO-19 is still being conducted 
to improve its uptake efficiency.155  
Similar to TMPyP4 and BRACO-19, there have been many other examples of G4 
ligands equipped with positively charged side chains. PIPER, a perylene based 
compound, has two piperidine moieties with positive charges on the terminals and can 
efficiently stack with G-quadruplexes and inhibits telomerase (Figure 2-7).157-158 An 
interesting observation for PIPER is that their binding selectivity against G-quadruplexes 
over duplex DNA is correlated their aggregation states in solution. Monomeric molecules 
intercalate into duplex DNA and aggregated products stack on G-quartets.159      
From above well-developed G4 ligands, many lessons of designing highly 
selective G-quadruplex stacking ligands can be learned: 1) A highly extended aromatic 
system is the best core structure for G-quadruplex stacking and provides the best 
selectivity (like telomestatin); 2) For relatively small ligands with practical synthetic 
yields, the side chains are crucial. The structures and locations of the side chains do not 
only improve the binding affinity but also affect the selectivity for G-quadruplexes over 
duplex. 3) Potent G4 ligands are always tethered with side chains with positive charges 
and optimized geometry for G-quadruplex interactions.     
Metallo-aromatic structures are another group of potent G-quadruplex binders in 
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which small molecular ligands coordinate with a metal ion and form an extended 
aromatic surface. Other than the planar geometry of the coordinating ligands stacking on 
G-quartets, the metal ions at the center also interact with the guanine channel through 
electrostatic force. 1,10-Phenanthroline is an example of such aromatic ligands for G-
quadruplex recognition, which will be extensively discussed in section 2.4.  
2.3.2 G-quadruplex groove binders. G-quadruplex is formed by four successive 
G-rich segments where adjacent sequences form loops and provide distinct recognition 
environments for groove binders. Pyrrole amide antibiotics were discussed in the section 
of duplex DNA groove binders and they can also bind to G-quadruplex grooves (Figure 
2-8). An NMR study revealed that distamycin dimers can bind with two opposite grooves 
in a G-quadruplex through hydrogen bonds and electrostatic force. Widened grooves 
were observed to accommodate the distamycin molecules.160 In another study of 
distamycin derivatives, the formamide group in distamycin was replaced by a charged N-
formimidoil moiety and the resulting compound decreased the duplex DNA binding 
(Figure 2-8).161 Alkaloids peimine and peiminine were also reported interact with G-
quadruplex through groove binding (Figure 2-8). These two compounds showed clear 
preference to a parallel G-quadruplex rather than duplex DNA, which may result from the 
different geometry of the grooves in these structures.162  
Lastly, ligands that intercalate into the G-quartets have not been discovered 
experimentally to our best knowledge, and only a few computational studies were 
reported.163 The G-quadruplex structure is highly compact, which makes intercalation 






Figure 2-8. Structures of G-quadruplex groove binders. 
 
In summary, G4 ligands have recently attracted much attention for their anti-
cancer activities. Though natural product telomestatin exhibited excellent binding affinity 
and selectivity against G-quadruplexes, its clinical applications are hindered by the 
extremely complicated synthesis. Therefore, the development of small molecules that 
selectively target G-quadruplexes is highly demanded. Lessons can be learned from the 
above studies that both the binding affinity and selectivity are significantly affected by 
side chains. The numbers, orientations and positive charge densities are the factors for 
potent binding. In light of these findings, we selected two core structures, 1,1-
phenanthroline and thiazole orange and studied the binding affinity and selectivity toward 
G-quadruplex DNA. A brief summary of the research on these two types of compounds 
will be presented below.   
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2.3. 1,10-Phenanthroline Analogues Metal Complexes as G-quadruplex Ligands.  
1,10-Phenanthroline (1,10-Phen) is a heterocyclic organic compound that chelates 
a broad-spectrum of metal ions (Figure 2-9). The structure of 1,10-Phen is similar to 2,2'-
bipyridine, but with a much higher coordinating efficiency. It has been used as a 
photometric reagent for chelating Fe2+ ions in solution. In addition, 1,10-Phen is 





Figure 2-9. Structures of 1,10-phenanthroline (left) and 2,2'-bipyridine (right).  
 
When DNA G-quadruplex became a promising target for cancer therapy, 1,10-
Phen has been used as a building block for developing G4 ligands because of its extended 
aromatic surface. In addition, the chelated metal ions may enhance the interactions by 
substituting the cations in the G-quadruplex. It is commercially available and can be 
readily synthesized. In this section, the previous development of 1,10-Phen and its 
analogues as G4 ligands will be reviewed and serve as the important background of our 
research in the following chapter.  
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2.4.1. 1,10-phenanthroline analogues as G-quadruplex ligands. As discussed 
in previous sections, the two common features of G4 ligands are extended aromatic 
surfaces and suitable positively charged side chains. 1,10-Phen has a well-defined 
crescent shape with fused aromatic rings, which is a suitable trait of G4 ligands. De Cian 
and co-workers designed a 1,9-disubstituted-1,10-phenanthroline compound (Phen-DC3), 
in which, two quinolinium groups were anchored to the 1 and 9 positions of 1,10-Phen by 
amide linkers (Figure 2-10a).164 Phen-DC3 at 1 µM elevated the melting temperature of a 
human telomeric G-quadruplex by 29.7 °C monitored by fluorescence. More importantly, 
Phen-DC3 showed a remarkable selectivity against G-quadruplexes, which is comparable 
to telomestatin and better than most of the known synthetic G4 ligands. An X-ray 
crystallography revealed that Phen-DC3 has a similar surface size compared to the G-
quartet providing optimized stacking force. Later, an NMR titration experiment showed 
that Phen-DC3 binds to G-quadruplexes by end stacking mode with 1-1 and 1-2 ratios. 
The phenanthroline core structure and two quinolinium rings overlap with the four 
guanines of the terminal G-quartets.165 It is noteworthy that the two amide linkers in 
Phen-DC3 help to lock the structure in a planar conformation that greatly enhances its G-
quadruplex binding affinity. Removing this amide connectivity will lose its G-quadruplex 
stabilization effects.166 The in vivo G-quadruplex stabilization of Phen-DC3 showed that 
it can efficiently inhibit G-quadruplex unwinding by helicase without affecting other 
regular dsDNA.167  
Likewise, Wang et al. developed another group of 2,9 disubstituted-1,10-Phen 
(Figure 2-10b). The amide linkers were preserved because of the hydrogen bond locking 
effects. Cationic piperidine, pyridine, and tertiary amine groups were attached as side 
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chains. Slightly better G-quadruplex stabilization was achieved for these structures, 
compared to Phen-DC3. It was also proved that these ligands preferably bind to anti-
parallel G-quadruplexes. Cell viability experiments revealed their cytotoxicity was shown 
at approximately 2 µM.168       
 
 
Figure 2-10. Structures of Phen-DC3 (left) and its cationic amino side chain derivatives 
(middle); 4,7-diamino-1,10-Phen derivative (right). 
 
Other than 2,9 disubstituted-1,10-Phen, 4,7 disubstituted derivatives were also 
studied. Nielsen and co-workers synthesized a range of 4,7-diamino-1,10-Phen. Many of 
them stabilized G-quadruplex examined by CD (Figure 2-10c). The derivatives with 
longer side chains bearing positively charged guanidine groups exhibited better 
stabilization compared to shorter and neutral side chains. It was also noteworthy that 
1,10-Phen itself did not stabilize G-quadruplexes in the absence of metal ions because of 
its small planar structure.169   
To the end, many modifications have been made at the 2,9 and 4,7 positions of 
1,10-Phen. To our best knowledge, reports on modifications made at 5 and 6 positions of 
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1,10-Phen for developing G4 ligands are scarce. NMR and X-ray crystallography studies 
of 1,10-Phen derivatives suggested that side chains at 5 and 6 positions could effectively 
interact with G-quadruplex grooves.164-165 
2.4.2. 1,10-phenanthroline analogues metal complexes as G-quadruplex 
ligands. Because of the two well-organized nitrogen atoms, 1,10-Phen is an outstanding 
chelating agent which can form complexes with a broad range of metal ions including 
nickel(II), copper(II), ruthenium(II), platium(II), manganese(II), magnesium(II), and 
zinc(II) with 1-1, 1-2, or 1-3 ratios. By forming a complex, the extended aromatic surface 
can significantly contribute to G-quadruplex stacking. Meanwhile, metal ions may sit at 
the center of the channel of a G-quadruplex and coordinate with the carbonyl oxygens of 
the guanines, further enhancing the stability. Thus, many 1,10-Phen metal complex 
derivatives have been synthesized.  
Nickel salphen (Figure 2-11a) is the first metal complex used as a G4 ligand and 
synthesized by Reed and co-workers.170 Two piperidine structures were attached as the 
side chains. Computation studies revealed that this square planar structure overlaps with 
the terminal G-quartets and the Ni
2+ ion lies above the center channel. Nickel salphen 
exhibited an outstanding G-quadruplex stabilization and selectivity comparable to 
BRACO-19.  
The success of nickel salphen inspired the development of metal complexes as G4 
ligands. In this scenario, the same research group designed a Pt-1,10-Phen complex with 
a piperidine side chain on the carbon 9 (Figure 2-11b). This compound adopts an amide 
linker that similar to Phen-DC3 and the nitrogen atoms coordinate with the Pt2+ ions. A 
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computational study suggested that the conformation is fixed in a plane so that the 
benzene ring stacks on the guanines, and the extended piperidine side chain interacts with 
the grooves. The Pt2+ ion was chosen because it forms a stable planar 1-2 complex with 
the ligand.171 The Pt2+ ion sits in the center of the G-quadruplex and may replace the 
cationic ions in the G-quadruplex channel. In a FRET thermal denaturation experiment, 
the complex at 1 µM increased the melting temperature of a telomeric G-quadruplex by 
20 °C while showed negligible effects on duplex DNA. This stabilizing effect was highly 
dependent on the presence of Pt2+ ion and only 9 °C increment of melting temperature 








In another report, Pt-1,10-Phen complex (Figure 2-11c) exhibited stabilization 
effects on an antiparallel G-quadruplex in the absence of any side chain. In the presence 
of 1 µM complex, the melting temperature of the telomeric G-quadruplexes was 
enhanced by 21 °C. An X-ray crystallography experiment revealed that Pt-1,10-Phen 
complex has a dimension matching the G-quartets. Interestingly, this complex has a 
remarkable preference to antiparallel G-quadruplexes. By replacing 1,10-Phen with 
bipyridines (Figure 2-11d), the resulting complex did not stabilize the G-quadruplex 
probably because of its flexibility, suggesting that the rigid extended aromatic structure of 
1,10-Phen is pivotal for its G-quadruplex stabilization effect.173 Ruthenium ions (Ru2+) 
are also frequently used in this type of complexes. Different from Pt2+, Ru2+ ions usually 
form 1-3 complexes with ligands. Many Ru-1,10-Phen complex derivatives have been 
developed as G4 ligands and exhibited various stabilization effects.174-178    
Like in the nickel salphen, cheaper metal ions were often utilized in the 
complexes to stabilize G-quadruplexes. Bianco and co-workers synthesized a bis-
phenanthroline, in which, two phenanthrolines were linked by a tertiary amine (Figure 
2-11e). Mn2+, Cu2+, Ni2+, Mg2+, and Zn2+ ions were all studied with this ligand and the 
formation of 1-1 (1 metal ion coordinated with two phenanthroline function groups) 
complexes was observed.179 A FRET assay revealed that Ni2+ complexes had the best G-
quadruplex stabilization effect amongst the above metal ions, followed by Cu2+ and Zn2+ 
complexes. Mn2+ and Mg2+ ions had a very low affinity with the bis-phenanthroline 
ligand, so the complexes could not be formed readily in the solution. Compared to Pt2+ 
and Ru2+ complexes, the Ni2+ complex is more cost-friendly and, more importantly, can 
be readily formed in solution without special reaction conditions. For Cu2+ complexes, 
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DNA cleavage effect was frequently observed in the presence of a reducing reagent since 
Cu2+ ion can undergo a reduction reaction to produce reactive species for DNA damage. 
Cu2+-Bis-Phen complexes showed less cleavage of DNA because the generation of 
reactive species requires a perpendicular arrangement of two aromatic functional groups 
which is unlikely to happen for a bis-phenanthroline ligand.  
Musetti and co-workers synthesized 2,9-disubstituted (K35, Figure 2-11f) and 7-
monosubstituted (K34, Figure 2-11g) 1,10-Phen.180 The Ni2+ and Cu2+ complexes were 
investigated for their G-quadruplex stabilization. K34 formed a 1-2 complex with Ni2+ 
and K35 only formed a 1-1 complex, because the bulky groups at 2,9 positions hindered 
the coordination of metal ions with the phenanthroline ligands. As a consequence, the G-
quadruplex stabilization effect of K35 was not as good as K34, because K35 had a much 
smaller stacking surface. K34 could only form a 1-1 complex with Cu2+, which in turn 
had a lower G-quadruplex binding affinity compared to the Ni2+-K34 complex. All these 
observations suggested that forming 1-2 complexes between metal ions and 1,10-Phen is 
critical for the G-quadruplex stabilization effects. Modifications on 2 or 9 positions of 
1,10-Phen may affect the coordination of ligands with metal ions because of the steric 
hindrance of the substituent(s). This was also confirmed by another 9-substituted-1,10-
Phen derivative P120 (Figure 2-11h), which only formed a 1-1 Ni complex with a 
moderate G-quadruplex binding affinity.181  
Many 5 and 6 substituted 1,10-Phen compounds have been developed mainly for 
photophysical detection of metal ions.182-183 Reports on the use of them as G4 ligands are 
limited. Fang and co-workers synthesized a Ni2+ complex NPH (Figure 2-11i), by 
coordinating a Ni2+ ion with two 1,10-Phen ligands and one p-idip (p-idip=2-(4-indole)-
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imidazo-[4,5-f][1,10]phenanthroline). This 1-3 complex could stack on the G-quartets 
with a higher affinity than Ni2+-1,10-Phen complexes. A FRET assay showed that a DNA 
G-quadruplex had a 14 °C increment of Tm in the presence of 1 µM of NPH.
184  
To that end, 1,10-Phen derivatives have been developed into a class of G4 ligands 
and several of them exhibited very prominent binding affinity and selectivity. Side chains 
have been attached onto different locations of 1,10-Phen. Several 2,9 substituted 1,10-
Phen derivatives are much better G4 ligands compared to 1,10-Phen. However, the 
substituents at 2 and/or 9 positions could hinder the coordination with metal ions. Ni2+ 
was the most cost-friendly and efficient metal to form 1,10-Phen-based G4 ligands. To 
improve the coordination efficiency with metal ions, side chains should be attached to the 
outer edge (4, 5, 6, or 7 positions) of 1,10-Phen if we recognize it as a crescent shape.   
2.4. TO Derivatives as G-quadruplex Ligands 
Thiazole orange (TO) is a cyanine dye that was firstly synthesized by Linda G. 
Lee for the staining of reticulocytes RNA in flow cytometry analysis.185 Most of this type 
of DNA dyes contain two aromatic rings that skew from each other when they are free in 
solution. They bind to DNA via intercalation by stacking between two nucleobase pairs, 
and the fluorescence arises when the two aromatic rings are constrained on the same 
plane.186 TO has a N-methylated benzothiazole ring linked to a quinolinium by a methine 
bridge (Figure 2-12a). It intercalates with duplex DNA with a stoichiometric ratio of 1 
dye per 2 base pairs. TO also binds to DNA G-quadruplexes via end-stacking. The 
binding affinities of TO with G-quadruplex and duplex DNA are approximately the same. 
As a DNA dye, TO has many advantages compared to its predecessors such as high 
quantum yield and good cell membrane permeability. When it binds to DNA, it shows 
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more than 1000 times fluorescence increment.187 In addition, TO is permeable to cell 
membrane which makes it highly useful for staining of nucleic acid in living cells.  
 
 
Figure 2-12. Structures of thiazole orange and derivatives.  
 
Utilizing TO as a DNA dye, David Monchaud et al. developed a fluorescent 
intercalator displacement (FID) assay which has been extensively used in G4 ligands 
research.188 The design rationale of the FID assay is as follows. Firstly, the binding of TO 
to DNA is reversible; therefore, the bound TO could be displaced out of DNA by other 
strong DNA ligands in solution. Because of the drastic difference in fluorescence between 
free TO and bound TO, one can monitor the fluorescence change to determine the binding 
affinity of the ligand of interest. The lower the concentration (DC50 value) of the ligand is 
needed to displace 50% TO, the stronger the ligand binds to DNA. Secondly, because 
thiazole orange binds to G-quadruplex and duplex DNA with almost the same affinities, 
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the FID results can be used to evaluate the selectivity of the ligand for G-quadruplex over 
duplex DNA.  
Due to its distinct property of fluorescence, TO has been used as a structural motif 
for developing G4 ligands. For instance, some known G-quadruplex selective moieties 
were fused onto the quinolinium ring of TO such as benzofuroquinolinium (d), 
isaindigotone (c), and pyridodicarboxamide bisquinolinium (b) (Figure 2-12). These 
extended aromatic structures all exhibited improvements on G4 selectivity over duplex 
compared to thiazole orange.189-191 These TO based derivatives could be used as good G-
quadruplex probes but their binding affinities to G-quadruplex DNA are moderately 
increased compared to TO. In addition, the synthetic approach is not convenient to 
generate a large library of TO with various side chains.   
Interestingly, a recent report suggested that TO can bind to a string of consecutive 
G-quadruplexes with high selectivity over duplex DNA. In the same report, the authors 
even detected the strong binding of TO to the G-quadruplex string in the absence of Na+ 
and K+. In addition, the binding of TO with other noncanonical DNA structures was 
observed.192 Given the fact that consecutive G-quadruplexes are most likely formed in 




Chapter 3. 5-Substituted 1,10-Phenanthroline Ni(II) Complexes as G4 Ligands 
 
G-quadruplex has received much attention because of its important regulatory 
functions in telomerase-mediated cancerization and oncogene expression. Phenanthroline 
is a type of G4 ligand scaffold that coordinates with metal ions, and the consequent 
complex has an extended aromatic surface that can aptly stack on G-quadruplexes. In this 
project, a series of 5-substituted phenanthroline-based Ni(II) complexes were investigated 
for their ability to bind to telomeric G-quadruplex DNA and inhibit telomerase. 
Biophysical studies including Förster Resonance Energy Transfer (FRET) G-quadruplex 
thermal denaturation, Circular Dichroism (CD) titration, and Fluorescence Intercalator 
Displacement (FID) indicated that complexes with either cationic side chains or aromatic 
side chains bound to and stabilized telomere G-quadruplex DNA with significant 
affinities. More importantly, complexes with arylsulfanyl side chains at the 5-position 
exhibited improved selectivity against G-quadruplex over duplex DNA, which can be 
used as a promising motif for G4 ligand development in the future. Results from a 
Telomeric Repeat Amplification Protocol (TRAP) assay suggested that these complexes 
can inhibit telomerase activity in vitro with micromolar concentrations. Cytotoxicity was 




Cancer is the second leading cause of death in the United States and was 
responsible for 22.5 percent of deaths over the last five years.193 More than 100 types of 
cancer have been discovered so far while finding the efficient therapy with low side-
effects is still a huge challenge. The most common treatments for cancer are surgery and 
chemotherapy, and obviously, surgery is only feasible for solid tumors, not metastatic 
cancers. The very first chemotherapy drug nitrogen mustard was investigated in 1942, 
which had been used as a chemical weapon in World War I. Since then, many other 
cytotoxic compounds have been developed as anti-cancer drugs. Most of these 
compounds were designated to target DNA and subsequently lead to cell cycle arrest by 
forming stable adducts or cross-links in DNA. Regression of tumors was observed after 
the treatment of these drugs; however, the acute and long-term toxicity becomes a huge 
obstacle in their applications for cancer chemotherapy. In the 1980s, thanks to the 
advanced knowledge and technologies of cell biology, a network of cell signaling 
pathways was deciphered, and some biomarkers of cancer were discovered and became 
the targets of receptor inhibitors. Glivec (a kinase inhibitor), Gefitinib (an EGFR 
inhibitor), and Avastin (a VEGF antibody) are the benchmarks of these targeting drugs 
and exhibit outstanding effects on several major types of cancer. However, the over-
expression of the corresponding biological targets is patient-dependent, and hence only 
individuals with a certain genotype, determined by genomic tests or proteomics, are 
sensitive to specific drugs. Therefore, in spite of acute side-effects, cytotoxic drugs are 
still playing pivotal roles in cancer therapy and usually are combined with the targeting 
inhibitors, nowadays.194 The development of new broad-spectrum chemotherapy drugs 
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with low side-effects is still a pressing task for researchers.  
DNA is the target for most of the chemotherapy drugs. Some of them like 
nitrogen mustard and cisplatin form stable DNA adducts or cross-links, and thus inhibit 
the DNA replication. However, these drugs are non-selective and lead to acute side 
effects. As mentioned in the previous chapters, G-quadruplex is a secondary DNA 
structure that is formed by successive G-rich sequences through Hoogsteen hydrogen 
bonds. G-quadruplex is prevalently present in oncogene promoter regions and telomeric 
regions. Its formation and stability are closely correlated to cancer cell proliferation. 
Oncogene such as c-myc can be down-regulated in the presence of stabilized G-
quadruplexes. Meanwhile, G-quadruplexes in telomeric regions hinder telomerase 
binding and inhibit the consequent telomere length maintenance, which is only present in 
cancer cells. In light of these observations, many strategies have been developed to use 
G-quadruplexes as a target for potential anti-cancer therapies.  
Like duplex DNA ligands, some small molecules have been found interact with 
G-quadruplexes, and consequently increase their stability. There are two principles of 
successful G4 ligands: 1) high binding affinity with G-quadruplex DNA; 2) sufficient 
selectivity against G-quadruplex over duplex DNA. Therefore, most of the outstanding 
G4 ligands were designed with two types of functional motifs: 1) positively charged side 
chains that interact with DNA backbones to enhance the binding affinity; 2) an extended 
planar aromatic system that can stack with the G-quartets to enhance the selectivity. A 
natural product, telomestatin is one of the most potent G4 ligands with remarkable 
selectivity. However, its structural complexity became a huge obstacle for its efficient 
synthesis and production as a drug.139 Some synthesized small molecules have been 
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developed targeting G-quadruplex utilizing fused aromatic ring structures including 
acridine, perylene, naphthalene, phenanthroline, etc. Many of these compounds have high 
binding affinities against G-quadruplexes; however, very few of them have sufficient 
selectivity. Several phenanthroline derivatives exhibited remarkable affinity and 
selectivity against G-quadruplex DNA.164 In addition to having a rigid aromatic crescent 
structure and various side chain attaching positions, phenanthroline can also coordinate 
with metal ions and form complexes with a large stacking surface. The metal ions sit in 
the center of the planar surface, which may replace the original cations of G-
quadruplexes and coordinate with the guanines.  
Many of these phenanthroline derivatives have been synthesized, and their G-
quadruplex stabilization effects were evaluated in the presence and absence of metal ions. 
A majority of developed derivatives were modified by tethering cationic moieties such as 
bisquinolinium, piperidine, pyridine, and amino groups at the 2 and 9 positions of 
phenanthroline and exhibited remarkable G-quadruplex binding affinities.164, 168, 172, 180-181 
The modifications at the 4 and 7 positions of phenanthroline has also been reported, and 
the resulting derivatives showed limited selectivity for G-quadruplex over duplex 
DNA.169, 180 To the best of our knowledge, the modification at 5 or 6 positions of 
phenanthroline for G-quadruplex stabilization has not been extensively studied. NMR 
and X-ray crystallography studies revealed that when phenanthroline derivatives stack at 
the end of G-quadruplexes, the 5 and 6 positions of the phenanthroline ring are closely 
located at the G-quadruplex grooves.165, 172 Hence, the interactions between side chains at 
these two positions and the G-quadruplex grooves could exist. A Ni complex of 
phenanthroline derivative with 2-(4-indole)-imidazole at the 5 and 6 positions exhibited 
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better G-quadruplex affinity and selectivity compared to the parent complex, suggesting 
that the 5 and 6 positions are attractive modifying sites for developing novel G4 
ligands.184  
Many phenanthroline derivative metal complexes have been synthesized with Pt2+ 
or Ru2+ ions, and showed significant G-quadruplex stabilization effects.173, 177 Complexes 
with similar structures were also prepared with cheaper metal ions including Cu2+, Ni2+, 
Mn2+, Mg2+, and Zn2+, in which, Ni2+ and Cu2+ ions formed more stable complexes with 
phenanthroline derivatives than the others.179 Other than the lower cost, Ni2+ ions have 
another advantage over Pt2+ and Ru2+ ions that they can be conveniently coordinated by 
mixing the metal salts and ligands in water solutions without any special treatment.195-196 
A facile synthesis of 5-substituted phenanthroline derivatives was reported by 
Samoshin and his co-workers. They kindly provided us nineteen 5-substituted 
phenanthrolines for evaluation.197 Using their method, our group also synthesized an 
additional derivative (21) with a piperidine side chain, which is a known moiety 
enhancing G-quadruplex binding. In the previous work, Ni2+ complexes of these twenty 
derivatives were prepared by simply mixing NiCl2 and the corresponding compounds 
with 1-2 ratio in water solutions. The G-quadruplex stabilization was also evaluated by 

















































In the present research, the stoichiometry of the Ni2+ coordination was first 
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confirmed by ESI mass spectrometry. FID was used to determine the G-quadruplex 
stacking effects of the complexes and the results were compared with other biophysical 
studies. In vitro telomerase inhibition and cytotoxicity were investigated using a modified 
TRAP assay and MTT experiments. 
3.2. Experimental  
3.2.1. Materials and general methods. Unless otherwise specified, all chemicals 
for synthesis were purchased from Sigma-Aldrich or Fisher Scientific and used without 
further purification. Oligonucleotides were synthesized on an Applied Biosciences 392 
DNA/RNA synthesizer using standard phosphoramidite protocols and purified using 
polyacrylamide gel electrophoresis. All the chemicals for DNA synthesis were purchased 
from Glen Research (Sterling, VA). The concentrations of oligonucleotide solutions were 
determined by a Varian Cary 100 Bio UV-Vis spectrophotometer (Walnut Creek, CA), 
using the molar extinction coefficients (in units of mol of nucleotide/L-1 cm-1) obtained 
from Oligo Analyzer 3.1 (www.idtdna.com). T4 polynucleotide kinase was obtained from 
New England Biolabs. [γ-32P]-ATP was purchased from PerkinElmer (Waltham, MA). 
Quantification of 5' 32P-labeled oligonucleotides was carried out using a Storm 860 
phosphorimager and ImageQuant 5.1 software (Molecular Dynamics). DNA labeling was 
performed by incubating [γ-32P]-ATP (300 µCi) and T4 polynucleotide kinase (20 units) 
in the presence of an oligonucleotide at 37 °C for 45 min. Unreacted [γ-32P]-ATP was 
removed using a MicroSpin G-25 column (GE Healthcare). Cancer cell lines were a 
generous gift from Dr. William. K. Chan. Cell culture media and supplements (fetal 
bovine serum, L-glutamine, and antibiotic-antimycotic) were from Invitrogen. MTT 
(Thiazolyl blue tetrazolium bromide) was purchased from Fisher Scientific, and the 
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absorbance were read on a TriStar LB 941 multimode microplate reader.  
3.2.2. Mass spectrometry analysis of complexes. A Varian 320L triple 
quadrupole mass spectrometer coupled to an electrospray ionization (ESI) source 
(Agilent Technologies, Santa Clara, CA) was used to analyze the complexes in positive 
ion mode. The sample solutions were prepared by dissolving 5-substituted phenanthroline 
derivatives and NiCl2 in a 2:1 ratio with 50% methanol-water (unless otherwise 
specified), and the final concentration of complexes was 200 μM. An aliquot of the 
sample solution (20 μL) was introduced into the ESI source via a six-port valve. The 
following instrument parameters were employed: 4.5 kV for the ESI needle onset voltage, 
30 V for the capillary voltage, 30 psi for the nebulizing nitrogen gas, and 10 psi and 
150˚C for the drying gas. The designated ions were isolated for the collision-induced 
dissociation (CID) measurements which were performed at collision energies of -40~- 50 
eV.  
3.2.3 Fluorescent intercalator displacement assay. A stock solution containing 
100 μM human telomeric G-quadruplex sequence (PCG1) (5’-AGG GTT AGG GTT 
AGG GTT AGG GT-3’) or duplex (D1) (5’-AGC GAT GAG AGG CCA CGA GGA ATC 
GCT GGT ACC G-3’/ 5’-CGG TAC CAG CGA TTC CTC GTG GCC TCT CAT CGC T 
-3’), 10 mM lithium cacodylate buffer (pH=7.0) and 50 mM KCl was prepared and 
incubated at 90 ℃ for 5 min, and slowly cooled to room temperature. All solutions were 
stored at 4 ℃ before further use.   
The reaction solution containing 0.25 μM DNA, 10 mM lithium cacodylate buffer 
(pH=7.0) and 50 mM KCl was prepared from the stock solution before use. This solution 
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was incubated with 0.5 μM thiazole orange (TO) for 30 min in the dark. Aliquots of 
ligands were added into this mixture solution and equilibrated for 5 min in the dark 
before measurement. The fluorescence spectra (λ excitation: 501 nm, slit width: 5.0 nm, 
scan speed 120 nm/min) were recorded from 510-650 nm after each addition. The percent 
fluorescence displacement (%FI displacement) was calculated at λ max by using the formula 
%FI displacement=100-[(FA/FA0)×100], where FA0 is the initial fluorescence intensity in the 
absence of ligand, and FA is the fluorescence intensity upon addition of ligand.  
3.2.4. Preparation of cell lysate for TRAP assay. Cell lysates containing 
telomerase were extracted from cultured HeLa cells. The cells from a 90% confluent 225 
cm2 culture flask were washed once with cold phosphate-buffered saline (PBS) and 
scraped off from the culture flask in 1 ml cold PBS. The cells were pelleted in a 1.5 ml 
centrifuge tube by spinning for 5 min at 1000 rpm and suspended in 1 ml cold 
TRAPeze® 1× CHAPS Lysis Buffer (Millipore, Sigma). The suspension was incubated 
on ice for 30 min and centrifuged at 12,000 X g for 10 min at 4°C. The supernatant was 
extracted and stored at -80°C.  
3.2.5. Real-time PCR telomeric repeat amplification protocol (TRAP) assay. 
The reaction mixture (30 µl) was prepared containing 1×SYBR Green Mix (Thermo 
Fisher Scientific, polymerase included), EGTA (1 mM), TS primer (2 µM, extension 
substrate of telomerase, 5’-AATCCGTCGAGCAGAGTT-3’), RP (1 µM, reverse primer 
for telomerase extended products, 5’-GCGCGGCTTACCCTTACCCTTACCCTAACC-
3’), cell lysis (2.5 µl, lysis buffer was used in control samples) and ligand (various 
concentrations). Samples were incubated at 30°C for 30 min in a 96-well plate for 
telomerase extension followed by 95°C for 10 min to deactivate telomerase and activate 
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polymerase. A two-step PCR thermal cycle (95 °C for 15 s, 60 °C for 60 s) was 
performed for 41 times using an MJ research option-2 real-time PCR machine (St. Bruno, 
Canada) and fluorescence was recorded after each cycle using the SYBR Green setting 
mode of the instrument. The data was plotted as the logarithm of fluorescence signal 
versus the cycle number, and the threshold was set to the value of 10 times standard 
deviation of the background.   
3.2.6. 32P telomeric repeat amplification protocol (TRAP) assay. The 5′-[32P] 
end-labeled TS primer (0.1 μg, 5’-AATCCGTCGAGCAGAGTT-3’) was incubated in a 
reaction mixture (50 μL) [buffer: Tris-HCl (20 mM, pH 8.3), MgCl2 (1.5 mM), KCl (63 
mM), 0.05% Tween 20, EGTA (1 mM)] with cell lysate (1 μL), RP (0.1 μg, reverse 
primer for telomerase extended products, 5’-
GCGCGGCTTACCCTTACCCTTACCCTAACC-3’), NT (0.1 μg, primer for polymerase 
as internal standard, 5’-ATCGCTTCTCGGCCTTTT-3’), TSNT (0.01 amol, template for 
NT primer, 5’-AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3’), 2 units 
of Taq polymerase, dNTP mix (50 μM), and ligand (3.125-100 μM) at 30°C for 30 min 
and 94°C for 2 min to deactivate telomerase. The reaction mixture was then incubated 
using a three-step PCR method (94 °C for 20 s, 59 °C for 30 s, and 72 °C for 30 s) with a 
total of 25 cycles. The reaction solutions were mixed with 10 μL 10×loading dye and 
resolved with 10% denaturing polyacrylamide gel [5% crosslink, 45% urea w/w]. 
3.2.7. MTT cell viability assay. MCF-7 cells (human breast adenocarcinoma 
cells) and HeLa cells (cervical cancer cells) (a generous gift from Dr. William Chan, 
UOP) were maintained in advanced DMEM medium supplemented with 5% fetal bovine 
serum, L-glutamine and antimycotic (antibiotic) at 37 °C in a humid atmosphere 
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containing 5% CO2. The compounds were pre-dissolved in sterilized water. The cells 
(3000 cells/well) were seeded in 96-well plate. After 24h incubation, the supernatant was 
removed followed by adding 200 µl FBS free media containing the compound. After 72h 
incubation, 20 µl MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-di- phenyl tetrazolium 
bromide) (0.5 mg/ml) was added for further another 4h incubation. Formazan product 
was dissolved in 150 µl of DMSO, and the absorbance was measured at 590 nm using a 
TriStar LB 941 Multimode Microplate Reader. Untreated cells and media without cells 





Atreated: The absorbance of the solution containing treated cells 
Amedia: The absorbance of the media 
Auntreated: The absorbance of the solution containing untreated cells 
3.3. Results and Discussion  
3.3.1. 5-substituted 1,10-phenanthroline formed 1-2 and 1-3 complexes with 
Ni(II) ions. Ni2+ ions were reported forming 1-1, 1-2 and 1-3 (Ni2+/Phen) complexes with 
different 1,10-Phen derivatives. In the previous work of our group, a continuous variation 
analysis (Job plot) was performed and the stoichiometry of the complexes 20-Ni and 21-
Ni was determined.198 In these experiments, Ni2+ ions were titrated against compound 20 
and 21, and the UV absorbance was measured after each addition. The molar extinction 
coefficients at 315 nm were plotted against the metal ion molar fraction [metal ion molar 
fraction = metal ion concentration / (metal ion concentration + compound 
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concentration)]. The cross points were determined at 0.34 and 0.30 for 20-Ni and 21-Ni, 
respectively (Figure 3-1). This observation revealed the dominance of forming a 1-2 




Figure 3-1. Job plots obtained based on continuous variation analysis for (A) 20-Ni and 
(B) 21-Ni. 
 
 To further confirm the stoichiometry, we used a triple quadrupole mass 
spectrometer coupled to an electrospray ionization (ESI) source to analyze the 
representative complexes that have a good solubility in methanol (1-Ni, 12-Ni, 15-Ni, 18-
Ni, 20-Ni and 21-Ni). All spectra (Figure A-1 to Figure A-5) are shown in relative 
abundances with the most abundant ion in each spectrum corresponding to 100% ion 
intensity (base peak). 
To study the effect of solvent on complexation, the spectra of Ni-1,10-Phen complex (1-
Ni) were prepared in three different solution compositions with 0%, 50% and 90% 
methanol, respectively. Both of the complex ion [1-2]2+, m/z 209.02, and complex ion [1-
3]2+, m/z 299.12 were identified ( 
Figure 3-2). The [1-3]2+ ion was the more abundant ion under all three conditions. 
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The relative abundance of the 1-2 complex increased from 49.21% to 82.20% with the 
increasing methanol ratio from 0 to 90%. This trend can be a result of the different 




Figure 3-2. ESI spectra of phenanthroline and Ni2+ solutions with a 2:1 molar ratio in 
three different solvent compositions. 
 
Then, five other derivative complexes (12-Ni, 15-Ni, 18-Ni, 20-Ni and 21-Ni) 
were analyzed in 50% MeOH solutions, and both 1-2 and 1-3 complexes were observed 
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for all of them (Figure A-1 to Figure A-5). Different from 1-Ni, all five derivative 
complexes had 1-2 complexes as the more abundant ions compared to the corresponding 
1-3 complexes (Table 3-2). There was no 1-1 complex present in any of the samples. It 
was reported that the mechanism of the kinetics of complexation between Ni2+ and 
phenanthroline derivatives are side-chain dependent. The formation of the complexes can 
be significantly affected by the solvation properties of the ligand with different side 
chains.199 Although the accurate explanation of the side-chain effect remains unclear, the 
five derivative complexes exhibited a notable preference for 1-2 complexation when 
compared to the parent compound 1-Ni. Interestingly, chloride ions were observed in the 
1-2 complexes for 20-Ni and 21-Ni, but not for their 1-3 complexes. It is possible that the 
chloride ions coordinated with the Ni2+ ion instead of interacting with the side chains; 
otherwise, it should also be found for 1-3 complexes and has the same number as the 
compound.  
 
Table 3-2. Characteristic m/z values and the relative abundance (%) in ESI-MS spectra of 
the 1,10-Phen-Ni complexes. 
 
  12-Ni 15-Ni 18-Ni 20-Ni 21-Ni  
 1-2 complexes m/z 367.11










100 100 100 134.28d 112.02d  





47.00 71.02 65.85 100 64.34  
 




The collision-induced dissociation (CID) experiments were used to confirm the 
structures of 20-Ni and 21-Ni. Fragmentation of 20-Ni complex [1-2-Cl]+, m/z 714.8 
produced a complex ion [1-1-Cl]+, m/z 403.8 (Figure 3-3). The ion at m/z 99.9 
representing a side-chain fragment ion (N,N-diethylethenamine) was observed and the 










Scheme 3-1. Fragmentation mechanisms of Phen-Ni complexes in a CID experiment. 
 
Fragmentation of complex ion [1-3]2+, m/z 495.4 produced a complex ion [1-1]+, 
m/z 369.1 and [1-2]+, m/z 679.8 (Figure 3-4). The ion at m/z 579.7 corresponded to a 
fragment ion losing a side chain. Interestingly, the 1-2 complex ion at m/z 679.8 and 1-1 
complex ion at m/z 369.1 in this spectrum were present with a reduced charge state 
(single charge) which was not observed for the fragment ions of 1-2 complexes. This 
unexpected reduction of metal ions was also reported by another group when they 
conducted electrospray mass spectrometry in positive mode, which was attributed to a 
charge transfering.200 The reduction was only found in the product ions of 1-3 complexes, 
indicating that the charge transferring can only take place when Ni2+ is coordinated with 






Figure 3-4. CID spectrum of 20-Ni complex ion [1-3]2+ at m/z 495.4. 
 
Similar to 20-Ni, 1-3 and 1-2 complexes of 21-Ni were also fragmented under the 





Figure 3-5. CID spectrum of 21-Ni complex ion [1-2-Cl]+ at m/z 739.2. 
 
A side chain fragment ion, m/z 111.9 and a complex ion [1-1-Cl]+, m/z 415.8 was 
produced by the fragmentation of the complex ion [1-2-Cl]2+, m/z 739.2 (Figure 3-5). 
Fragmentation of the complex ion [1-3]2+, m/z 513.8 produced a complex ion [1-1]+, m/z 
380.9 and a complex ion [1-2]+, m/z 703.6 (Figure 3-6). The ions at m/z 591.6 was 
corresponding to a fragment [1-1]+ complex ion losing one of the side chains. A fragment 
[1-1]+ ion was also observed at m/z 269.8. Similar to 20-Ni, reduced charge state was 










Figure 3-6. CID spectrum of 21-Ni complex ion [1-3]2+ at m/z 513.8.  
 
In summary, the observations from both continuous variation analysis and ESI 
MS spectrometry measurements suggested that the 5-substituted phenanthroline 
derivatives predominately form a 1-2 complex with Ni2+ ions, which can potentially bind 
to G-quadruplexes with its enlarged aromatic surface. The 1-2 phenanthroline derived 
metal complexes gave better G-quadruplex stabilization effect than the other 
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complexation ratios due to their square planar geometry.180-181  
3.3.2. 5-Substituted Phen-Ni complexes induced telomeric G-quadruplex 
formation under Na+ and K+ deficient conditions. Circular Dichroism (CD) 
spectrometry is frequently used to analyze G-quadruplex conformations and the CD 
spectral features can be empirically correlated to the conformational structures of G-
quadruplexes. In the present work, we used CD spectroscopy to confirm that 20-Ni and 
21-Ni can induce the formation of G-quadruplexes in the absence of cations, which 
indicated their strong G-quadruplex binding affinities.198 In these experiments, a CD 
spectrum was first recorded for a solution containing the human telomeric DNA sequence 
PCG1 (G4, 5’-AGGGTTAGGGTTAGGGTTAGG GT-3’) without Na+ or K+. It exhibited 
a negative peak at 238 nm, a major positive peak at 257 nm and a minor positive peak at 
295 nm, representing a typical random coil. Then, aliquots of 20-Ni and 21-Ni were 
gradually added into the solution respectively, and the CD spectra were measured after 
each addition. The change of the molar ellipticity revealed a transition of the 
conformation from a random coil to an antiparallel G-quadruplex conformation (Figure 
3-7). With the concentration of the complexes increasing from 0 to 20 µM, the peaks at 
238 and 257 nm decreased, a positive peak at 295 nm and a negative peak at 260 nm 
appeared. This observation is consistent with a previous report.169 In order to confirm that 
the G-quadruplex was induced by the complexes but not the free 5-substituted 
phenanthroline derivatives, 20 and 21 were also titrated against the human telomeric 
DNA sequence under the same condition. Slightly conformational change was observed 
for 20, but this change was significantly smaller compared to the one observed for 20-Ni. 
Addition of 21 gave nearly no change of the molar ellipticity (Figure 3-7). These 
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observations suggested that 20-Ni and 21-Ni are strong G4 ligands and promoted us to 
carry out further studies to achieve a broader picture for the G-quadruplex binding 











Figure 3-7. CD spectra of PCG1 measured when titrating with A) 20-Ni; B) 20; C) 21-Ni; 
D) 21. The continuous changes in the CD spectra correspond to the incremental amount 
of Phen-Ni ranging from 0 -20 µM. DNA = 5 µM. 
 
3.3.3. 5-Substituted Phen-Ni complexes with cationic and aromatic side 
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chains increased the thermal stability of telomeric G-quadruplex DNA. In previous 
studies, a high-throughput thermal denaturation experiment of G-quadruplex DNA 
monitored by Förster Resonance Energy Transfer (FRET), was conducted to investigate 
the stabilization effects of all twenty-one complexes.198 In this experiment, a fluorescence 
(fluorescein) and a quencher (DABSYL) molecule were linked to the two ends of the 
same human telomeric G-quadruplex sequence (5’-Fluorescence 
AGGGTTAGGGTTAGGGTTAGGGT-3’-DABSYL) and form the G-quadruplex (G2). 
When the G-quadruplex is folded, the fluorescence signal can be quenched by the 
proximate quencher. When the G-quadruplex is dissociated at a temperature above the 
melting temperature (Tm), the fluorescence signal can be restored because unfolding the 
G-quadruplex into a random coil makes fluorescein and DABSYL quencher apart. The 
Tm is defined as the temperature, at which 50% of the G-quadruplexes dissociate into 
random coils. It can be extrapolated by the first derivatives from the plots of the 
fluorescence intensities against the temperatures. The G-quadruplex melting experiments 
were conducted in the presence of complexes Phen-Ni or their metal free compounds 
Phen with a 4:1 (ligand: DNA) ratio on a 96 well plate using a real-time PCR machine, 
and the derived ΔTm values (Tm increment compared to the compound free control 57.7 




Table 3-3. Tm values of G-quadruplex derived from fluorescent thermal denaturation in 
the presence of free compound or Ni2+ complexes at a 4:1 ligand/DNA ratio. 
 
 Compound  1 2 3 4 5 6 7  
 R Group 
No 
ligand 
H       
 
 Phen 57.5 57.3 58.4 58.4 57.8 58.4 56.6 57.0 
 
 Phen-Ni 57.5 62.3 64.4 60.0 67.7 65.0 66.5 58.2 
 
 
Compound 8 9 10 11 12 13 14 15  
 R Group        
 
 
 Phen 57.2 57.0 57.0 57.0 57.0 57.2 56.0 56.4 
 
 Phen-Ni 58.2 58.4 68.0 60.2 57.6 63.2 60.0 56.0 
 
 Compound 16 17 18 19 20 21   
 







 Phen 58.4 56.4 56.4 57.0 59.2 57.0   
 




Firstly, in the absence of Ni2+, compound 1 (1,10-phenanthroline) gave no Tm 
increment on the G-quadruplex melting temperature (57.3 ˚C) compared to the free G-
quadruplex sample (57.5 ˚C). 1-Ni increased the melting temperature to 62.3 ˚C while 
free Ni2+ showed no effect. Therefore, it is safe to conclude that Phen-Ni can stabilize G-
quadruplex and this effect comes from the complexation with Ni2+ ions. The 
complexation provides an enlarged aromatic surface that aptly stacks on the G-quartets. 
Like phenanthroline, none of the 5-substituted compounds stabilized the G-quadruplex in 
the absence of Ni2+ because of their relatively small aromatic planar structures. The 
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observation was consistent with previously reported studies from other groups.169, 180-181   
Stabilization effects were observed for eighteen Ni-containing complexes except 
12-Ni and 15-Ni. The Tm value in the presence of 15-Ni, with an octyl side chain, was 
56.0 °C which was lower than the control (57.5 °C), suggesting that octyl group 
significantly affected the G-tetrad stacking ability of the ligand. In principle, it is well 
acknowledged that a long hydrophobic alkyl chain without positive charges cannot 
efficiently interact with DNA phosphate backbones.  
 
 
Figure 3-8. ΔTm (Tm increment compared to the compound free control 57.7 ˚C) values of 
G-quadruplex derived from fluorescent thermal denaturation in the presence of Phen-Ni 
at a 4:1 ligand/DNA ratio. π: Complexes with aromatic side chains; +: Complexes with 
cationic side chains, and the pKa value of conjugate acid is between 2.0 and 7.0; ++: 





Nine (20-Ni, 21-Ni, 10-Ni, 4-Ni, 6-Ni, 5-Ni, 2-Ni, 17-Ni and 13-Ni) out of 
eighteen G-quadruplex stabilizing complexes have better stabilizing effects according to 
the Tm values, compared to 1-Ni. In these nine compounds, five of them (20-Ni, 21-Ni, 
10-Ni, 6-Ni, 5-Ni and 9-Ni) have side chains that can be positively charged (Figure 3-8). 
To understand the significance of the positive charges in G4 ligands, we compared the 
pKa values of the positively charged sites in these compounds (Table 3-4). Complexes 5-
Ni, 20-Ni, and 21-Ni all contain amines that can be readily protonated and form positive 
charges under physiological conditions (pKa value of conjugate acid > 7.0). Indeed, these 
three compounds were all found with stabilization effects for G-quadruplexes. Complexes 
containing nitrogen atoms with lower pKa values are unlikely to be protonated under the 
physical condition. Most of them were found with much less significant stabilization 
effects on the G-quadruplex such as 9-Ni, 14-Ni and 17-Ni. This observation is consistent 
with previously reported studies that cationic side chains can enhance G-quadruplex 





Table 3-4. Approximate pKa value of conjugate acid of the designated side chains of 5-
substituted phenanthroline. 
# 






























   
11.1202 
*: pKa values were determined experimentally in the publications for a same 
functional group.  
 
 
Except for positive charges, aromatic stacking is the other critical contributing 
factor for G-quadruplex stabilization. Out of the nine complexes that efficiently stabilize 
G-quadruplex here, four of them (10-Ni, 6-Ni, 17-Ni and 13-Ni) have aromatic side 
chains. Although, overall, the aromatic side chain tethered complexes exhibited less 
stabilization effect compared to those with cationic side chains in this assay, it is 
important to note that aromatic motifs may provide better selectivity for the G-
quadruplex over duplex DNA because the former contains a more extended aromatic 
surface for stacking.  
In addition to the positive charge and stacking surface, there are other factors 
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enhancing the G-quadruplex binding. 2-Ni and 17-Ni have a hydroxy or carbonyl group, 
which may form hydrogen bonds with nucleobases or DNA backbones as a hydrogen 
donor or acceptor.162-163 Hence, due to the complexity of G-quadruplex stabilizing factors, 
an accurate side-chain rule for Phen-Ni as G4 ligands cannot be successfully acquired. 
However, a general trend can still be concluded. Based on the results from the FRET 
assay, both cationic side chains and aromatic side chains are important factors for G-
quadruplex stabilization.  
In general, these observations were consistent with the previously reported G4 
ligands that cationic motifs can significantly enhance the G-quadruplex binding affinity. 
However, it is important to notice that, although FRET is a frequently used method for 
screening G4 ligands in a high-throughput fashion, this method has its disadvantages. The 
interference from the fluorophore and quencher molecules exists.206 The add-on 
fluorophore and quencher molecules could affect the stability and conformation of the G-
quadruplex. Meanwhile, the fluorescence signal is also temperature and pH dependent 
which may introduce some bias to the data. Additionally, the interaction between the 
fluorophore/quencher molecules and ligands may exist. Hence, it is necessary to cross-
inspect the FRET assay results using other methods as described below. 
3.3.4. Aromatic side-chains enhanced the stacking affinity and selectivity of 
5-substituted Phen-Ni complexes against telomeric G-quadruplex DNA. The binding 
of Phen-Ni to the telomeric G-quadruplex was further investigated by the fluorescent 
intercalator displacement (FID) assay. Meanwhile, we also investigated the binding of 
Phen-Ni to duplex DNA using the same method. Molecules as such with a large stacking 
surface, in general, could also bind to duplex DNA. Because duplex DNA is more 
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abundant than G-quadruplex DNA in vivo, it is important to study the selective binding of 
Phen-Ni to G-quadruplex DNA over duplex DNA, which is crucial to develop 
telomerase-specific inhibitors. In our experiments, thiazole orange (TO) was first bound 
to G-quadruplex DNA (G1) or duplex DNA (D1), and the pre-bound TO was 
successively displaced out of DNA by the addition of a ligand. The binding of TO is 
known to be end stacking and such binding is reversible. Upon binding to DNA, TO 
fluorescence increases 1000-fold compared to free TO in solution that has a negligible 
quantum yield. When bound TO is displaced out of DNA by a DNA ligand, a dramatic 
decrease of fluorescence is detected. The amount of ligand needed to displace 50% of 
pre-bound TO is defined as G4DC50 for G-quadruplex and 
dsDC50 for duplex DNA. Both 
values can be used to compare the relative binding affinities of the ligand to G-
quadruplex and duplex DNA.186 
11-Ni and 7-Ni exhibited higher G4DC50 values compared to 1-Ni. 11-Ni gave the 
worst G4DC50 value (46.1 μM) amongst all Phen-Ni compounds probably due to the 
repulsion between the negatively charged amine oxide and DNA backbones. Glucose is 
not an effective side chain for G4 ligands as the G4DC50 value for 7-Ni was also amongst 
the worst, 29.9 µM. Though the sugar moiety could interact with DNA grooves via H-
bonding,121 the linker of 7-Ni may not be long and flexible enough to properly position 





Figure 3-9. The G4DC50 values of all Phen-Ni complexes from the FID assay. 
  
 The corresponding rank order of Phen-Ni with G4DC50 values less than 5 
µM was 3-Ni < 10-Ni < 13-Ni < 16-Ni < 21-Ni < 17-Ni < 14-Ni < 20-Ni < 19-Ni < 8-Ni 
< 12-Ni. This order did not exactly match the order of these complexes from the thermal 
denaturation experiments with G2 (Table 3-3). For instance, 21-Ni and 20-Ni that 
stabilized G2 the most were only ranked at the 5th and 8th. 3-Ni showed no significant 
thermal stabilization of G2 (Tm = 60.0 °C); however, it exhibited the lowest 
G4DC50 value 
(0.92 μM). Other discrepancy was also overserved. 6-Ni showed a very high G4DC50 
value (30.5 μM) but with a good stabilization of G2 (Tm = 66.5 °C). Such discrepancy for 
3-Ni and 6-Ni could result from the interference of fluorophore and quencher with the 
complexes in solution in fluorescence melting as mentioned in the previous section.206 
Another plausible explanation of the observed discrepancy, especially for complexes 
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containing positively charged side chains such as 21-Ni and 20-Ni is the difference in 
binding sites. In the melting experiments monitored by fluorescence, the thermal 
stabilization of G-quadruplex DNA is direclty correlated to the binding affinity of the 
ligand. 21-Ni and 20-Ni gave the highest Tm values of G2 probably because they both 
contain a positively changed side chain that electrostatically interacted with DNA 
backbones and further stabilized DNA. On the other hand, such an interaction may cause 
21-Ni and 20-Ni not to bind to the exact site as TO binds. Therefore, in the FID assay, the 
displacement of TO by 21-Ni and 20-Ni is not as efficient as that by other ligands, 
resulting in slightly higher G4DC50 values. Further evidence of this explanation comes 
from the observation that except for 20-Ni and 21-Ni, all the complexes with low G4DC50 
values contain an aromatic moiety as a side chain. The proper alignment of the aromatic 
side chains could enhance their end-stacking with G-quartets and more efficiently 
displace TO out of G-quadruplex DNA. Without Ni2+, 5-substituted phenanthrolines 20 
and 21 could not act as potent G4 ligands because their G4DC50 values were drastically 
large, 83.2 μM for 20 and 72.3 μM for 21. The G4CD50 values for 20 and 21 were 28 times 
and 36 times higher than those of 20-Ni and 21-Ni, respectively (Figure 3-10). The 
compounds 20 and 21 also showed no stabilization of G2 in the melting experiment 
monitored by FRET. These observations suggest that the end-stacking interaction is an 





Figure 3-10. The G4DC50 values of free 20, 21 and 20-Ni, 21-Ni determined by FID assay. 
 
For eleven complexes (except for 10-Ni and 16-Ni, reason explained in the next 
section) with a G4DC50 value less than 5 µM, their corresponding 
dsDC50 values (Figure 
3-11) were measured using a DNA duplex (D1), and their selectivity of G-quadruplex over 
duplex was determined by the ratio of dsDC50/
G4DC50. The rank order for such selectivity 
was 3-Ni (8.2) > 14-Ni (7.2) > 13-Ni (5.5) > 17-Ni (5.1) > 19-Ni (4.1) > 8-Ni (3.9) > 12-
Ni (2.7) > 20-Ni (2.3) > 21-Ni (1.4). 20-Ni and 21-Ni containing cationic groups at 
physiological pH gave the worst selectivity amongst these nine complexes. The G4DC50 
value for 20-Ni was 2.99 µM, 2.3 fold lower than its dsDC50 (6.94 µM). It is clear that 20-
Ni more preferably binds to G-quadruplex than duplex DNA. The G4DC50 value of 21-Ni 
was 2.01 µM, 1.5 fold lower than that of 20-Ni, suggesting that 21-Ni is a slightly stronger 
G4 ligand. However, the selectivity of 21-Ni to G-quadruplex over duplex was worse than 




(2.75 µM). Although the piperidine moiety in 21-Ni is a known effective side chain for G4 
ligands, its ability to dictate binding selectivity is strongly pH-dependent. Kerwin and 
coworkers reported that PIPER (with piperidine as a side chain) had diminished binding 
selectivity for G-quadruplex and duplex DNA at low pH.207 The G4DC50 value was 23.4 µM 
for 1-Ni, 7.7 fold and 11.6-fold higher than that of 20-Ni and 21-Ni, respectively. This 
observation clearly reveals that side chains at the 5 position are important for developing 
such phenanthroline-based G4 ligands.  
 
 
Figure 3-11. The G4DC50 and 
dsDC50 values of the Phen-Ni complexes from the FID 
assay. 
 
Overall, the results obtained from the FID assay were somewhat in agreement 
with the data from the thermal denaturation experiments. However, a clear discrepancy 
between G4DC50 and Tm values could not be neglected. Thermal denaturation monitored 
122 
 
by fluorescence is suitable to capture a coarse picture of the effect of Phen-Ni on G-
quadruplex stabilization in a high-throughput manner; however, it cannot provide precise 
information due to the nature of its system. Indeed, in the thermal denaturation 
experiments monitored by fluorescence, we were not able to observe a saturation plateau 
of the melting temperature (Tm) even when the concentration of Phen-Ni was increased to 
a ligand/DNA ratio of 10. Such a saturation plateau was observed when we conducted 
thermal denaturation of a native G-quadruplex DNA (same sequence as G2) monitored by 
circular dichroism, suggesting the possible interference amongst fluorescein, DABSYL 
and Phen-Ni. The FID assay allows us to directly compare the binding affinities of the 
ligands with similar binding modes semi-quantitatively. It is particularly useful to 
compare the binding selectivity of the ligands between G-quadruplex and duplex DNA. 
The results presented above further validates that cross inspection of the fluorescence 
melting data with other methods is important. It is necessary to point out that the 
observed discrepancy between the data from fluorescence thermal denaturation and FID 
could also result from the temperature dependence of affinities in Tm. Nevertheless, all 
the biophysical methods mentioned above clearly indicate that side chains and Ni2+ ions 
are two crucial factors to make 5-substituted phenanthrolines good G4 ligands. A 
positively charged side chain tethered to the 5-position of phenanthroline is a structural 
motif for enhancement of the binding affinity G-quadruplex DNA but it has little effect 
on the selectivity for G-quadruplex over duplex DNA. By contrast, an arylsulfanyl group 
tethered to the 5-position of phenanthroline is useful to improve both the binding affinity 
and selectivity of the ligand because it expands the stacking surface of the ligand. The 
surface of G-quartets is much larger than base pairs; therefore, ligands with expanded 
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stacking surface bind more tightly to G-quadruplex DNA than duplex DNA. 
3.3.5. 5-Substitued Phen-Ni complexes inhibited telomerase activity in vitro. 
Upon confirming the binding and stabilization of telomeric G-quadruplex DNA by our 
novel 5-substituted phen-Ni complexes, we investigated their inhibition of human 
telomerase activity in vitro using a TRAP (Telomeric Repeat Amplification Protocol) 
assay. As discussed in the previous sections, telomerase is an enzyme that can bind and 
extend telomeric DNA and maintain the telomere length. Telomerase is over-expressed in 
90% of tumors and helps cancer cells to compensate telomere shortening. It is well 
acknowledged that stabilized G-quadruplexes formed by the telomeric DNA can 
efficiently inhibit the telomerase binding and extension activity. Therefore, in the 
development of G4 ligands and telomerase inhibitors, quantitative analyses of telomerase 
activity are crucial, and the most frequently used method is the TRAP assay. 
Before PCR became an extensively used technique, telomerase activity had been 
directly studied in vitro by the following method. Radioactively labeled nucleotide 5’-
triphosphates were incorporated to its substrate sequence by telomerase. The resulting 
radioactive products were measured using autoradiography. Due to the low abundance of 
telomerase in living cells, the quantitation of telomerase activity with this assay was not 
reliable, even a large amount of radioactive materials were used.208-209 To increase the 
detection sensitivity, Kim and coworkers developed the first PCR-based TRAP assay. It 
can also be used for the detection of telomerase activity in a high throughput fashion.92  
A PCR-based TRAP assay can be divided into two main stages: elongation of 
primers by telomerase and subsequent amplification of telomerase products using PCR. 
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In the elongation stage, the primer oligonucleotides (TS) are extended with addition of 
repeat segment (5’-TTAGGG) by telomerase. The pure form of telomerase is not 
commercially available. The experiments are normally conducted by using cell lysate 
extracted from telomerase-positive cells such as HeLa cells. In the following PCR 
amplification stage, these extended products are used as the templates and amplified in 
the presence of a reverse primer ACX. Utilization of the PCR amplification significantly 
increases the detection sensitivity; therefore, the products can be detected using low-dose 
radioactive materials or even conventional fluorescent DNA dyes such as SYBR Green 
(Figure 3-12).   
 
 
Figure 3-12. Scheme of a TRAP (Telomeric Repeat Amplification Protocol) assay for 
telomerase activity detection.  
 
In the present work, we explored the feasibility of using two different TRAP 
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assays. In the first method (real-time PCR TRAP), we conducted the PCR amplification 
in a real-time PCR machine and monitored the amplified products using SYBR Green. 
This assay was carried out in a 96-well plate in a high throughput fashion, which in 
principle can screen hundreds of compounds in a 3-4 hours period. The biggest advantage 
of this method is free of radioactive materials. In the second method, we used a 5’-32P 
labeled primer in the PCR amplification and the final products were measured using 
autoradiography. Both methods will be explicitly discussed in the following section.  
Real-time PCR TRAP. SYBR Green is a conventional DNA dye. Upon binding to 
DNA, it fluoresces with an excitation wavelength 497 nm (blue light) and an emission 
wavelength 520 nm (green light). The intensity of the fluorescence is positively 
correlated to the amount of the DNA present in solution. During the real-time PCR 
amplification, the fluorescence of the solution is recorded after each thermal cycle, and 
the intensities are plotted versus the cycle number. Telomerase-positive cell lysate can 
extend the primer to yield products that are used as templates in the PCR amplification. 
The fluorescence intensity of such a sample increases as a function of increasing thermal 
cycle numbers in PCR. No fluorescence increment can be observed if telomerase-
negative cell lysate is used. A threshold of the fluorescence intensity was set as 10 times 
over the deviation of the background in a DNA free sample. The thermal cycle number is 
needed to reach the threshold is defined as a Ct value. In the presence of a G4 ligand, 
telomerase is inhibited so it produces fewer extended products, namely fewer template 
copies for PCR amplification. Hence, more thermal cycles (Ct) are needed to reach the 
fluorescence threshold. The Ct value is correlated to the ability of a G4 ligand to inhibits 
telomerase. The greater the Ct value is, the stronger the inhibition effect is. To determine 
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this concept, we used a well-studied G4 ligand TMPyP4 as a model compound. The 
results are shown in Figure 3-13. In the absence of TMPyP4, it requires 25 thermal cycles 
to reach the threshold. As the concentration of TMPyP4 increases, more thermal cycles 
are needed to reach the same threshold. For instance, in the presence of 6.25 µM 
TMPyP4, it requires 34 cycles to reach the threshold. When the concentration of TMPyP4 
are larger than 12.5 µM, the threshold cannot be reached even after 41 thermal cycles that 




Figure 3-13. The results of real-time PCR TRAP concentration-dependent inhibition 
profile for TMPyP4. 
 
All twenty-one Ni containing complexes and the free phenanthroline derivatives 
were studied by this real-time PCR TRAP assay (Figure 3-14). In the absence of Ni2+, all 
compounds except for 13 exhibited no telomerase inhibition effect. This observation is 
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highly consistent with the data from the FRET and FID assays. 5-Substituted 
phenanthroline derivatives are not good G4 ligands due to the relatively small aromatic 
surfaces. Interestingly, compound 13 showed a telomerase inhibition effect in this TRAP 
assay, but it had no G-quadruplex binding ability based on other two assays. Hence, 
compound 13 was suspected to be a telomerase inhibitor that may directly affect the 
telomerase without interactions with DNA. This assumption warrants further 
investigation.  
Ni2+ containing complexes 3-Ni, 8-Ni, 10-Ni, 12-Ni, 13-Ni, 14-Ni, 16-Ni, 17-Ni, 
19-Ni, 20-Ni, and 21-Ni had Ct values that were greater than 40 (pre-defined limitation of 
the thermal cycle numbers), suggesting the inhibition of telomerase activity by these 
complexes. These results were highly consistent with the previous conclusion from the 
FID experiments that they are good G4 ligands. However, there are nonnegligible 
discrepancies between the TRAP and the FRET assay. Complexes 19-Ni, 16-Ni, 3-Ni, 14-
Ni, 8-Ni and 12-Ni showed higher G-quadruplex binding affinities (determined by the 
FID assay) and better telomerase inhibition effects (determined by the TRAP assay) than 
1-Ni. However, none of them showed a G-quadruplex stabilization in the FRET assay, 
compared to 1-Ni. This discrepancy further validates our previous discussion in section 
3.3.3 that the FRET assay has certain disadvantages: The G-quadruplex conformation and 
ligand binding can be affected by fluorescence and quencher molecules; the fluorescence 
signals can be disturbed by ligands, temperature, and pH conditions. Interestingly, all the 
complexes that were underestimated in the FRET assay only contain aromatic side 
chains. Therefore, it is reasonable to conclude that the aromatic moieties at the 5-position 
of phenanthroline derivatives may have a notable interference with the fluorophore in the 
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FRET assay.   
 
 
Figure 3-14. Ct values acquired from the real-time PCR TRAP assay for twenty-one 
complexes.  
 
Concentration-dependent studies were performed for the above effective 
telomerase inhibitors using the real-time PCR TRAP assay. The TRAP reactions were 
performed in the presence of ligands at various concentrations ranging from 0 to 100 µM, 






Figure 3-15. Ct values acquired from the real-time PCR TRAP assay for the 
concentration studies of effective inhibitors. 
 
Clear concentration-dependent telomerase inhibition effects were observed for all 
the inhibitors (Figure 3-15). To compare their inhibition effects, a telomerase inhibition 
factor was defined as the integrals of the areas under the curves in Figure 3-15 for each 
complex. Overall, the rank order of the inhibition effects obtained from the TRAP assay 
(Figure 3-16) is somewhat in agreement with the data from the FID experiments (Figure 
3-9). Complexes 10-Ni, 16-Ni, and 3-Ni exhibited the best inhibition effects in the TRAP 
assay, and they all showed strong binding affinities in the FID assay. Compound 13, in 
the absence of Ni2+ ion, was a strong telomerase inhibitor without G-quadruplex 
interactions and addition of Ni2+ ion even decreased its inhibition effect. The rest of the 
inhibitors were all observed with efficient G-quadruplex binding in the FID assay with a 




Figure 3-16. Telomerase inhibition factors calculated from the real-time PCR TRAP 
assay for effective inhibitors. 
 
Although the real-time PCR TRAP assay is a high-throughput protocol to study 
telomerase inhibitors, it has a major disadvantage. In this assay, the telomerase products 
produced by telomerase in the first step and subsequently amplified by DNA polymerase 
and quantified using SYBR Green in the second step. Theoretically, the formation of the 
PCR products can be inhibited in either the telomerase elongation stage or the DNA 
replication stage. Ideally, when telomerase adds more than four 5’-TTAGGG-3’ repeats to 
the TS primers, a G-quadruplex can be induced and stabilized by a G4 ligand in 
solutions. Then, the G-quadruplexes will inhibit the binding of telomerase and stop the 
further extensions. This leads to fewer telomerase products as templates in the following 
PCR process, resulting in a larger number of thermal cycles to reach the threshold. 
However, the ligands of interest can potentially bind to duplex DNA as well due to the 
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nature of its stacking surface. Such binding could inhibit DNA polymerase activity in the 
PCR step. If a ligand binds to duplex DNA not G-quadruplex DNA, it will give a false 
positive result because more thermal cycles are still needed to reach the threshold. In this 
scenario, a telomerase inhibitor and a duplex DNA binder will give similar results in the 
real-time PCR TRAP assay. This possibility could not be neglected especially for some of 
our complexes such as 20-Ni and 21-Ni that function as both telomerase inhibitors and 
duplex DNA binders in real-time PCR experiments. To clarify, we further performed an 
electrophoresis-based 32P TRAP assay to get a more detailed picture of the telomerase 
inhibition effects of the 5-substituted phenanthroline Ni2+ complexes.  
Electrophoresis-based 32P TRAP assay. In a radioactive TRAP assay, the TS 
primers are labeled at the 5’-end with a 32P phosphate group. Thus, when the PCR 
products are resolved in an acrylamide gel, the extended TS primers with different copies 
of 5’-TTAGGG-3’ can be separated by electrophoresis and form a ladder. The gel is 
visualized by autoradiography and the length of the ladders is correlated to the telomerase 
activities. To determine whether the positive effects resulting from inhibition of 
telomerase or inhibition of DNA polymerase, we added an internal standard 
oligonucleotide TSNT and its reverse primer NT into the reactions. TSNT is a non-G-rich 
oligonucleotide that cannot be extended by telomerase. It can be replicated by DNA 
polymerase using TS as the forward primer and NT as the reverse primer. Using this 
modified method, several scenarios could exist. If a ligand binds to G-quadruplex DNA 
but does not affect DNA polymerase, we should observe the PCR products of TSNT and 
no elongated products from telomerase extension. If the ligand has no effect on both 
telomerase and DNA polymerase, we should observe both TSNT products from PCR and 
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elongated products by telomerase. If the ligand only inhibits DNA polymerase activity, 
we should observe elongated products from telomerase and no TSNT products from PCR. 
Therefore, the presence of the TSNT products can report the ligands selectivity against 
G-quadruplex (telomerase) over duplex DNA (polymerase).  
We first analyzed all the complexes with the 32P-TRAP at a relatively high 
concentration (50 µM). The internal standard TSNT is a 36 nt (nucleotide) product (IS, 
Figure 3-17) that has a higher mobility than the products elongated by telomerase on the 
gel. The length of telomerase products starts from 50 nt and they form a ladder with a 6 nt 
gap between two adjacent bands (Figure 3-17). Regardless the hybridization position of 
the primer (RP) on TS, the first three telomerase products are all 50 nt long (Figure 3-17). 
Thus, the band representing the 50 nt long product has a high intensity on the gel. In the 
presence of a G4 ligand, the formation of the first three telomerase products will not be 
inhibited, because the products are not long enough to form a G-quadruplex. Therefore, 




Figure 3-17. Illustration of the telomerase-extended products in a TRAP assay.  
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We employed two well studied small molecules BIBR and TMPyP4 (50 µM and 
100 µM) as the control compounds. BIBR is a noncompetitive telomerase inhibitor 
without interactions with DNA.210 TMPyP4 is a well-studied DNA ligand that binds to 
both G-quadruplexes and duplex DNA.211-212 In the resulted gel, a telomerase positive 
control lane (lane 1in Figure 3-18) gave a clear ladder for telomerase products with 
different lengths and an internal standard band (IS) located at the bottom. A telomerase 
negative control lane (lane 14 and 28) only showed an internal standard band. In the 
presence of BIBR, no telomerase products ladder can be found, and the intensity of the 
internal standard was not affected suggesting that it only inhibits telomerase not DNA 
replication (lane 2). When TMPyP4 was added, both telomerase products ladder and the 
internal standard disappeared suggesting the inhibition of both telomerase and DNA 
polymerase activities (lane 3). The twenty-one complexes were studied with this TRAP 
assay at a concentration of 50 µM, and the results are highly consistent with the data from 
previous experiments (lane 5 to 27). Complexes 3-Ni, 8-Ni, 12-Ni, 13-Ni, 14-Ni, 17-Ni, 
19-Ni, 20-Ni, and 21-Ni inhibited telomerase activity with various selectivity. Complexes 
3-Ni, 8-Ni, 17-Ni, 21-Ni, and 20-Ni had strong inhibition effects at this concentration 
because both the telomerase elongated products and internal standards were completely 
missing. For these complexes, it is necessary to perform a concentration-dependent study 
because when the duplex amplification was completely inhibited, it was not clear if the 
telomerase extension was inhibited or not. Complexes 13-Ni and 14-Ni gave a better 
selectivity at the same concentration than the others, and the internal standards were not 
affected. Meanwhile, the effect of 10-Ni and 16-Ni was not able to be analyzed using 
electrophoresis. Their PCR products remained in the loading wells of the acrylamide gels 
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probably due to DNA condensation by these two complexes. The reason of this 




Figure 3-18. 32P TRAP reactions for all Phen-Ni complexes (50 µM). Reactions in the 
absence or presence of Ni2+ (50 μM), BIBR (50 μM), and TMPyP4 (100 μM) were 
carried out as controls. IS: PCR product as internal standard (TSNT as template). The 
reaction in the right lane has no telomerase. 
 
 The results of concentration-dependent experiments for 13 and 13-Ni are shown 
in Figure 3-19. Inhibition of telomerase by 13 was observed when its concentration was 
larger than 25 µM. No inhibition of DNA polymerase activity by 13 was observed even at 
the concentration of 50 µM. When 13 was coordinated with Ni2+ ions, the resulting 13-Ni 
showed significantly decreased telomerase inhibition effect. The inhibition of telomerase 
activity was barely observed when 30 µM of 13-Ni was used. By contrast, no inhibition 
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of DNA polymerase by 13-Ni was observed up to 50 µM. All these results are consistent 
with the data from the real-time PCR TRAP assay. It is reasonable for us to conclude the 
13 may inhibit telomerase activity via the direct interaction with the protein, not the G-
quadruplex formation approach. The detailed mechanism of action is still unclear. It is 
noteworthy that the complex 13-Cu (50 µM) formed by mixing 13 and Cu2+ in a 1:2 ratio 
also showed the inhibition effect of telomerase activity.   
 
 
Figure 3-19. 32P TRAP reactions in the presence of 13 (left) at concentrations of 50, 25, 
12.5, 6.25 and 3.125 µM (from left to right). 32P TRAP reactions in the presence of 13-Ni 
(right) at concentrations of 50, 40, 30, 20, 15 and 10 µM (from left to right). Reactions in 
the presence of 13-Cu2+ (50 μM), Ni2+ (50 μM), BIBR (50 μM), and TMPyP4 (100 μM) 




The complex 14-Ni also exhibited a significant telomerase inhibition effect at 25 
µM (Figure 3-20). No inhibition of DNA polymerase activity was observed in the 
presence of 50 µM 14-Ni, suggesting selective inhibition of telomerase over DNA 
polymerase could be achieved under the concentration range used. In the presence of 50 
µM 14, the inhibition of both telomerase and DNA polymerase was not observed. Unlike 
13-Cu, the complex 14-Cu (50 µM) could not inhibit telomerase activity. 
 
 
Figure 3-20. 32P TRAP reactions in the presence of 14-Ni at concentrations of 50, 25, 
12.5, 6.25 and 3.125 µM (from left to right). Reactions in the presence of 14 (50 μM), 14-
Cu2+ (50 μM), Ni2+ (50 μM) and BIBR (50 μM) were carried out as controls. IS: PCR 
product as internal standard (TSNT as template). 
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In the presence of 50 µM 8-Ni, the inhibition of DNA polymerase and telomerase 
activity was observed. Selective inhibition of telomerase over DNA polymerase was 
detected in the presence of 45 µM 8-Ni. The minimal telomerase inhibitory concentration 
of 8-Ni was 25 µM. As a comparison, compound 8 did not exhibit any telomerase and 
DNA polymerase inhibition at 50 µM. 
    
 
Figure 3-21. 32P TRAP reactions in the presence of 8-Ni at concentrations of 
50,45,40,35,30,25 and 20 µM (from left to right). Reactions in the presence of 8 (50 μM), 
BIBR (50 μM) and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as 
internal standard (TSNT as template). 
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In the presence of 30 µM 17-Ni, the inhibition of both DNA polymerase and 
telomerase activity was observed (Figure 3-22). Selective inhibition of telomerase over 
DNA polymerase was detected in the presence of 25 µM 17-Ni. The minimal telomerase 
inhibitory concentration of 17-Ni was 15 µM. As a comparison, compound 17 at 50 µM 




Figure 3-22. 32P TRAP reactions in the presence of 17-Ni at concentrations of 30, 25, 20, 
15 and 10 µM (from left to right). Reactions in the presence of 17 (50 μM), BIBR (50 
μM) and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as internal 
standard (TSNT as template). 
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The results of 3-Ni were similar to all the complexes mentioned above except that 
it has worse inhibitory selectivity for telomerase over DNA polymerase (Figure 3-23). At 
the concentration of 30, 40 and 50 µM 3-Ni, the inhibition of both enzymes was 
observed. In the presence of 20 µM 3-Ni, the inhibition of telomerase activity was 
detected while no inhibition effect on DNA polymerase was observed. 3-Ni at 10 µM 
showed no inhibition effect on both enzymes, suggesting a very narrow concentration 
range for selectivity inhibition of telomerase over duplex DNA polymerase.   
 
 
Figure 3-23. 32P TRAP reactions in the presence of 3-Ni at concentrations of 
50,40,30,20,10 and 5 µM (from left to right). Reactions in the presence of 3 (50 μM), 
BIBR (50 μM) and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as 




All the Phen-Ni mentioned contain an aromatic moiety (arylsulfanyl group) at 5-
position of phenanthroline. In this section, we studied two complexes 20-Ni and 21-Ni 
that contain a positively charged side chain. At the highest concentration (50 µM), 
inhibition of both telomerase and polymerase was observed (Figure 3-24). Between 6.25 
and 25 µM, the telomerase extension product bands gradually decreased as a function of 
increasing ligand concentration while the intensity of the PCR product remained 
unchanged, a strong evidence of selective inhibition of telomerase over polymerase by 
these two complexes. No telomerase inhibition could be detected at 3.125 µM, the lowest 
ligand concentration used. Interestingly, when the TRAP reactions were conducted with 
either 20 or 21 with Cu2+, in a 2:1 ratio, no inhibition effect could be observed. Phen and 
Cu2+ most likely form a geometry intermediate between the trigonal bipyramid and 
square pyramid213 which stacks to G-quadruplex DNA less efficiently. Several complexes 
formed by coordination of phenanthroline and Cu2+ ions have been used as G4 ligands. 
However, they were modified by attaching side chains at the inner crescent side of 
phenanthroline. These side chains are closer to the chelation sites of phenanthroline can 





Figure 3-24. 32P TRAP reactions in the presence of 20-Ni (left) and 21-Ni (right) at 
concentrations of 50, 25, 12.5, 6.25 and 3.125 µM (from left to right). Reactions in the 
presence of 20 or 21 (50 μM), 20-Cu2+ or 21-Cu2+ (50 μM), Ni2+ (50 μM), BIBR (50 μM) 
and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as internal standard 
(TSNT as template). 
 
It is noteworthy that the concentration of Phen-Ni to inhibit the telomerase 
activity reported here were comparable with other known G4 ligands such as PIPER214-215 
and phenanthroline derivatives216. Our TRAP results were in close agreement with the 
data from the FID assay-most of the complexes with a low G4DC50 value showed a good 
telomerase inhibition effect, implying that the observed telomerase inhibition by Phen-Ni 
could result from their binding to/inducing G-quadruplex structures. 
3.3.6. 5-Substitued Phen-Ni complexes inhibited telomerase positive cancer 
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cell growth. By inhibiting the telomerase-mediated telomere maintenance, many G4 
ligands showed cytotoxicity against telomerase-positive cancer cell lines.141 In this 
section, we investigated the cytotoxicity of Phen-Ni against two telomerase-positive 
cancer cell lines including HeLa (cervical cancer) and MCF-7 (breast cancer) using the 
MTT assay.217-218  
 In a typical experiment, cancer cells in a growth media were incubated with the 
Phen-Ni complex at 100 µM for 72h at 37 ˚C. The reaction mixture was treated with 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) and the cell 
viability was determined by measuring the absorbance at 520 nm using a microplate 
reader. MTT can be reduced to the colorful formazan by a reductase in live cells. The 
number of liveing cells in the media is directly correlated to the absorbance.  
Four complexes (3-Ni, 4-Ni, 20-Ni, and 21-Ni) significantly inhibited the 
proliferation of both HeLa and MCF-7 cells and two complexes (10-Ni and 14-Ni) only 
inhibited the growth of MCF-7 cells. Except for 14-Ni, all the complexes with detectable 
cytotoxicity were proved to be telomerase inhibitors in the TRAP experiments. 3-Ni, with 
a benzene ring as the side chain, exhibited the greatest inhibition amongst them. Though 
3-Ni was the best G4 ligand, it showed moderate inhibition effect on telomerase activity. 
The direct correlation between cell viability and telomerase inhibition could not be fully 
established. It is plausible that the cytotoxicity of 3-Ni makes it readily permeable 
through the lipid bilayer in cell membranes.219 The accumulation of 3-Ni with relatively 
high concentration in cells accounts for its cytotoxicity. By contrast, 20-Ni and 21-Ni 
contain cationic side chains that should have low permeability. In our experiments, 
though 20-Ni and 21-Ni have the strongest telomerase inhibition, they both exhibit 
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moderate cytotoxicity toward two cancer cell lines used (Figure 3-25).  
 
 
Figure 3-25. Cell proliferation of two cancer cell lines in the presence of 5-substituted 
Phen-Ni complexes, determined by an MTT assay. 
 
To test if the inhibition effect came from the G-quadruplex stabilization and 
telomerase inhibition, the corresponding free compounds in the absence of Ni2+ ions were 




Figure 3-26. Cell proliferation of HeLa cells in the presence of free 5-substituted 
phenanthrolines determined by an MTT assay. The cell proliferation in the absent of 
ligand was normalized to 100%.  
 
 Interestingly, only complex 3-Ni exhibited significantly improved cell 
cytotoxicity compared to the free compound. This further supported that 3-Ni was able to 
be diffused into the cells and exhibited its inhibition effects. Since 3-Ni exhibited the 
inhibition of internal standards in the TRAP assay, the cytotoxicity could also be, at least 
partially, attributed to replication inhibition. The further studies and development of these 
complexes in vivo must be combined with drug delivery vehicles that can efficiently 
transport them into cells and cell nuclei.  
3.4 Conclusion 
We investigated a series of 5-substituted 1,10-phenanthroline Ni2+ complexes as 
telomeric G-quadruplex DNA ligands. Their binding affinity and selectivity were highly 
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depending on the type of their side chains. Both cationic side chains and aromatic side 
chains can enhance the G-quadruplex binding affinity of the ligands. Compared to those 
cationic diethyl amines and piperidine, arylsulfanyl side chains improved the selectivity 
of the ligands against G-quadruplex over dsDNA, which could be used as a better side 
chain motif for selective G4 ligands.  
Meanwhile, we evaluated several biophysical and biochemical methods used for 
studying G4 ligands. Thermal denaturation monitored by fluorescence can be used as a 
high throughput method for screening G4 ligands from a large library; however, some 
deficiencies must be taken into consideration due to the interferences of fluorophores on 
DNA and DNA ligands. In contrast, fluorescent intercalator displacement (FID) assay is a 
useful method for semi-quantitatively determine the binding affinity of G4 ligands. This 
method is especially useful if the ligand of interest binding to the same location as TO. It 
also provides a meaning way to directly measure the selectivity of ligands for G-
quadruplex DNA over duplex DNA. Telomeric repeat amplification protocol (TRAP) is 
highly useful for telomerase inhibitor studies. Real-time PCR TRAP is a high throughput 
assay that can evaluate telomerase activity. However, for G-quadruplex stabilizing 
telomerase inhibitor studies, real-time PCR TRAP is not able to differentiate the signals 
caused by ligand binding to duplex DNA. For this reason, 32P-TRAP is a reliable method 
for G4 ligand studies, in which the duplex DNA binding can be monitored by introducing 
an internal standard. For minimal usage of radioactive materials and reliability, we 
consider a combination of both methods is ideal for studying G4 ligands.  
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Chapter 4. Development of Thiazole Orange Derived G-quadruplex Ligands and 
Telomerase Inhibitors.  
 
Thiazole Orange (TO) is a DNA dye that is frequently used to stain DNA in living 
cells. The aromatic rings of TO enable it to intercalate to nucleobase pairs and light-up 
the DNA as a fluorescence probe. The TO-DNA binding is a reversible process and the 
TO can be displaced off from the DNA by other strong DNA ligands. This behavior is 
often utilized in a Fluorescent Intercalator Displacement (FID) assay to evaluate the 
DNA-ligands binding affinity. In recent years, TO attracts more attention because of its 
G-quadruplex DNA binding property. G-quadruplex is a secondary DNA structure that is 
closely related to the telomeres maintenance and oncogene regulations in human genome. 
TO stacks on G-quadruplexes with a binding affinity that is similar to its duplex DNA 
binding. In order to develop novel G4 ligands with a good binding affinity and selectivity, 
our group synthesized twelve novel TO derived compounds (CP1-12). Twelve positively 
charged side chains were chosen and tethered to the quinoline ring of TO to enhance the 
G-quadruplex binding affinity by electrostatic interactions with DNA backbones. In the 
present work, several TO derivatives exhibited better G-quadruplex stabilization than 
TO, determined by biophysical studies including Circular Dichroism (CD) thermal 
denaturation, fluorometric titration, and ESI mass spectrometry. Polyamine and 
piperidine/pyrrolidine side chains with suitable chain length significantly improved the 
G-quadruplex binding affinity of TO. In a TRAP assay, CP6, with a triply protonated 
147 
 
polyamine side chain, exhibited a significant telomerase inhibition effect (nanomolar), 
with is comparable with the best reported synthetic G4 ligand BRACO-19.   
4.1 Introduction 
As discussed in the previous sections, G-quadruplex is a DNA secondary structure 
that is extensively present in DNA telomeric regions and oncogene promotor regions. 
Because of its crucial roles in telomere maintenance and oncogene expressions, many 
small molecules have been designed to stabilize G-quadruplexes. All successful G-
quadruple ligands share two features: aromatic surfaces that stack onto the G-quartet and 
cationic sites that bind onto the phosphate backbones (DNA grooves). Thiazole Orange 
(TO) is one of the molecules that meet these requirements (Figure 4-1).  
 
 
Figure 4-1. The structure of Thiazole Orange. 
 
As discussed in Chapter 2, TO is a DNA dye that binds to both G-quadruplex and 
duplex DNA. TO has a similar binding affinity with single G-quadruplex structure and 
duplex DNA. It has been reported that TO selectively binds to consecutive G-quadruplex 
structures in long G-rich sequences with 700-2000 nucleotides over duplex DNA.192 
Therefore, TO is an interesting scaffold for developing novel G4 ligands.   
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Most of the well-studied G4 ligands such as PIPER or BRACO-19 have long 
cationic side chains that efficiently interact with DNA backbones. In a TO molecule, 
there is only one positive charge, and it is located at the aromatic surface that stacking on 
the G-quartets. Thus, TO does not provide sufficient interactions with DNA backbones. 
As a result, the G-quadruplex binding of TO is relatively weak. In the present research, 
we investigated TO derivatives with positively charged side chains, aiming to enhance 
the G-quadruplex binding affinity.  
Twelve TO derivatives with a range of side chains were synthesized in the earlier 
work of our group (Figure 4-2). The side chains were carefully chosen to study the effects 
of the factors including side chain length, positive charge density and chain flexibility. 
Accordingly, these side chains can be grouped into three categories: aliphatic amines, 
polyamines, and polyethylene glycol amines. The derivatives (CP1, CP2, and CP3) 
containing aliphatic amino side chains with two, three or six carbons were used to study 
the G4 stabilization effects depending on the distance between the positively charged 
sites and TO. The derivatives (CP4, CP5, and CP6) containing polyamine with different 
number of protonated sites were used to evaluate the charge density effect on the G-
quadruplex binding. The derivatives (CP7 and CP8) containing polyethylene glycol side 
chains were designed to investigate the effect of side-chain flexibility on G4 binding. 
Lastly, the derivatives containing piperidine/pyrrolidine side chains (CP9, CP10, CP11, 
and CP12) were also studied because these side chains were used in many successful G4 





Figure 4-2 . Structures of twelve TO derivatives and TO acid. 
 
These side chains were tethered onto the nitrogen atom in the quinolinium ring 
with an amide linkage. A molecular docking study showed that, when TO stacks on the 
G-quartets, the methyl group on this location points out from the G-quartets to the 
groove.220 It is reasonable to conclude that a long side chain tethered to this nitrogen can 
readily interact with the DNA grooves.  
In another study, a homodimeric TO molecule (TOTO) was prepared by bridging 
two TO molecules with a cationic chain on the designated nitrogen atoms to increase the 
duplex DNA binding affinity (Figure 4-3). Based on the data of an NMR study, TOTO 
adopted a bis-intercalation mode on a 5’-CTAG-3’/3’-CTAG-5’ sequence. The 
benzothiazole moiety is sandwiched between two pyrimidines (CT), and the quinolinium 
between two purines (AG). The N-methyl group of the benzothiazole ring protrudes the 
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major groove, and the cationic linker lies in the minor groove crossing from edge to edge 
with a perfect matching size (Figure 4-3). This duplex DNA binding is greatly enhanced 
by the doubled aromatic stacking size of TOTO and the Columbic attraction between the 
side chain linker and the DNA phosphate backbones.221 Therefore, the nitrogen atom in 






Figure 4-3. The structure of TOTO and an illustration of bis-intercalation of TOTO. 221 
 
In the present work, the G-quadruplex stabilization effects of these TO 
derivatives were studied using a thermal denaturation monitored by Circular Dichroism. 
CP6, with a polyamine side chain, and CP9, with a pyrrolidine side chain, exhibited the 
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best G4 stabilization amongst all the compounds tested. The binding affinities of these 
compounds toward a human telomeric G-quadruplex DNA were determined using 
fluorometric titration experiments. Results from ESI mass spectrometry suggested that, 
similar to TO, the TO derivatives produced 1-1, 1-2 and 1-3 complexes with a telomeric 
G-quadruplex. In addition, we evaluated their inhibition of telomerase activity in vitro 
using the telomerase repeat amplification protocol (TRAP) assay. CP6 exhibited a 
remarkable telomerase inhibition effect which is comparable to the most advanced 
synthetic G4 ligand BRACO-19. Thus, a polyamine side chain with a suitable length 
could be a potential structural motif for developing more potent G4 ligands and 
telomerase inhibitors.  
4.2 Experimental  
4.2.1 Materials and general methods. All chemicals for synthesis were 
purchased from Sigma-Aldrich or Fisher Scientific and used without further purification. 
All the enzymes were purchased from New England Biolabs. Oligonucleotides were 
synthesized on an Applied Biosciences 392 DNA/RNA synthesizer using standard 
phosphoramidite protocols and purified using polyacrylamide gel electrophoresis. All the 
chemicals and phosphoramidites for DNA synthesis were purchased from Glen Research 
(Sterling, VA). The concentrations of oligonucleotide solutions were determined by a 
Varian Cary 100 Bio UV-Vis spectrophotometer (Walnut Creek, CA), using the molar 
extinction coefficients (in units of mol of nucleotide/L-1 cm-1) obtained from Oligo 
Analyzer 3.1 (www.idtdna.com). DNA labeling was performed by incubating [γ-32P]-ATP 
(300 µCi) and T4 polynucleotide kinase (20 units) in the presence of an oligonucleotide 
(1 µg) at 37 °C for 45 min. Unreacted [γ-32P]-ATP was removed using a MicroSpin G-25 
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column (GE Health care). [γ-32P]-ATP was purchased from PerkinElemer (Waltham, 
MA). Quantification of 5' 32P-labeled oligonucleotides was carried out using a Storm 860 
phosphor imager and ImageQuant 5.1 software (Molecular Dynamics). Cell culture 
media and supplements (fetal bovin serum, L-glutamine, and sntibiotic-antimycotic) were 
purchased from Invitrogen.  
4.2.2. Circular dichroism G-quadruplex denaturation analysis. A stock 
solution containing 100 µM human telomeric oligonucleotides PCG1 (5’-AGG GTT 
AGG GTT AGG GTT AGG GT-3’), 20 mM lithium cacodylate buffer (pH=7.0) and 150 
mM NaCl was prepared and incubated at 95˚C for 5 min, slowly cooled to room 
temperature and stored at 4 ˚C for overnight to form the corresponding G-quadruplex 
structure.  
CD thermal denaturation spectra of solutions containing 5 µM PCG1, 20 µM TO 
derivatives, 20 mM lithium cacodylate buffer (pH=7.0) and 150 mM NaCl were collected 
at 290 nm as a function of temperature (25-95 ˚C) at a heating rate of 0.5 ˚C/min with a 
Jasco J-810 spectropolarimeter. The data in CD mdeg units were converted into molar 
ellipticity using the Spectra Manager (Jasco). Melting profiles were smoothed and 
analyzed using Originlab and the temperature with the lowest first derivative was 
determined as the melting temperature (Tm).  
4.2.3. Fluorometric scan of TO derivatives interacting with G-quadruplex. A 
stock solution containing 100 μM human telomeric G-quadruplex sequence PCG1 (5’-
AGG GTT AGG GTT AGG GTT AGG GT-3’), 10 mM lithium cacodylate buffer 
(pH=7.0) and 50 mM KCl was prepared and incubated at 95 ℃ for 5 min, slowly cooled 
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to room temperature and stored at 4 ℃ for overnight.   
Reaction solutions containing 0.25 μM PCG1, 10 mM lithium cacodylate buffer 
(pH=7.0) and 50 mM KCl were prepared from the stock solution before use. This 
solution was incubated with 0.5 μM TO derivatives for 30 min in the dark. Spectra 
(excitation: 501 nm, slit width: 5.0 nm, scan speed 120 nm/min) were recorded in the 
range of 510-650 nm. 
4.2.4. Fluorometric titration of TO derivatives interacting with G-quadruplex 
and duplex DNA. Stock solutions containing 200 μM human telomeric G-quadruplex 
sequence PCG1 (5’-AGG GTT AGG GTT AGG GTT AGG GT-3’) or 100 μM 17 mer 
dsDNA S1 (5’-GCCAGTTCGTAGTAACC-3’/3’-GGTTACTACGAACTGGC-5’), 10 
mM lithium cacodylate buffer (pH=7.0) and 100 mM NaCl were prepared and incubated 
at 90 ℃ for 5 min, slowly cooled to room temperature and stored at 4 ℃ for overnight. A 
solution containing 0.5 µM TO derivatives, 10 mM sodium cacodylate buffer (pH=7.0) 
and 100 mM NaCl was prepared and aliquots of the stock solution of PCG-1 or 17 mer 
duplex DNA were gradually added. The spectra of fluorescence (excitation: 501 nm, slit 
width: 5.0 nm, scan speed 120 nm/min) were recorded from 510-650 nm after each 
addition. The maximum fluorescence intensities were plotted against the equivalent 
concentrations of the DNA and the binding parameters were extrapolated using a 
software Prism 7.0.  
4.2.5. Mass Spectrometry. A human telomeric DNA sequence PCG1 (5’-AGG 
GTT AGG GTT AGG GTT AGG GT-3’) and two complementary DNA sequences S1(5’-
AGC GAT GAG AGG CCA CGA GGA ATC GCT GGT ACC G-3’/ 5’-CGG TAC CAG 
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CGA TTC CTC GTG GCC TCT CAT CGC T -3’) were heated to 95 °C for 5 mins 
followed by cooling slowly to room temperature and stored in 4°C for overnight in 150 
mM NH4OAc solution. TO derivatives (250 µM) were mixed with the DNA (50 µM) and 
the resulting complex solutions were injected into a Thermo Fisher Orbitrap Fusion 
Tribrid Mass Spectrometer (San Jose, CA) with 50% methanol-water at a rate of 5 
µl/min. The ion spray voltage was set to -2,250 V and ion transfer tube temperature to 
300 °C. Nitrogen sheath and auxiliary gas flows were 45 and 0 arbitrary units, 
respectively. The collision energy was adjusted to 5 or 10 arbitrary unit (au). MS spectra 
were recorded in the m/z range from 1400 to 1800 with an average of 150 scans. Data 
were collected and analyzed using the Xcalibur software.  
4.2.6. TRAP assay. Cell lysates containing telomerase were extracted from 
cultured HeLa cells. The cells from a 90% confluent 225 cm2 culture flask were washed 
with cold phosphate-buffered saline(PBS) and scraped off from the culture flask in 1 ml 
cold PBS. The cells were pelleted in 1.5 ml conical tubes by spinning for 5 min at 
1000rpm and suspended in 1ml cold 1× CHAPS Lysis Buffer. The suspension was 
incubated on ice for 30mins and centrifuged at 12,000g for 10 minutes at 4°C. The 
supernatant was extracted and stored at -80°C.  
A reaction mixture (50 μL) was prepared containing 5′-[32P]-labeled TS primer 
(0.1 μg 5’-AATCCGTCGAGCAGAGTT-3’), RP (0.1 μg, 5’-
GCGCGGCTTACCCTTACCCTTACCCTAACC-3’), NT (0.1 μg, 5’-
ATCGCTTCTCGGCCTTTT-3’), TSNT (0.01 amol, 5’-
AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3’ ), buffer: [Tris-HCl (20 
mM, pH 8.3), MgCl2 (1.5 mM), KCl (63 mM), 0.05% Tween 20, EGTA (1 mM)], cell 
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lysate (1 μL), Taq polymerase (2 units), dNTP mix (50 μM), and TO derivatives (3.125-
100 μM). This solution was incubated at 30°C for 30 min, 94°C for 2 min followed by a 
3-step PCR method (94 °C for 20 s, 59 °C for 30 s, and 72 °C for 30 s) with 25 cycles. 
The reaction solution was mixed with 10 μL 10×loading dye and resolved with 10% 
denaturing polyacrylamide gel [5% crosslink, 45% urea w/w]. 
4.2.7. MTT cell viability. MCF-7 cells (human breast adenocarcinoma cells) and 
HeLa cells (cervical cancer cells) (a generous gift from Dr. William. K. Chan, UOP) were 
maintained in advanced DMEM medium solutions supplemented with 5% fetal bovine 
serum, L-glutamine and antimycotic at 37 °C in a humid atmosphere containing 5% CO2. 
The TO derivatives were pre-dissolved in sterilized water. The cells were seeded in a 96-
well plate (3000 cells/well). After 24h incubation, the supernatant was removed followed 
by adding 200 µl FBS free media containing TO derivatives. After 72h incubation, 20 µl 
MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-di- phenyl tetrazolium bromide) (0.5 mg/ml) was 
added for further 4h incubation. The supernatant was removed, and the formazan product 
was dissolved in 150 µl of DMSO before measurement. The absorbance was measured at 
590nm using a TriStar LB 941 Multimode Microplate Reader. Untreated cells and media 






Atreated: The absorbance of the solution containing treated cells 
Amedia: The absorbance of the media 
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Auntreated: The absorbance of the solution containing untreated cells 
4.3 Results and Discussion 
4.3.1. Thiazole orange derivatives stabilized human telomeric G-
quadruplexes. In the previous studies of our group, all twelve derivatives were examined 
by a thermal denaturation experiment monitored by fluorescence. CP6 containing a 
polyamine side chain and CP9 containing a pyrrolidine side chain exhibited strong G4 
stabilization effect. At the ratio of 10:1 (ligand:DNA), CP6 and CP9 elevated the melting 
temperature (Tm) of the human telomeric G-quadruplex with 8.60 ˚C and 8.85 ˚C, 
respectively. However, there were some concerns with this assay. A saturation of the Tm 
increment induced by the compounds was never reached even in the presence of highly 
concentrated compounds. As discussed in chapter 3, thermal denaturing monitored by 
Fluorescence has certain drawbacks due to the interferences between the fluorescence 
molecules and the tested compounds. Specifically, TO and TO derivatives have an 
excitation/emission spectra at 501 nm/510 nm which is partially overlapping with the 
spectra of the fluorophore probe in the thermal denaturation experiment (492 nm/517 
nm). Thus, to obtain more reliable data, we conducted a thermal denaturation monitored 
by Circular Dichroism (CD) in the present research.  
Circular Dichroism (CD) spectrometry is a common technique to analyze DNA 
G-quadruplex conformations. Different G-quadruplex structures can be distinguished 
from the distinct features of their CD spectra.222 The conformation of the human 
telomeric G-quadruplex DNA (G4, 5’-AGGGTTAGGGTTAGGGTTAGGGT-3’) is 
cation dependent.58 It forms two distinguished conformations in the presence of Na+ and 
K+ ions respectively (Figure 4-4). In the presence of K+ ions, a hybrid-type telomeric G-
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quadruplex is observed with a positive peak around 290 nm and a negative peak around 
240 nm.58, 169 When Na+ ion is used, a positive peak around 290 nm and a negative peak 
around 265 nm are observed indicating the presence of a basket-type G-quadruplex.58 
Under both conditions, the positive peak at 290 nm represents the G-quadruplex 
structures, and its intensity will decrease when a G-quadruplex dissociates into a random 
coil (Figure 4-4). Thus, thermal denaturation of G-quadruplex DNA can be conducted by 
monitoring the CD ellipticity at 290 nm. The melting temperature (Tm) is defined as the 
temperature, at which 50% of the G-quadruplexes dissociate into random coils. It can be 
extrapolated by the first derivatives from the plots of the molar CD ellipticity against the 
temperatures.   
CD thermal denaturation experiments in the presence of twelve derivatives were 
conducted under two conditions: 100 mM K+ ions and 150 mM Na+ ions. These are the 
most frequently used conditions in G-quadruplex related studies because they produce 
reliable data. The physiological intracellular concentrations for these two ions in a normal 
cell are approximately 14 mM for Na+ and 150 mM for K+.223 In cancer cells, a 30% 
decrement of K+ ion concentration and a 30% elevation of Na+ ion concentrations 
compared to those in normal cells are observed, which are closely related to 
carcinogenesis and related signaling pathways.224 The concentration elevation of these 
ions in cancer cells could directly regulate the G-quadruplex formation and are 
considered as a sign of aggressive cancer cells.225-226 Thus, even not exactly same as the 
intracellular concentrations in cancer cells, the conditions in our experiments are still 
suitable for G4 ligands studies.  
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Figure 4-4. CD spectra of G4 in the presence of 150 mM Na+, 100 mM K+, and in the 
absence of cation.  
 
Under the designated conditions, CD thermal denaturation experiments were 
conducted in the presence of twelve derivatives, together with TO and TO acid in the 
ratio of 1:4 (DNA:ligand). TO acid was tested here because it was the precursor used to 
tether the side chains (Figure 4-1). The Tm values were extrapolated from the thermal 





Figure 4-5. G-quadruplex Tm values determined by the CD thermal denaturation 
experiments in the presence of TO derivatives.  
 
Table 4-1 . Tm values (˚C) of G4 in the presence of TO derevetives. 
    Blank CP1 CP2 CP3 CP4 CP5 CP6 CP7 
 100mM K+   52.60 59.24 60.23 62.28 60.48 62.44 71.02 58.68 
 150mM Na+   57.54 57.53 56.53 60.03 61.53 58.54 65.04 56.03 
    CP8 CP9 CP10 CP11 CP12 TO TO acid 
 100mM K+   59.41 69.44 64.03 59.67 64.88 63.99 NA  
 150mM Na+   57.03 62.53 56.04 60.52 60.53 60.03 57.05  
 
 
In the absence of any ligands (blank), the Tm value in 150 mM Na
+ solution (57.54 
˚C) was significantly higher than that in 100 mM K+ solution (52.60 ˚C). It is well-known 
that Na+ and K+ ions have similar stabilization effects on G-quadruplexes and a higher 




For the same ligand, the Tm increments in 100 mM K
+ solution were always 
greater than that in 150 mM Na+. All the compounds stabilized the G-quadruplexes 
(produced a higher Tm than the blank) in 100 mM K
+ and the highest Tm was acquired by 
CP6 (71.02˚C). In 150 mM Na+, only seven compounds stabilized the G-quadruplexes 
(CP3, CP4, CP5, CP6, CP9, CP11, CP12, and TO), and the highest Tm was 65.04 ˚C 
produced by CP6. As discussed in previous chapters, cations sit between the G-quartets 
and coordinate with the guanines. Meanwhile, cations also form a hydrated spine in the 
DNA grooves. Thus, the highly concentrated salts in 150 mM Na+ solution will compete 
with the ligand binding. This observation was consistent with many reports that highly 
salted conditions significantly reduce the DNA-ligand binding.192   
Regardless of the different extent of Tm values, two conditions produced similar 
trends of G-quadruplex stabilization for the compounds. Lower stabilization effects were 
observed for aliphatic amine side chain containing derivatives CP1 (59.24 ˚C), CP2 
(60.23 ˚C), and CP3 (62.28 ˚C) than TO (63.99 ˚C) in 100 mM K+ and nearly no 
stabilization effect in 150 mM Na+. Aliphatic chains sometimes can provide hydrophobic 
interactions with DNA in some reported ligands. However, in these TO derivatives, no 
improvement was observed. This may occur due to the geometry of the side chains which 
are not efficiently fitting with the G-quadruplex structure and consequently provides no 
additional interactions. CP3, with the longest aliphatic chain, produced the highest Tm in 
both conditions amongst the aliphatic amine derivatives, and suggested that the longer 
side chain with higher flexibility may provide better interactions of the positive charge 
with the grooves.  
Amongst the compounds with polyamine side chains CP4 (60.48 ˚C /61.53 ˚C), 
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CP5 (62.44 ˚C /58.54 ˚C) and CP6 (71.02 ˚C /65.04 ˚C), CP6, with the longest side 
chain, had a much stronger stabilization effects than TO (63.99 ˚C /60.03 ˚C). Similarly, 
a longer side chain is more favored for the G-quadruplex stabilization. CP6 was the 
strongest ligand amongst all twelve ligands under both conditions and significantly 
improved the binding affinity of TO. CP6 consists of three positively charged amine 
groups on a long flexible side chain. Positively charged sites in CP6 interact with the 
phosphate groups of the DNA backbones and enhanced the G-quadruplex binding. CP4 
with one less positive charge exhibited a weaker stabilization effect than CP6.  
Meanwhile, CP5 with similar two positive charges but a shorter chain length did not 
exhibit the same stabilization effect as CP6, suggesting that a flexible long side chain is 
indispensable for the binding of TO derivatives to G-quadruplexes. This was also 
consistent with the stabilization behaviors of aliphatic amine derivatives CP1, CP2 and 
CP3.  
Polyethylene glycol side chains are more flexible than aliphatic side chains. 
However, CP7 (58.68 ˚C/56.03 ˚C) and CP8 (59.41 ˚C/57.03 ˚C) gave the worst 
stabilization effects under both conditions. The electronegative oxygen atoms have 
charge repulsion effects against the DNA phosphate backbone and consequently decrease 
the stabilization effects. For the same reason, TO acid also exhibited poor stabilization 
effect.  
CP9, CP10, CP11, and CP12 contain piperidine or pyrrolidine side chains. Both 
piperidine and pyrrolidine motifs can be protonated under physical conditions and form 
positive charges. CP9 with a pyrrolidine ring at the end of the side chain was the second 
strongest stabilizer amongst all twelve ligands. A pyrrolidine group in CP9 (69.44 
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˚C/62.53 ˚C) gave better G-quadruplex stabilization than a piperidine group in CP10 
(64.03 ˚C/56.04 ˚C). A similar observation was also reported by another research 
group.228 Ligands with polyethylene glycol side chains, CP11 (59.67 ˚C /60.52 ˚C) and 
CP12 (64.88 ˚C/60.53 ˚C), did not significantly enhance the G-quadruplex stabilization 
effects of TO (63.99 ˚C/60.03 ˚C) because of the charge repulsion forces from the oxygen 
atom(s), even coupled with a pyrrolidine or piperidine ring.  
Overall, CP6 and CP9 exhibited the best stabilization among twelve compounds. 
The pyrrolidine and polyamine side chain significantly improved the G-quadruplex 
stabilization effect of TO. Meanwhile, a long flexible linear geometry side chain of the 
ligands is essential for efficient interactions of the terminal amino groups with the G-
quadruplexes.   
4.3.2. Thiazole orange derivatives preserve G-quadruplex light-up probe 
properties. DNA dyes such as TO has significant fluorescence enhancements upon 
binding to DNA.229 TO-DNA complexes emit intensive fluorescence at around 530-540 
nm with a significant quantum yield when excited at 500 nm. This light-up feature 
enables TO and some of its derivatives to be used as probes for both duplex and G-
quadruplex DNA in living cells and electrophoresis gels. Meanwhile, TO is frequently 
used in a Fluorescence Intercalation Displacement (FID) assay to study other DNA 
ligands, in which a pre-bond TO molecule can be displaced off from the DNA by a strong 
ligand. In order to study the side chain effects on the fluorescence signal of TO-DNA 
complexes, we incubated all the derivatives with a human telomeric G-quadruplex (G4, 





Figure 4-6. Fluorescence scan of TO derivatives in the presence of human telomeric G-
quadruplex. CG-quadruplex=0.25 µM; CTO=0.5 µM.  
 
The background signals of the derivatives in the absence of DNA are nearly zero 
in solution. The maximum fluorescence intensities of the compounds were all present at 
around 535 nm. No significant shift of the maximum fluorescence emission was observed 
for any of the derivatives because the conjugated chromophore structures of the 





Figure 4-7. Maximum fluorescence intensities of twelve TO derivatives in the presence 
of G-quadruplexes.  
 
The maximum fluorescence intensities of the ligand-DNA complexes were plotted 
in a bar graph and compared with TO (Figure 4-7). Firstly, the overall quantum yield of 
twelve derivatives and TO acid in the presence of G-quadruplexes were notably lower 
than TO (342.7 au). Most of the side chains have more than one positive charges and 
may decrease the hydrophobicity of the local environment which can partially quench the 
fluorescence signal. Another previous reported TO conjugate with a positively charged 






Table 4-2. Fluorescence intensities (au) of TO derivative-G-quadruplex complexes. 
 
 
 Amongst all the derivatives, a general trend was observed: the derivatives that 
exhibited good stabilization effects in the CD thermal denaturation experiments also 
showed a relatively higher quantum yield including CP9 (288.7 au), CP4 (265.9 au), 
CP10 (288.7 au), CP12 (262.8 au), CP6 (250.9 au), CP11 (224.7 au) and CP3 (181.8 
au). Electronegative groups containing compounds CP7 (31.7 au), CP8 (96.7 au), and 
TO acid (76.9 au) showed extremely low quantum yield. However, the rank order of G-
quadruplex stabilization and fluorescence intensity are not exactly same. This 
discrepancy may be partially explained by the different charge locations and charge 
densities of the side chains. For instance, CP6 exhibited the best stabilization effect in 
CD thermal denaturation experiment but was only at the fifth for the fluorescence 
intensity measurements (250.9 au). CP6 has a side chain with three positive charges and 
its fluorescence response can be significantly attenuated by the hydrophilicity of this side 
chain.  
Even with lower quantum yield compared to TO (342.7 au), the derivatives still 
preserve the light-up probe properties, and several of them such as CP6 (250.9 au) and 
CP9 (288.7 au) can be used to detect the presence of G-quadruplex with stronger binding 
affinity than TO.  
 Compound CP1 CP2 CP3 CP4 CP5 CP6 CP7 
 Intensity (au) 98.4 88.8 181.8 265.9 126.3 250.9 31.7 
 Compound CP8 CP9 CP10 CP11 CP12 TO TO acid  
 Intensity (au) 96.7 288.7 288.7 224.7 262.8 342.7 76.9  
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4.3.3. Thiazole orange derivatives interact with human telomeric G-
quadruplex with enhanced affinities. Because TO derivatives still preserve 
fluorescence light-up properties, the binding constants of these compounds can be 
conveniently extrapolated from the fluorescence titration curves. In a typical experiment, 
a stock solution of human telomeric G-quadruplex (G4, 5’-
AGGGTTAGGGTTAGGGTTAGGGT-3’) was prepared and gradually titrated into a 
solution containing the designated compound. The fluorescence spectra were recorded 
after each addition and the maximum intensities were plotted against the concentrations 
of the G-quadruplex in the mixture. The consequent curves were processed by least-
squared fitting and the equilibrium dissociation constant (Kd) values were calculated 
accordingly. Monchaud and co-workers utilized this titration experiment to compare the 
binding affinities of TO against G-quadruplexes with different conformations and a one 
site binding mode was discovered for the TO-G-quadruplex complex.188 Similar to the 
reported results, our titration indicated that TO binds to G-quadruplex with a one site 
binding mode with the Kd value around 0.87 µM (Figure 4-8).  
Six compounds (CP4, CP6, CP9, CP10, CP11, and CP12) were studied with this 
titration method because they yielded relatively higher fluorescence intensities than the 
others upon binding to DNA. CP4, CP9, CP10, CP11, and CP12 exhibited a similar one 
site binding mode as TO. The Kd values of CP4 (0.32 ± 0.01 µM), CP6 (0.27 ± 0.02 
µM), and CP9 (0.77 ± 0.01 µM) were lower than that of TO (0.87 ± 0.02 µM), while 
CP10 (1.13 ± 0.04 µM), CP11 (1.65 ± 0.05 µM), and CP12 (2.18 ± 0.07 µM) produced 
higher Kd values than TO (0.87 ± 0.02 µM) (Figure 4-8). This observation was highly 
consistent with the results of CD thermal denaturation in the presence of Na+ ions, which 
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was a similar condition used in this titration. In the CD thermal denaturing experiments, 
CP10, CP11, and CP12 had similar or lower stabilization effects compared to TO, while 
CP4, CP6 and CP9 had a higher stabilization effects than TO.  
Interestingly, the binding mode evidenced by the least-square fitting of CP6 was 
different from those of TO and other derivatives (Figure 4-8). By fitting with one binding 
site mode, CP6 produced a Kd value of 0.27 µM which was the lowest amongst all the 
derivatives (Figure 4-9). However, the chi-square value of the fitting was 0.97 which was 
notably worse than those for other ligands (>0.99). Therefore, the same titration curve for 
CP6 was fitted using the two binding sites mode and a chi-square value of 0.999 was 
obtained. Two Kd values of CP6 obtained from this fitting mode were 0.07 ± 0.04 µM 
and 1.73 ± 0.11 µM. The Kd value of the main binding of CP6 with the G-quadruplex 
was remarkably lower than the value of TO (0.87 ± 0.02 µM), suggesting a very strong 
binding. This result is consistent with the previous observation that CP6 stabilized the G-
quadruplex most among all the TO derivatives. This fitting also suggested that there is a 
second binding site in the G-quadruplex for CP6. Since CP6 is tethered with a side chain 
containing three positive charges, groove binding could occur due to the charge 






Figure 4-8. Fluorometric titration curves of TO and TO derivatives against human 





Figure 4-9. Kd values of TO and derivatives binding to G4 (solid) and ds17 (blank) 
determined by the fluorometric titration experiments. 
 
For the development of G4 ligands, selectivity against G-quadruplex over duplex 
DNA is always a contradictory objective when improving the binding affinity. The most 
efficient strategy to elevate the binding affinity of a ligand is to incorporate positively 
charges that interact with DNA phosphate backbones. However, electrostatic interactions 
do not usually provide sufficient selectivity for the ligands. In order to study the 
selectivity of the twelve derivatives, the same titration experiments were conducted 
against a 17 mer non-G-rich duplex DNA (ds17, 5’-GCCAGTTCGTAGTAACC-3’/3’-
GGTTACTACGAACTGGC-5’) (Figure 4-10). It was reported that TO has a similar 
binding affinity against G-quadruplex and duplex DNA.188 In our experiments, the Kd 
value of TO binding to ds17 was determined as 0.40 ± 0.00 µM which was within the 
same range as that of G-quadruplex binding (0.87 ± 0.02 µM) under the same 






Figure 4-10. Fluorometric titration curves of TO and TO derivatives against ds17 ----two 
binding site mode; —one binding site mode.   
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The Kd values of CP4, CP6, CP9, CP10, CP11 and CP12 binding to ds17 were 
also determined. Their selectivity for G-quadruplex over duplex DNA was compared with 
the ratio of Kd-G4/Kd-ds17 (Table 4-3). The smaller the ratio is, the better the binding 
selectivity is. As expected, the derivatives did not show a noteworthy improved 
selectivity compared to TO because of the additional positively charged side chains. As 
discussed in chapter 1, highly selective G4 ligands such as telomestatin usually contain 
enlarged aromatic surfaces. The addition of multiple positively charged side chains 
improves their binding affinity through the charge interactions with the DNA phosphate 
backbones. This Coulombic attraction does not differentiate G-quadruplex from duplex 
DNA. CP6 (Kd-G4/Kd-ds17=3.20) exhibited the worst selectivity amongst the 
compounds because of the multiple charges in the side chain. CP9 (Kd-G4/Kd-
ds17=2.04) was the only compound that produced a slightly better selectivity than TO 
(Kd-G4/Kd-ds17=2.17). This was consistent with other researcher’s work that pyrrolidine 
side chains can produce better selectivity than linear positively charged side chains in a 
G4 ligand.230   
 




4.3.4. Thiazole orange derivatives associate with human telomeric G-
quadruplexes with various ratios. Electrospray-ionization mass spectrometry is a 
 Compound TO CP6 CP4 CP9 CP10 CP11 CP12 
 Kd-G4/Kd-ds17 2.17 3.20 2.59 2.04 4.14 2.72 3.05 
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highly sensitive analytical tool for biomolecules including oligonucleotides, peptides and 
their non-covalent ligand complexes.231 Compared to other analytical technologies 
including NMR and X-ray crystallography, ESI-MS has the advantages of easy sample 
preparation and low sample consumption. Because of the known ion suppression effect 
from non-volatile salts, ammonium acetate is one of the few salts that is compatible with 
ESI-MS oligonucleotides analysis. Similar to K+ and Na+ ions, NH4
+ ions can also 
coordinate with guanines and stabilize G-quadruplexes. NH4
+ ions locate themselves 
between two adjacent G-quartets, and the observed number of the NH4
+ ions (n) in the 
MS spectra can be used to estimate the number of G-quartets layers (n+1).232 Thus, the 
presence of NH4
+ ions in the G-quadruplexes is very useful to report the formation of G-
quadruplexes. Meanwhile, an intercalating G4 ligand may expel the bound HN4
+ ions 
from the G-quadruplexes which can be observed in the MS spectra. Therefore, ESI-MS is 
capable to generate a plenty of information of the ligand-DNA association including the 
binding affinity, stoichiometry and binding mode.233 In the present research, we examined 
all the compounds mixed with the G-quadruplex (G4, 5’-AGGGTTAGGTTAGGGTTAG 
GGT-3’) with negative-ion ESI-MS and Higher Energy Collisional Dissociation (HCD) 
experiments. All the spectra are shown in relative abundances with the most abundant ion 
in each spectrum corresponding to 100% ion intensity (base peak). 
ESI-MS spectra obtained from a solution only contained G-quadruplex 
(MW=7270.77) showed the most abundant ions at m/z 1459.85, corresponding to [G4+2 
NH4
+ -7H+]5- (calculated m/z 1459.95) (Figure 4-11, top graph). There were also two 
smaller peaks representing [G4+1 NH4
+ -6H+]5- at m/z 1456.46 and [G4+5H+]5- at m/z 
1453.04. The latter peaks represent the unfolded, or half unfolded G-quadruplexes that 
173 
 
were produced in the process of ionization. Then, the same G-quadruplex solution was 
mixed with TO or a TO derivative in the ratio of 1-5 (DNA-ligand), and the 
corresponding spectra were obtained under the same condition.  
 
 
Figure 4-11. Negative ion ESI mass spectra of solutions containing CP1-3 and G4. *: 
Free G4, α: 1-1 complexes, β: 1-2 complexes γ: 1-3 complexes.  
 
In the spectra obtained from the solution of TO and the G-quadruplex, 1-1, 1-2 
and 1-3 complexes were observed, and the 1-1 complex was the most abundant ion 
(Figure 4-11-TO). This observation was consistent with previously reported studies that 
TO forms complexes with a human telomeric G-quadruplex in the same three ratios.188  
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Both CP1 and CP2 formed 1-1 and 1-2 complexes and the 1-3 complex was not 
detected in the mass spectra. Similar to TO, CP3 formed three complexes with a ratio of 
1-1, 1-2 and 1-3, respectively. The relative intensity of free G-quadruplex in the spectra 
of CP3 was significantly lower than those in the spectra of TO, CP1, and CP2, 
suggesting stronger binding of CP3 to the G-quadruplex. This observation is consistent 
with the CD thermal denaturation results. CP3 showed better stabilization of the same G-
quadruplex than TO, CP1, and CP2. It is plausible the longer side chain (six carbons) of 
CP3 allows the terminal amino group to interact with the G-quadruplex groove and thus 
stabilize the ligand-DNA complex. The side-chain length for CP1 and CP2 are two 
carbons and four carbons respectively, which may not be long enough to optimize the 
interaction between the amino group and G-quadruplex.  
The binding of CP1, CP2, and CP3 to G-quadruplex could also result from the 
hydrophobic interaction between aliphatic chains and G-quadruplex groove. However, 
such interactions should be reduced or not exist without solvent in the gas phase 
condition of ESI mass spectrometry.234 Therefore, the enhanced binding of CP3 came 
from the electrostatic attraction between the terminal amino group and negatively charged 
DNA backbones. In addition, the longer aliphatic chain of CP3 may allow it to have an 





Figure 4-12. Negative ion ESI mass spectra of solutions containing CP4-6 and G4. *: 
Free G4, α: 1-1 complexes, β: 1-2 complexes γ: 1-3 complexes. 
 
 
CP4, CP5, and CP6 all contain a side chain of polyamines. CP4 that contains a 
short side chain with two amino groups formed three complexes with a ratio of 1-1, 1-2 
and 1-3 (DNA-ligand), respectively (Figure 4-12). The mass spectrum of CP4 was 
similar to that of CP3, with a decreased intensity of the peak representing free G-
quadruplex. Surprisingly, CP5 and CP6 each containing three amino groups formed 
much less abundant complexes. The intensities of 1-1, 1-2, and 1-3 complexes for these 
two compounds were much less than those in the spectrum of CP4. The peaks 
representing free G-quadruplex were dominant in the mass spectra of CP5 and CP6. 
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These observations were not consistent with our previous studies that side chain with 
multiple positive changes should enhance the binding of a ligand to DNA. This 
discrepancy could be attributed to the following factors: 1) it was reported that for the 
compounds with a polyamine side chains, when the charge number and charge distance 
increase, their solubility will drop significantly.235-237 2) side chains of CP5 and CP6 are 
similar to spermine which was known to cause DNA condensation at high 
concentrations.238 Indeed, DNA condensation was observed when the concentration of 
CP6 was over 80 µM in our experiments, which could reduce the detectable amount of 
the complexes. 3) In the ESI mass spectrometric experiments, the interference between 
the high concentration (150 mM) of NH4
+ and CP5 or CP6 may exist. A recent study 
suggested that ammonium ions competitively bind to DNA phosphate backbones and can 
significantly decrease the binding of multiply charged compounds to the target DNA.239 
In our case, the formation of low abundance of complexes between CP5 or CP6 with the 






Figure 4-13. Negative ion ESI mass spectra of solutions containing CP7-8 or TO-acid and 
G4. *: Free G4, α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes. 
 
The formation of complexes between CP7 and the G-quadruplex was negligible 
(Figure 4-13). Only a very small amount of 1-1 complex was observed (Figure 4-13). 
CP8 formed good amounts of 1-1 and 1-2 complexes with the G-quadruplex. The short 
ethylene glycol linker of CP7 significantly decreased the binding of CP7 to the G-
quadruplex probably due to the repulsion between the electron-dense oxygen atom and 
negatively charged DNA backbones. The longer ethylene glycol linker for CP8 enables 
the interaction between the terminal amino group and DNA grooves; therefore, no 
noticeable decrease of CP8 in the formation of the complexes was observed. TO acid 
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formed less abundance of 1-1 and 1-2 complexes because of the repulsion between the 




Figure 4-14. Negative ion ESI mass spectra of solutions containing CP9-12 and PCG1.  
*: G-quadruplexes, α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes. 
 
CP9 with a pyrrolidine side chain exhibited a much higher affinity than TO with 
three complexes (1-1, 1-2, and 1-3) formed (Figure 4-14). The most abundant ions were 
1-2 complexes and almost no free G-quadruplex was observed in the presence of CP9. 
CP10, CP11 and CP12 also produced similar MS spectra comparable to CP9. The strong 
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binding CP9 to the G-quadruplex determined by ESI mass spectrometry was consistent 
with the results from CD thermal denaturation. The strong binding of these four 
complexes with the G-quadruplex was probably due to the known binding effect of 
pyrrolidine and piperidine to G-quadruplex DNA. In addition, the ESI-MS spectra 
revealed that the most abundant complexes of these four ligands were with a ratio of 1-2 
suggesting there are two main binding sites in G-quadruplex suitable for these four 
ligands.    
The relative binding affinity of ligands with DNA can be quantitatively 
determined using the Intensity Ratio (IR), which is defined as an abundance ratio of all 
the complex ions to the sum of all free G-quadruplexes and complex ions in an ESI-MS 




                           (1) 
Here, ∑ 𝐼𝑟(𝐺 + 𝑛𝐿) is the total intensities of the complexes where n=1, 2 and 3; 
∑ 𝐼𝑟(𝐺) is the intensity of free G-quadruplexes that was not associated with the 
compounds. Therefore, the IR value reflect the binding affinity of the ligands to the G-




Figure 4-15. IR values for TO derivatives binding with G4. 
 
Overall, all the derivatives except for CP7, produced abundant peaks in the ESI-
MS spectra representing the DNA-ligand complexes in the ratios of 1-1, 1-2, and 1-3. The 
weak binding of CP7 to the G-quadruplex was also observed in the previous CD thermal 
denaturation experiments. CP9, with a pyrrolidine side chain was proved to be a good G4 
ligand binding to G-quadruplex with 1-1, 1-2 and 1-3 mode. The trend of the complex 
formation by CP1, CP2, CP3, CP7, and CP 8 suggested that a long flexible side chain is 
essential to enable the terminal positively charged group to interact with G-quadruplex 





Table 4-4. IR values for TO derivatives binding with the G4 and the corresponding 
complex compositions. 
  
 Compound CP1 CP2 CP3 CP4 CP5 CP6 CP7  
 Free G4 (%) 100 100 37.17 68.39 100 100 100 
 
 1-1 (%) 97.81 77.43 96.79 100 42.66 46.61 3.38 
 
 1-2 (%) 36.74 24.60 100 61.20 5.69 5.96  
 
 1-3 (%) 0 0 22.39     
 
 IR (%) 57.36 50.50 85.50 70.21 32.59 34.46 3.27 
 
 Compound CP8 CP9 CP10 CP11 CP12 TO TOacid 
 
 Free G4 91.32 8.80 11.16 31.28 14.58 85.32 100 
 
 1-1 (%) 100 41.81 46.19 78.70 52.71 100 67.36 
 
 1-2 (%) 38.89 100 100 100 100 48.21 31.77 
 
 1-3 (%)  60.20 45.10 40.75  13.16 11.96 
 
 IR (%) 60.33 95.83 94.49 87.52 91.28 65.41 52.63 
 
IR (%)= [1-1] + [1-2] + [1-3]/ G4 + [1-1] + [1-2] + [1-3] 
 
 
Similar experiments were performed with CP3, CP6 and CP9 binding to a 17mer 
duplex DNA (ds17, 5’-CCTCGGCCGGCCGACC-3’/3’GGAGCCGGCCGGCTGG-5’, 
MW=10999.25) to study the binding selectivity. These three compounds were chosen 
because they are the representative derivatives binding to the G-quadruplex efficiently in 
each category.   
The ESI-MS spectra showed that TO binds to ds17 with 1-1, 1-2 and 1-3 ratios 
(Figure 4-16). CP3, and CP6 bind to ds17 with 1-1 and 1-2 ratios. In addition to these 
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three ratios, CP9 binds to ds17 with a 1-4 binding ratio. In all the spectra, the peaks at 
m/z 1833.00 representing intact ds17 [ds17-6H]6- were observed (calculated m/z 
1832.21).   
 
 
Figure 4-16. Negative ion ESI mass spectra of solutions containing ds17, CP3, CP6, and 
CP9. *: ds 17, α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes, ρ: 1-4 complexes.  
 
The IR values for duplex binding were calculated using the following equation 
(equation 2). 
𝐼𝑅𝑑𝑠 =
∑ 𝐼𝑟(𝑑𝑠 + 𝑛𝐿)
∑ 𝐼𝑟(𝑑𝑠) + ∑ 𝐼𝑟(𝑑𝑠 + 𝑛𝐿)
                             (2)  
 Here, ∑ 𝐼𝑟(𝑑𝑠 + 𝑛𝐿) is the total intensities of the complexes with ds17 where 
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n=1, 2, 3, and 4; ∑ 𝐼𝑟(𝑑𝑠) is the intensity of free ds17 that was not associated with the 
compounds. The IR value reflects the binding affinity of the ligands to ds17.  
The obtained IRds values (Figure 4-17) were compared with their IRG4 values. TO 
exhibited minimal selectivity as the IRds value is slightly higher the IRG4 value. CP9 
showed a better selectivity for G4 over duplex DNA, indicated by its higher IRds than 
IRG4. The selectivity of CP6 was worse than TO, suggested by the relatively higher 
IRds/IRG4 ratio (Table 4-5). This observation is highly consistent with the results of 
fluorometric titration, except for CP3 which was not studied by fluorometric titration due 
to the low quantum yield. These data further confirmed that the pyrrolidine side chain of 
CP9 enhances a moderate selectivity for G-quadruplex over duplex DNA. The overall 
rank order for the strength of G4 binding is CP9 > CP3 > TO > CP6 and the rank order 
for the strength of duplex DNA binding is CP9 > TO > CP3 > CP6. It is noteworthy that 
the binding of CP6 could be underestimated because of its multiple positive charges as 
stated in the previous sections.
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Figure 4-17. Comparison of IRG4 and IRds values of TO and derivatives. 
 




4.3.5. Thiazole orange derivatives form complexes with human telomeric G-
quadruplexes with various binding modes. The binding modes of TO derivatives with 
the G-quadruplex DNA were further investigated by studying the gas-phase dissociation 
 Compound TO CP3 CP6 CP9 
 IR-ds/IR-G4 1.15 0.56 1.30 0.91 
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behavior using the High Energy Collision Dissociation (HCD). Since CP9 gave the most 
abundant complex ions in the ESI-MS spectra amongst all compounds, we chose CP9 as 
a representative compound to demonstrate the binding modes. The study of the binding 
mode of G4 ligands is based on previously reported collisional activated dissociation 
(CAD) behaviors of the ligand-G-quadruplex complexes. The conclusions from this 
report are as follows. A ligand with a low binding affinity can easily dissociate from the 
G-quadruplexes at a relatively low collision energy and produces an intact G-quadruplex 
(three G-quartets) with two NH4
+ ions. In gas phase, G-quartets stacking ligands are often 
observed for this dissociation behavior. By contrast, a strong ligand will be retained on 
the G-quadruplex even when a high collision energy is applied. Usually, the loss of 
guanine nucleobase(s) will happen before the strong ligand dissociates from the 
oligonucleotide. If the ligand is a groove binder, the G-quadruplex complex can fully or 
partially unfold into a complex structure with the groove binder attached, which can be 
detected in the HCD. The distinct feature of the complex is that it has zero or one NH4
+ 
ions, instead of two NH4
+ ions as observed in the ligand-G-quadruplex complexes.240 
Meanwhile, some ligands form dimers to bind with the G-quadruplexes which should be 
taken into the considerations.241   
In the HCD experiments, the energy-dependent product ion spectra for 1-1, 1-2 
and 1-3 G4-ligand complexes were obtained at the collision energies of 5 and 10 arbitrary 
units (au), respectively. For clarity, the rule of annotations below will be used for all the 
spectra. The Greek letters α, β, and γ represent 1-1, 1-2 and 1-3 complexes, respectively; 
The symbol nN denotes the number of NH4
+ ions in the designated complexes. For 
example, γ2N represents a 1-3 complex with two NH4
+ ions. The symbols 0N and 1N 
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represent zero or one NH4
+ in the complexes. As indicated above, these two cases mostly 
reflect a unfolded or partially unfolded complex structure (not an intact G-quadruplex 
secondary structure). The possible fragment pathways of G4-CP9 complexes were 
proposed based on the patterns we observed in MS/MS spectra, which will be explained 











Figure 4-19. Energy dependent product ion spectra of G4-CP9 1-3 complexes (γ2N). 
From top to bottom: a) ESI-MS spectrum of a solution containing CP9 and G4; MS/MS 
product ion spectra of G4-CP9 [1-3] complexes at the collision energy of b) 5 au and c) 




In this experiment, the 1-3 complexes γ2N [3CP9+G+2NH4
+-7H]5- at m/z 1726.57 
were isolated and collisionally activated at the energy of 5 au (Figure 4-19a). As 
expected, the relative intensity of the precursor ion decreased to 24.13% compared with 
the base peak (Figure 4-19b). The dissociation of the ligand yielded a 1-2 complex β2N 
[2CP9+G+2NH4
+ -7H]5- at m/z 1637.71 (Figure 4-19b). The presence of two NH4
+ ions 
suggested that this was a complex between two ligands and one intact G-quadruplex. In 
addition, the binding of the lost ligand was relatively weak. The binding of the remaining 
two ligands was stronger than the dissociated one; otherwise, we would observe a 1-1 
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complex or fully dissociated complex. The binding mode of the dissociated ligand could 
be end-stacking. It was reported that a G-quartets stacking ligand has relatively low 
affinity in the gas phase and even the strongest stacking ligand can be easily removed 
from the G-quadruplex at a low collision energy in MS/MS.240 Under the HCD condition 
at the 5 au collision energy, β2N further dissociated into β1N [2CP9+G+NH4
+-6H]5- at 
m/z 1634.33 and β0N [2CP9+G-5H]5- at m/z 1630.94. The binding mode of the remaining 
two ligands could be groove binding because β1N and β0N both contained unfolded or 
partially folded G-quadruplexes. No observation of the 1-1 complex in the HCD 
experiment also supported this conclusion (step c and d in Figure 4-18).  
The binding mode of the third ligand could also be groove binding. There were 
also 1-3 complexes γ1N [3CP9+G+NH4
+-6H]5- at m/z 1723.15 and γ0N [3CP9+G-5H]5- 
at m/z 1719.75 present in the product ions of 1-3 complexes at the 5 au energy level. 
These product ions were produced by a precursor 1-3 complexes with three strong groove 
binders (γ2N* in Figure 4-18). Three groove binders bind to the G-quadruplex with a 
high affinity and they were all retained on the unfolded G-quadruplex (Step e and f in 
Figure 4-18). The evidence for three groove binders also came from the HCD experiment 
of γ2N [3CP9+G+2NH4
+-7H]5- with the collision energy of 10 au (Figure 4-19c). Under 
this condition, G-quadruplex fully dissociated, forming a complex ion γ0N [3CP9+G-
5H]5- at m/z 1719.75 with no NH4
+ ions. The complex ion β0N [2CP9+G-5H]5- at m/z 
1630.93 became the dominant peak amongst the complex ions containing two ligands and 
DNA. Almost no 1-1 complex or free G-quadruplex was observed with the collision 
energy of 10 au, further suggesting that two or three ligands of the 1-3 complexes had a 




Figure 4-20. Energy dependent product ion spectra of G4-CP9 1-2 complexes (β2N). 
From top to bottom: a) ESI-MS spectrum of a solution containing CP9 and G4; MS/MS 
product ion spectra of G4-CP9 [1-2] complexes at the collision energy of b) 5 au and c) 




1-2 complexes with two NH4
+ ions β2N [2CP9+G+2NH4
+-7H]5- at m/z 1637.53 
were also isolated and collisional activated at the energy of 5 au (Figure 4-20a). No 
precursor ions were observed at the 5 au collision energy (Figure 4-20b). The dissociation 
pattern was similar to that of 1-2 product complexes in the HCD experiments of 1-3 
complexes. At both energy levels, peaks representing 1-1 complexes were observed with 
very low abundance. With the collision energy of 10 au, only β0N [2CP9+G-5H]5- at m/z 
1630.93 was observed as the dominant peak, suggesting two groove binders present in 
the parent ion. The low abundance of α2N[CP9+G+2NH4
+-7H]5- at m/z 1545.08 
represented a complex formed between an intact G-quadruplex and one CP9 that strongly 
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binds to G-quadruplex via groove binding (step d and k in Figure 4-18).   
Interestingly, at the 10 au collision energy, a fragment ion at m/z 1600.89 was 
observed, representing the loss of a guanine from the complex ion β0N [2CP9+G-5H]5- 
at m/z 1630.90 (step o and k in Figure 4-18). The same guanine loss fragment pathway 
was previously reported for several other strong G4 ligands especially those with 
positively charged side chains.242 This observation indicated that the groove binding of 
CP9 was remarkably strong and will be retained by the oligonucleotide even when the 
fragmentation of DNA occurred.  
 
 
Figure 4-21. Energy dependent product ion spectra of G4-CP9 1-1 complexes (α2N). 
From top to bottom: a) ESI-MS spectrum of a solution containing CP9 and PCG1; 
MS/MS product ion spectra of G4-CP9 [1-1] complexes at the collision energy of b) 5 au 
and c) 10 au. α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes; nN, n=the number 
NH4
+ ions.  
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The 1-1 complexes α2N [1CP9+G+2NH4
+-7H]5- at m/z 1548.75 were isolated and 
activated at the 5 au collision energy (Figure 4-21a). The single ligand CP9 remained 
associated with the DNA, but all the secondary G-quadruplex structures were unfolded to 
give α0N [1CP9+G-5H]5- at m/z 1541.89 (step m in Figure 4-18) (Figure 4-21b). At the 
10 au collision energy, α0N still remained as the most abundant peak. There was still no 
free G-quadruplex was produced but instead, many fragment ions were observed (Figure 
4-21c). The major peak was a guanine loss fragment ion at m/z 1512 that was produced 
from the ion α0N [1CP9+G-5H]5- m/z 1541.89 (step n in Figure 4-18).  
Based on all the results from the HCD experiments of CP9, we can reasonably 
conclude that three CP9 molecules could bind to the G-quadruplex. Two of them have 
stronger binding affinities than the third one. The binding of the third CP9 to the G-
quadruplex could be either end stacking or groove binding or both. Therefore, the 
complexes formed by CP9 with different binding modes in the same solution may exist. 
Such complexes cannot be differentiated via m/z values. Two CP9 molecules with 
stronger binding affinities could also bind to the G-quadruplex via different modes. They 
can bind to the G-quadruplex in two separate grooves with similar interactions. It is also 
possible that they bind to the same groove of the G-quadruplex as a dimeric form. The 
binding of DNA by cyanine dimers have been previously reported.243 Nevertheless, the 
binding affinities of these two CP9 molecules should be similar because the dissociation 
of one CP9 from the 1-2 complex was minimal in the HCD experiments. 
There is a noteworthy discrepancy between ESI-MS and fluorometric titration 
experiments (section 4.3.3). MS/MS suggested multiple binding sites for CP9, while only 
1-1 binding mode was observed in the fluorometric titration experiments. In a 
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fluorometric titration, the emission of the fluorescence majorly comes from the stacking 
of the ligand to the G-quadruplexes. The groove binders does not provide as efficient 
quantum yields as stacking ligands because the structure of bound groove binders is 
relatively flexible.188 For most of the derivatives and TO, the quantum yields from the 
groove binding were negligible. In addition, a perfect agreement between results from 
fluorescence and ESI-MS should not be expected due to the differences in experimental 
conditions. 
We further studied CP9 with an intermolecular G-quadruplex [d(T2G5T)]4(G5) to 
investigate the binding modes. Different from the human telomeric G-quadruplex PCG1 
(G4), G5 was formed by four short G-rich sequences (S1, 5’-TTGGGGGT-3’, 
MW=2496.70) containing five G-quartet layers. Therefore, four NH4
 + ions were 
incorporated in the structure. The use of the intermolecular G-quadruplex in a MS/MS 
study allows us to determine the nature of the complex ions. For instance, if the ligand 
non-selectively binds to DNA random coils, a complex ion (S1+ CP9) will be observed. 
If the ligand can bind to the G-quadruplex, only the complex ion (G5 +CP9) can be 
observed. Unlike the experiments using intramolecular G4, the m/z values of these two 
complex ions are drastically different. In addition, if a ligand adopts the intercalation 
mode, the ejection of NH4




Figure 4-22. Energy dependent product ion spectra of G5-CP9 complexes. From top to 
bottom: a) ESI-MS spectrum of a solution containing CP9 and G5; MS/MS product ion 
spectra of G5-CP9 [1-3] complexes at the collision energy of b) 2 au and c) 6 au; d) 
MS/MS product ion spectra of G5-CP9 [1-2] complexes at the collision energy of 10 au. 
α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes;  
 
 
The ESI-MS spectra revealed that CP9 predominantly binds to G5 with the ratio 
of 1-2 β [2CP9+G5+4NH4
+-10H]6- at m/z 1822.88 and 1-3 γ [3CP9+G5+4NH4
+-10H]6- at 
m/z 1896.91 (Figure 4-22 a). A small amount of 1-1 α [CP9+G5+4NH4
+-10H]6- at m/z 
1748.68 was also present. No free G5 was observed, suggesting the strong binding 
affinity of CP9. Different from the binding of CP9 with G4, no ion peaks representing 
partially folded or unfolded G-quadruplexes were present in the spectra. All the G-
quadruplex exist as intact G-quadruplex with four NH4
+ ions.  
194 
 
The complex ion 1-3 γ [3CP9+G5+4NH4
+-10H]6- at m/z 1896.91 was isolated and 
subjected to the collision-activated dissociation at the energy of 2 au (Figure 4-22b). 
Removal of one CP9 ligand from the λ ion yielded a 1-2 complex β [2CP9+G5+4NH4
+-
10H]6-. The 1-1 complex, free G-quadruplex and S1 strand were not observed in the 
product ions. A similar spectrum was obtained even when the collisional energy increased 
to 6 au (Figure 4-22c). This observation suggested that, consistent with previous results 
of CP9 binding with G4, one of the ligands in the 1-3 complex has a relatively low 
binding affinity as compared to other two bound CP9. 
The 1-2 complex β [2CP9+G5+4NH4
+-10H]6- at m/z 1822.88 was also isolated 
and subjected to the collision-activated dissociation at a relatively high energy (10 au) 
(Figure 4-22d). No 1-1 complex or free G5 was observed, indicating a remarkably strong 
binding of these two ligands. The base peak was at m/z 1722.03. Based on the charge 
state and the m/z value, it represents the complex ion resulting from the loss of a 
thymidine (nucleotide) from the  ion. The exact mechanism of the loss of thymine 
remains unclear to us at this point. Interestingly, reanalyzing the ESI-MS spectra obtained 
from the HCD experiment of the CP9-G4 mixture showed a similar ion with a very low 
intensity. Apparently, the loss of thymidine from G5 is much easier than that from G4 
probably because the thymidines in G5 are more accessible (located at the both ends of 
the sequence). The intramolecular G4 only has one thymine at the end, and its 
accessibility is restricted by the loops on top of the G-quartets.  
Among the product ions of 1-2 complexes, the ions representing S1 single strand 
[S1-3H]3- at m/z 830.81 and [S1-2H]2- at m/z 1247.22 were observed. Interestingly, these 
two strands were found as free oligonucleotides without the association of any ligands. 
195 
 
The sequence of S1 is too short to form certain secondary structures for the binding of 
CP9.  
All the CP9 containing ions in the spectra have all four NH4
+ ions. It was reported 
that only ligands intercalating to the G-quadruplex can expel NH4
+ ions from the G-
quadruplex.140, 244 The preserved NH4
+ ions indicated that CP9 must adopt groove 
binding and/or end stacking mode.  
4.3.6. Thiazole orange derivatives inhibited the telomerase activity in vitro. 
Since significant human telomeric G-quadruplex binding was discovered by different 
biophysical methods for the TO derivatives, inhibition of telomerase-mediated telomere 
extension was studied by a modified 32P-TRAP assay as illustrated in section 3.3.5.  
Firstly, the concentration-dependent telomerase inhibition of TO was examined 
(Figure 4-23) and inhibition of telomerase was observed when its concentration was 
larger than 6.25 µM. To compare the telomerase inhibition of TO derivatives to TO, 6.25 





Figure 4-23. 32P-TRAP reactions in the presence of TO at concentrations of 50, 25, 12.5, 
6.25, 3.125, 1.56, 0.78 and 0.39 µM (from left to right). Reactions in the presence BIBR 
(50 μM) and TMPyP4 (50 μM) were carried out as controls. IS: Internal Standard (TSNT 
as template). 
 
For aliphatic amine side chain containing compounds CP1, CP2, and CP3, 
telomerase inhibition effect increased with the increasing length of the aliphatic side 
chains. CP3 exhibited a higher inhibition effect compared to TO at the same 
concentration. This observation is in agreement with the results from our previous 
biophysical studies. Hydrophobic side chains cannot provide sufficient interactions for 
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the ligands binding. However, a better inhibition effect can be observed when the length 
of the side chain is long enough to accommodate the terminal positive charge to the DNA 
phosphate backbones.  
Polyamine side chain containing compounds CP4, CP5 and CP6 exhibited the 
best inhibition effects amongst all twelve derivatives. At 6.25 µM CP6 inhibited both 
telomerase elongation and polymerase replication activity. Thus, a concentration-
dependent study was necessary for CP6 for the reason explained in section 3.3.5.  
Similar to our previous conclusions, CP7 and CP8 with polyethylene glycol 
amine side chains and TO acid did not inhibit telomerase activity at 6.25 µM. The 
electron-rich oxygen atoms in polyethylene glycol, and carboxylic acid group in TO acid 
have the repulsive force with the DNA negatively charged backbones.  
Piperidine/pyrrolidine side chains containing compounds CP9, CP10, CP11 and 
CP12 inhibited telomerase activity at various levels. CP9, with a pyrrolidine side chain 
was the best inhibitor amongst these four ligands which was consistent with the previous 
results. Our observations suggested again that pyrrolidine rings had a better G-quadruplex 
stabilization compared to piperidine rings.228 CP11 and CP12 showed less inhibition 





Figure 4-24. 32P TRAP reactions in the presence of TO derivatives at a concentration of 
6.25 µM. Reactions in the presence BIBR (50 μM), TMPyP4 (50 μM) were carried out as 
controls. IS: PCR product as internal standard (TSNT as template). 
 
We conducted concentration studies for the effective compounds including CP4, 
CP5, CP6, CP9, CP10, CP11 and CP12. The minimum inhibitory concentration for CP4 
and CP5 were 0.63 µM and 1.25 µM respectively (Figure 4-25), which were significantly 






Figure 4-25. 32P TRAP reactions in the presence of CP4 (left) and CP5 (right) at 
concentrations of 10, 5, 2.5, 1.25, and 0.625 µM (from left to right). Reactions in the 
presence BIBR (50 μM) and TMPyP4 (50 μM) were carried out as controls. IS: PCR 
product as internal standard (TSNT as template). 
 
CP6 showed the strongest inhibitory effect on telomerase activity. The minimum 
inhibitory concentration was determined as 0.16 µM which was significantly lower than 
TO. It is noteworthy that, CP6 adopted a similar structure of polyamine molecule 
spermine. The minimum telomerase inhibitory concentration of spermine that determined 
by the same assay was higher than 10 µM (Figure 4-26). Therefore, the significant G-
quadruplex binding and telomerase inhibition effect of CP6 resulted from the synergistic 




Figure 4-26. 32P TRAP reactions in the presence of CP6 at concentrations of 10, 5, 2.5, 
1.25, 0.625, 0.313, 0.156, and 0.078 µM (from left to right). Reactions in the presence 
BIBR (50 μM), TMPyP4 (50 μM) and spermine (100 and 10 μM) were carried out as 
controls. IS: PCR product as internal standard (TSNT as template). 
 
Because of the observed remarkable telomerase inhibition effect of CP6, we 
compared its activity with one of the best synthetic telomerase inhibitors BRACO-19155, 





Figure 4-27. 32P TRAP reactions in the presence of BRACO-19 (left) and CP6 (right) at 
concentrations of 10, 2.5, 0.625, 0.156 and 0.039 µM (from left to right). Reactions in the 
presence BIBR (50 μM) and TMPyP4 (50 μM) were carried out as controls. IS: PCR 
product as internal standard (TSNT as template). 
 
The results suggested that CP6 had a slightly better inhibition effect compared to 
BRACO-19. At the minimum inhibitory concentration of 0.625 µM, the reaction in the 
presence of CP6 produced less abundant telomerase elongated products than the reaction 
in the presence of BRACO-19. However, CP6 had slightly worse selectivity compared to 
BRACO-19. At the concentration of 10 µM, CP6 had a stronger inhibition effect for the 
polymerase replication.  
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Concentration-dependent studies were also performed for CP9, CP10, CP11 and 
CP12 (Figure 4-28). CP9 (minimum inhibitory concentration 1.25 µM) exhibited the 
strongest inhibition effect among these four ligands but not as good as CP6, and this 
observation is highly consistent with the results of CD thermal denaturation and 
fluorometric titration experiments. The minimum inhibitory concentrations were around -
2.5 µM for CP10, CP11, and CP12. Since piperidine and pyrrolidine side chains were 
incorporated into these compounds, PIPER, a known G4 ligand with a similar piperidine 
side chain, was examined under the same conditions. At 10 µM, all four TO derivatives 
exhibited much greater telomerase activity inhibition than PIPER.   
 
 
Figure 4-28. 32P TRAP reactions in the presence of CP9, CP10, CP11 and CP12 (from left 
to right) at concentrations of 10, 5, 2.5, 1.25, and 0.625 µM (from left to right). Reactions 
in the presence PIPER (10 μM), BIBR (50 μM) and TMPyP4 (50 μM) were carried out as 
controls. IS: PCR product as internal standard (TSNT as template). 
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Overall, the TRAP assay clearly showed that the TO derivative CP6 containing a 
polyamine side chain shows excellent inhibition of telomerase activity at a nanomolar 
concentration which is comparable to the best developed synthetic telomerase inhibitor 
BRACO-19. Conjugating with polyamine side chains at the nitrogen of the quinoline ring 
remarkably improved the telomerase inhibition activity of TO and this activity is a 
synergistic effect from the aromatic stacking of TO core structure and the electrostatic 
interaction from the charged side chain. TO is a suitable scaffold for developing more 
potent G4 ligands in the future.     
4.3.7. Positively charged side chains decrease the cytotoxicity of thiazole 
orange. TO was originally developed as a DNA dye for reticulocyte count in a flow 
cytometry. One of the advantages of TO being a live-cell dye is its good cell membrane 
diffusion ability, which is also one of the reasons that it was chosen as the core structure 
in the present research. After discovering the remarkable telomerase inhibition effect of 
CP6 by the TRAP assay, we investigated the cytotoxicity of twelve derivatives against 
two telomerase-positive cancer cell lines: HeLa (cervical cancer) and MCF-7 (breast 
cancer).  
At the concentration of 100 µM, TO was found with cell viability of 20.22% for 
HeLa and 40.09% for MCF-7. However, all our TO derivatives exhibited a lower 
cytotoxicity value compared to TO (Figure 4-29).  
This decreased cytotoxicity was closely related to the high polarity of the 
molecules and the consequent low uptake efficiency. Although there are some native 
endogenous polar molecules like polyamine present in living cells and can be transported 
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into the cell nucleus, specific transport proteins have to be recruited by cells helping them 
to pass through the cell membrane.246 The positively charged side chains increase the 
polarity of the compounds and consequently decrease their cell membrane diffusion 
efficiency.219 Thus, these TO derivatives cannot easily reach the cell nucleus where the 
telomeres and telomerase are located. In order to develop these good TO based 
telomerase inhibitors into anti-cancer drugs, we propose to explore the drug delivery 




Figure 4-29. Cell proliferation of two cancer cell lines treated by TO derivatives at 100 





Twelve newly synthesized TO derivatives with positively charged side chains at 
the nitrogen of quinoline ring were evaluated by various biophysical techniques for their 
G-quadruplex DNA stabilization effects. Marked stabilization effects against human 
telomeric G-quadruplexes were found for two of the derivatives with either a polyamine 
side chain(CP6) or a pyrroline side chain(CP9). In contrast to TO, these TO derivatives 
form 1-1, 1-2 and 1-3 complexes with a human telomeric G-quadruplex with both 
stacking and groove binding modes. The binding affinity was significantly enhanced by 
these positively charged side chains through electrostatic interactions with DNA 
backbones.  
In the TRAP assay, CP6 exhibited remarkable telomerase inhibition effect 
comparable to BRACO-19, which is the most potent synthetic telomerase inhibitor. 
Elongation of telomeric DNA by telomerase was significantly inhibited at nanomolar 
concentrations by CP6.  
Introducing positively charged side chains to TO decreased the cytotoxicity due 
to the higher polarity of the molecules. To utilize CP6, as a strong G4 ligand and 
telomerase inhibitor, we will explore suitable drug delivery systems. TO derivatives have 
slightly lower quantum yields compared with TO when they bind to DNA. However, the 
quantum yields of these compounds are still much higher than other fluorescent G4 
ligands; therefore, it is still feasible to use these compounds as highly sensitive G-
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Figure A-1. MS spectrum of Phen12-Ni_50% MeOH 
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Figure A-3. MS spectrum of Phen18-Ni_50% MeOH 
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Figure A-4. MS spectrum of Phen20-Ni_50% MeOH. 
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Figure A-6. FID G4 titration course of 5-substituted Phen Ni(II) complexes. 














































































































Figure A-7. dsDC50 plots for Phen-Ni  






































 Figure A-8. G4DC50 plots for 13, 20 and 21 in the absence of Ni. 





































































































































































































































































































































































































































































































































Figure A-11. Fluorometric titration of TO derivatives against a duplex 17mer. 
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